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ABSTRACT 
Several bacterial pathogens persist and survive in the host by modulating 
host cell death pathways. Previous studies have demonstrated that the sexually 
transmitted pathogen, Neisseria gonorrhoeae, can induce or inhibit host cell 
death. N. gonorrhoeae is a mucosal pathogen and, in females, initiates infection 
in epithelial cells of the ectocervix and endocervix. Mucosal epithelial cells of the 
female genital tract are the first line of defense, and thus their cellular fate can 
alter the early immune response to invading pathogens such as N. gonorrhoeae.  
The mechanisms by which N. gonorrhoeae modulates cell death are not clear, 
although a role for the inhibitor of apoptosis-2 (cIAP2) has been proposed. In the 
present study, we demonstrate that N. gonorrhoeae stimulation induces a 
transient increase in cIAP2 protein levels in human cervical epithelial cells. High 
intracellular protein levels were observed during early N. gonorrhoeae stimulation 
and were followed by a marked intracellular decrease at 24 h. At this time point, 
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we observed increased levels of extracellular cIAP2 associated with exosomes, 
which are nano-sized vesicles that carry protein and coding RNA as cargo from 
one cell to another. We also observed that depletion of cIAP2 in N. gonorrhoeae 
stimulated cells resulted in cell death resembling necroptosis, an inflammatory 
form of cell death. Furthermore, inhibition of cIAP2 led to an increase in 
interleukin-1β production. Exosomes have been found to have important roles in 
cell communication during microbial infection. Here, we demonstrate that N. 
gonorrhoeae induces exosome production and alters exosome content. We also 
demonstrate that exosomes elicit cytokine responses in uninfected naïve cells. 
Collectively, these studies highlight an additional mechanism for epithelial cells to 
orchestrate the immune response in the female genital tract during N. 
gonorrhoeae infection. 
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Chapter 1 Introduction 	  
Neisseria gonorrhoeae epidemiology 
Neisseria gonorrhoeae is a gram-negative diplococcus responsible for the 
sexually transmitted infection (STI), gonorrhea. Gonorrhea is the second most 
common reportable disease and in 2014, there were 331,000 reported cases in 
the U.S. Due to underreporting, the total number is estimated to be 800,000 
annually in the U.S. (Centers for Disease Control and Prevention) and 106 million 
cases worldwide (Organization, 2011). Besides infection with N. gonorrhoeae, 
many patients reporting to STI clinics with symptoms of gonorrhea may be 
suffering from co-infections with one or more organisms. In the U.S., 
approximately 40% of patients with gonorrhea are co-infected with Chlamydia 
trachomatis (Kahn et al., 2005). N. gonorrhoeae has a history of developing 
antimicrobial resistance. Since the introduction of antimicrobials, N. gonorrhoeae 
has become resistant to nearly every antibiotic used, narrowing the list of CDC 
recommended treatments to only include cephalosporins in 2007 (CDC, 2007, 
Kirkcaldy et al., 2013). Unfortunately, the recent emergence of cephalosporin-
resistant N. gonorrhoeae has further complicated therapeutic strategies (CDC, 
2011, Ohnishi et al., 2011, Unemo et al., 2012). In 2013, the CDC reported that 
antibiotic-resistant N. gonorrhoeae was a major cause for concern in the U.S. 
and abroad, and a recent study has described cephalosporin-resistant N. 
gonorrhoeae in the U.S. (Nguyen et al., 2014a). 
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Clinical aspects of N. gonorrhoeae infection 
N. gonorrhoeae infection begins at mucosal surfaces. While the most 
common sites of infection are the male and female urogenital tract (Mayor et al., 
2012), N. gonorrhoeae also actively infects anorectal and oralpharyngeal sites 
(Morris et al., 2006, van Liere et al., 2014). Anorectal and oralpharyngeal sites 
are most commonly identified in men who have sex with men and high-risk 
females, such as female sex workers (Kent et al., 2005, Giannini et al., 2010). 
Because infections of these anatomical sites are often asymptomatic, it may be 
unsurprising that these infections are often overlooked in STI screening and 
therefore undertreated (Lewis, 2015, van Liere et al., 2014). Antimicrobial 
resistant N. gonorrhoeae is more prevalent and more difficult to treat in the 
pharynx (Moran, 1995, Gratrix et al., 2013, Lewis, 2015). It is postulated that 
oralpharyngeal N. gonorrhoeae acquires antimicrobial resistance via horizontal 
gene transfer from commensal Neisseria species that have been previously 
exposed to antibiotics (Qvarnström and Swedberg, 2002, Osaka et al., 2008). 
However a recent survey is the U.S. cited no significant difference in 
cephalosporin susceptibility between anatomical sites (Kidd et al., 2015). 
Whether or not oralpharyngeal gonococcal infections are more antibiotic 
resistance, they propagate infection to urogenital sites and therefore a call has 
been made for thorough anatomical testing in the clinic (Garner et al., 2015). 
Similar to oralpharyngeal gonococcal infections, infection of the female 
genital tract (FGT) is also predominantly asymptomatic (Edwards and Apicella, 
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2004, Mayor et al., 2012), however, an untreated infection of the FGT has far 
greater consequences. Untreated infection in females can result in inflammation 
of the cervix and fallopian tubes, or the more general syndrome, pelvic 
inflammatory disease, which can lead to scarring and infertility (Soper, 2010). 
Moreover, efficiency of transmission from males to females is greater than vice 
versa. This phenomenon is likely due to female anatomy that allows for extended 
contact between the bacterium and epithelium (Edwards and Apicella, 2004). In 
contrast to FGT infections, male urogenital infections are clinically symptomatic 
and result in a robust urethral inflammatory response. In the clinic, males often 
present with purulent urethral discharge, which is associated with neutrophil 
influx and shedding of urethral epithelial cells (Edwards and Apicella, 2004). 
Although rare, an untreated male infection can ascend the urethra causing 
epididymitis (Trojian et al., 2009). In both males and females, untreated 
gonorrhea can also lead to disseminated gonoccocal infection in the joints and 
skin (Cohen and Sparling, 1992). Finally urogenital infections in both males and 
females enhance transmission of other STIs such as HIV (Jarvis and Chang, 
2012, Cohen et al., 1997). 
Differences in disease manifestation between males and females have been 
suggested to be molecular, anatomical and even psychological, as female 
discharge is not as striking to a female as male discharge is to a male. 
Gonococcal infection of the female genital tract is localized to the cervix, in both 
endocervical and ectocervical epithelial cells, and to the urethra in males (Cohen 
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and Sparling, 1992). On the molecular level, N. gonorrhoeae utilizes different 
epithelial receptors in male versus female cells during infection as well as 
different virulence factors (Table 1) (Edwards and Apicella, 2004). During 
infection of cervical cells, the primary interaction is between the N. gonorrhoeae 
opacity-associated proteins (Opa) and the epithelial  carcinoembryonic antigen-
related  family of cell adhesion molecules (CEACAM) (Sadarangani and Pollard, 
2011). Male urethral cells do not express CEACAM. Instead, there is a strong 
association between urethral asialoglycoprotein receptor and gonococcal lipo-
oligosaccharide (LOS) (gonococcal lipopolysaccharide (LPS)) (Harvey et al., 
2001). Several studies have demonstrated that N. gonorrhoeae can form 
protective biofilms in vitro as well as during in vivo infection in women, while this 
phenomenon has not yet been demonstrated in males (Steichen et al., 2008). 
In addition to the differences described above, the male and female 
genital tract host distinct commensal microbiomes. The FGT has a robust and 
diverse microbiome with over 250 identified microbial species in white females 
(Brotman et al., 2014, Ravel et al., 2011). A healthy male urethral tract has fewer 
microbial species but does harbor several bacterial genera including Lactobacilli, 
Sneathia, Veillonella, Corynebacterium, Prevotella, and Streptococcus (Dong et 
al., 2011, Nelson et al., 2012). In contrast to males, the FGT has a higher 
proportion of Lactobacilli and Gardnerella species (Nikolaitchouk et al., 2008b, 
Petrova et al., 2015), which protect the female host by lowering the pH of the 
vagina and competing for nutrients. 
	  5 
Table 1. Virulence factors of N. gonorrhoeae 
Virulence factor Function in N. gonorrhoeae 
LOS (Burch et al., 1997) Gonococcal LPS and adhesin 
Porin (Gotschlich et al., 1987) Ion exchange channels 
Opacity-associated proteins 
(Opa) (Dehio et al., 1998) 
Adhesin 
Pili (Källström et al., 2001) Bacterial fimbriae 
Lip (Woods et al., 1989) Outermembrane lipoprotein 
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 For example, in vitro studies have demonstrated Lactobacilli restrict 
growth of N. gonorrhoeae (Spurbeck and Arvidson, 2010, Graver and Wade, 
2011a). Though knowledge of microbiota and their influence on STIs is still in its 
infancy, it is clear that microbiomes help generate distinct environments and 
likely contribute to differences in gonococcal disease pathogenesis between 
sexes. 
 
Induction of innate immune responses by N. gonorrhoeae 
The immune response during N. gonorrhoeae infection of the genital tract 
begins with epithelial cell activation and the production of pro-inflammatory 
cytokines. Cytokines recruit immune cells [i.e. macrophages, dendritic cells, 
natural killer cells and polymorphonuclear neutrophils (PMNs)] to the site of 
infection. These immune cells contribute to clearance of N. gonorrhoeae through 
phagocytosis and, in some cases, degradation of bacteria. In gonorrhea and 
other STIs, PMNs are primarily responsible for the characteristic purulent 
discharge often associated with the disease (Criss and Seifert, 2012). Induction 
of adaptive immune responses and production of inflammatory mediators by 
professional immune cells amplify pathogen clearance. 
 The first step in gonococcal infection is colonization of the mucosal 
epithelium. Depending on the mucosal site, N. gonorrhoeae employs several 
virulence factors for attachment and invasion of epithelial cells. These 
outermembrane factors include pili (bacterial fimbriae), porins (ion exchange 
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channels), Opa proteins (adhesins) and LOS (gonococcal LPS and adhesin) 
(Table 1). Pili initiate contact with epithelial cells via binding to CD46, a 
complement protein expressed on the cell surface (Källström et al., 2001). Once 
attached, pili act on host cells by upregulating pathways involved in endocytosis 
(Lee et al., 2005) and releasing intracellular stores of Ca2+, which promotes 
bacterial intracellular survival (Ayala et al., 2001). The bacterium then retracts the 
pili, pulling itself closer to the epithelial cell so that either Opa proteins or LOS 
may mediate a more intimate attachment for subsequent internalization (Harvey 
et al., 1997, Merz and So, 2000). Human studies support the importance of pilin 
and Opa proteins: only piliated bacteria produced symptomatic disease in male 
volunteers (Blake and Swanson, 1978) and the majority of infecting strains 
isolated from both males and females express Opa proteins (Jerse et al., 1994, 
McClure et al., 2015). The importance of Opa proteins has also been determined 
in vitro as evidenced by the number of Opa proteins expressed and the intricate 
manner in which N. gonorrhoeae controls their expression. The 11 distinct Opa 
genes, OpaA-OpaK, are regulated by antigenic variation so that at any given time 
either none, several or all Opa proteins may be expressed and rapidly switched 
(Dehio et al., 1998, Hauck and Meyer, 2003). However, it should be noted that in 
vitro studies have demonstrated that porin, specifically PorB(IA), can mediate 
Opa-independent invasion as well (Bauer et al., 1999, Kühlewein et al., 2006).  
 Through in vitro studies, we have an understanding of how the 
gonococcus invades the epithelium during infection. Following attachment to 
	  8 
epithelial cells, the actin skeleton of the epithelial cell rearranges to form 
membrane protrusions, or ruffles, around the gonococci (Edwards et al., 2000). 
These epithelial ruffles internalize the bacteria within macropinosomes. Following 
internalization, the bacteria reside within vacuoles or within the cytoplasm near 
the apical side of the cell (Evans, 1977). N. gonorrhoeae cleaves lysosomal 
proteins, thereby avoiding lysosomal degradation and thus facilitating survival 
(Lin et al., 1997). Bacteria replicate in this intracellular niche (Shaw and Falkow, 
1988, Criss and Seifert, 2006) before exiting the cell either into the subepithelial 
matrix or recycling back to the apical surface (Ayala et al., 1998, Edwards et al., 
2000, L. et al., 2005). It is postulated that transcytosis through the cervical 
epithelium may promote invasion of sub-mucosal tissues, whereas recycling of 
the gonococci to the apical cell surface could generate biofilm formation and lead 
to ascension to the upper FGT (Edwards and Butler, 2011).  
 As determined from both human and in vitro studies, attachment and 
invasion of epithelial cells produces inflammatory mediators, such as tumor 
necrosis factor-alpha (TNFα), interleukin (IL)-6, IL-8 and IL-1β, which initiate and 
direct the innate immune response during gonococcal infection (Ramsey et al., 
1995, Hedges et al., 1998, Fichorova et al., 2001). Pro-inflammatory cytokine 
and chemokine production in response to N. gonorrhoeae has been 
demonstrated in both males and females, with males having a more robust 
cytokine profile than females (Ramsey et al., 1995, Hedges et al., 1998). In 
gonococcal infected men, IL-6, IL-8, IL-1β and TNF-α were detected in urine and 
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serum (Ramsey et al., 1995), while in females with N. gonorrhoeae, cytokine 
production was not elevated in genital secretions and only serum IL-6 was found 
to be elevated (Hedges et al., 1998). These findings propagated the notion that 
N. gonorrhoeae causes a non-inflammatory response in the FGT; however, more 
recent studies have demonstrated the contrary. In a cross-sectional study of 
women at high-risk for HIV, Masson et al. found N. gonorrhoeae to be the second 
most inflammatory STI when compared to Chlamydia trachomatis, bacterial 
vaginosis, Mycoplasma genitalium, herpes simplex virus, Trichomoniasis 
vaginalis and syphilis (Treponema pallidum) (Masson et al., 2014). N. 
gonorrhoeae infection lead to significantly elevated levels of IL-1α,   IL-1β,   IL-
12p70, TNF-α, IL-2, IL-5, IL-15 and IL-17, TNF-β and eotaxin in a 10mL cervico-
vaginal lavage. Interestingly, elevated cytokine levels did not correspond to 
clinical symptoms, as only 15% of women had clinical signs of infection.  
In vitro data also support the notion that N. gonorrhoeae induces 
cytokines: both immortalized male and female epithelial cells secrete elevated IL-
6, IL-8, IL-1β and TNF-α in response to N. gonorrhoeae stimulation (Fichorova et 
al., 2001, Harvey et al., 2001). Other innate immune cells such as macrophages, 
dendritic cells and PMNs also secrete cytokines following N. gonorrhoeae 
stimulation. The production of cytokines is driven by recognition of gonococcal 
components by pathogen recognition receptors (PRRs) expressed on host cells. 
For example, it has been documented that gonococcal porins stimulate Toll-like 
receptor-2 (TLR2) (Philip et al., 2003, Massari et al., 2002), LOS stimulates TLR4 
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(Packiam et al., 2014) and TLR9 can recognize gonococcal CpG DNA motifs 
(Dobson-Belaire et al., 2010). N. gonorrhoeae can also induce cytokines through 
intracellular receptors such as the nucleotide-binding oligomerization domain 
(NOD) receptors (NLRs) NOD1/2 (Mavrogiorgos et al., 2014) and the NOD-like 
receptor family, pyrin domain containing 3 (NLRP3) inflammasome (Duncan et 
al., 2009). After TLR and NLR activation, signaling cascades eventually lead to 
activation of the transcription factor nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB), which in turn leads to cytokine production (Escobar et 
al., 2013). 
Inflammatory mediators released from epithelial cells recruit and activate 
innate immune phagocytes, such as PMNs and macrophages, to the site of 
infection for bacterial clearance (Svanborg et al., 1999). The migration of PMNs 
to the site of infection is well documented; both endothelial and epithelial cells 
increase surface adhesion markers for PMNs thereby traversing the endothelium 
and through the sub-epithelial tissues to the site of infection (Chin and Parkos, 
2007). Monocyte derived macrophages and dendritic cells follow a similar 
migration as PMNs, while resident sub-epithelial macrophages and dendritic cells 
respond more rapidly (Iijima et al., 2008). These cells are recruited to the site of 
infection, leading to phagocytosis and killing of the pathogen, however, N. 
gonorrhoeae has evolved to subvert their immune offense and survive. For 
example, one mechanism by which N. gonorrhoeae can resist phagocytosis is 
through variation of the antigenic surface structures and thus avoiding antibody-
	  11 
mediated opsonization (Virji, 2009). Yet even within PMNs, more than 80% of 
gonococci are viable due to the pathogen’s ability to delay apoptosis and quench 
reactive oxygen species during the PMN oxidative burst (Criss and Seifert, 2008, 
Chen and Seifert, 2011, Seib et al., 2004). In macrophages, the gonococcus can 
induce a tolerogenic phenotype (Escobar et al., 2013) and induce production of 
immunosuppressive molecules in dendritic cells (Zhu et al., 2012). Consequently, 
these alterations in macrophages and dendritic cells lead to a dampened CD4 T 
cell response. 
 
Neisseria gonorrhoeae and the adaptive immune response 
  N. gonorrhoeae elicits an adaptive immune response in both males and 
females as measured by the presence of antibodies against the gonococcus. IgG 
and IgA molecules directed against outer membrane components have been 
detected in infected urethral exudate from men and vaginal secretions from 
women (Lammel, 1989). Gonococcal antigens also have been found to direct the 
activation of T cells. In serum, circulating CD4 and CD8 T cells from patients with 
mucosal gonococcal disease, but not from normal volunteers, proliferated in 
response to porin (Simpson et al., 1999). In a mouse model, it was recently 
demonstrated that N. gonorrhoeae induces the Th17 pathway and inflammatory 
response (Liu et al., 2012). In contrast to the innate response, the adaptive 
response to N. gonorrhoeae infections is relatively poor. Despite the evidence of 
an adaptive response in humans, immunological memory is not generated and 
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the same individual can be re-infected multiple times (Fox et al., 1999, Schmidt 
et al., 2001, Jerse et al., 2014). Because one infecting strain does not offer 
protection against other gonococcal strains, several studies have sought to 
identify mechanisms by which the pathogen subverts the adaptive immune 
response.  
One possible evasion mechanism may be distortion of signals and antigen 
presentation to T cells by macrophages and dendritic cells (Zhu et al., 2012, 
Escobar et al., 2013). N. gonorrhoeae can also directly inactivate T cells and B 
cells (Boulton and Gray-Owen, 2002, Pantelic et al., 2005, Yingru and Michael, 
2011). Another means of evasion is high-frequency antigenic variation of outer 
membrane immunogenic targets; the rapid shift of exposed antigens prevents 
antibody binding (Shafer et al., 2002, Cohen and Sparling, 1992). Moreover, N. 
gonorrhoeae expresses an IgA1 protease that can inactivate certain classes of 
secretory IgA antibodies in mucosal secretions (Blake and Swanson, 1978). 
Interestingly, the intact antibodies that remain bound to the gonococcus protect 
the bacteria instead of the host. Studies carried out in vitro show that human IgA 
can coat individual gonococcal bacterium and offer a protective covering for the 
bacteria from other more functionally active antibodies such as IgG (Apicella et 
al., 1986, Rice et al., 1986).  
 
Female-specific epithelial cell model  
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N. gonorrhoeae is a human-specific pathogen and has no other known 
animal or environmental reservoir, therefore establishing a relevant animal model 
system has been difficult (Cohen and Sparling, 1992). Thus, studying gonococcal 
disease in the laboratory is restricted to human tissue and cell culture. Because 
N. gonorrhoeae can infect a variety of mucosal tissues (endocervix, ectocervix, 
male urethra, pharynx), it is critical to have site-specific cell models in the 
laboratory in order to thoroughly understand molecular mechanisms of disease 
pathogenesis (Edwards and Apicella, 2004). To understand N. gonorrhoeae 
infection in the FGT, our laboratory used previously generated immortalized 
endocervical and ectocervical epithelial cells (Fichorova et al., 1997). Our 
laboratory also established that these cell lines respond to exogenous cytokines 
and N. gonorrhoeae stimulation, making them a suitable and physiologically 
relevant model for the study of N. gonorrhoeae pathogenesis (Fichorova et al., 
2001, Fichorova et al., 2002, Follows et al., 2009). The work presented here 
utilized these immortalized endocervical epithelial cells.  
 
Epithelial cells in female genital tract mucosal immunity 
The mucosal epithelium of the FGT provides the first line of defense 
against sexually transmitted pathogenic bacteria and viruses. Epithelial cells are 
the orchestrators of the early innate immune response during mucosal infection 
of pathogenic bacteria or viruses (Quayle, 2002, Kim et al., 2010). Their primary 
function is to serve as a physical barrier against invading pathogens. The vaginal 
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and ectocervical mucosa consist of multiple layers of non-polarized squamous 
epithelial cells that are fused into a barrier by various intercellular junctions 
(Blaskewicz et al., 2011). These junctions help maintain the infrastructure of the 
epithelium and selectively regulate or restrict the trafficking of soluble molecules 
and cells (Kaul and Hirbod, 2010, Marchiando et al., 2010). The endocervical 
epithelium is also connected by intercellular junctions, but is instead comprised of 
a single layer of columnar epithelial cells. These columnar epithelial cells 
maintain an unyielding barrier via tight junctions in addition to the adherens 
junctions and desmosomes of the ectocervix and vagina (Blaskewicz et al., 
2011). The additional tight junctions of the endocervix polarize the columnar 
epithelial cells in an apical (towards the lumen) and basal (towards the basement 
membrane) orientation (Shin et al., 2006). This structural and functional 
orientation allows for directional signaling from the lumen to the cells residing in 
the basement membrane (Fahey et al., 2005). The tight junctions of the 
endocervix also create a more impermeable apical barrier compared to those of 
the ectocervix (Blaskewicz et al., 2011). As a barrier fortifier, epithelial cells 
secrete mucins, which are glycosylated proteins that form a thick gelatinous fluid 
known as mucus (Gipson et al., 1997). Cervico-vaginal mucus provides a 
physical layer between pathogen and epithelium (Lai et al., 2009). 
Besides their barrier function, epithelial cells participate in the immune 
response through secretion of soluble immune factors (Fichorova et al., 2001, 
Gribar et al., 2008). Epithelial cells in the FGT express pattern recognition 
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receptors including TLRs and NLRs that recognize conserved pathogen 
associated molecular patterns (PAMPs) on microorganisms (Hickey et al., 2011, 
Amjadi et al., 2014). Upon stimulation, pattern recognition receptors initiate 
immune signaling cascades within the epithelial cells that lead to the secretion of 
cytokines, chemokines and antimicrobial peptides. The released inflammatory 
mediators recruit immune cells to the site of infection and facilitate in pathogen 
removal. PRR ligation on epithelial cells may also lead to the secretion of 
antimicrobial peptides that function on a broad spectrum of bacteria, fungi and 
encapsulated viruses (McCormick and Weinberg, 2010, Stolzenberg et al., 1997, 
Canny et al., 2006, Ylva et al., 2007).  
Epithelial cells also have a minor role in the adaptive immune response as 
antigen presenting cells (Quayle, 2002, Wira et al., 2005). Epithelial cells can 
transport antigens from the lumen to professional antigen presenting cells such 
as macrophages and dendritic cells, which then process and present the antigen 
to T cells (Berin et al., 1997). In a more direct fashion, epithelial cells in the FGT 
can process and present antigens to T cells via expression of major 
histocompatibility complex class II (MHC) (Fahey et al., 2006).  
 
Programmed cell death  
Programmed cell death is a crucial process in immune cell homeostasis 
and pathogen clearance. The induction of cell death during microbial infection is 
a common defense strategy employed by host cells. Dying cells orchestrate an 
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immune response with minimal tissue damage by carefully regulating the release 
of inflammatory mediators. Since cell death and inflammation are tightly coupled, 
alterations in cell death can have consequences on the innate immune response 
(Rock and Kono, 2008, Wallach et al., 2014, Weng et al., 2014). Pathogens have 
evolved strategies to manipulate cell death signaling in favor of their own survival 
(Rudel et al., 2010, Lamkanfi and Dixit, 2010, Luo et al., 2015).  
Several pathways of cell death exist, each with distinct morphological and 
inflammatory outcomes (Figure 1). Apoptosis is a tightly regulated and 
genetically programmed process of cell death that removes damaged cells with 
minimal inflammation and collateral damage to surrounding cells. The process 
eliminates abnormal or infected host cells through signaling cascades of either 
the intrinsic or extrinsic pathways. The extrinsic pathway is initiated by ligation of 
cell death receptors such as TNFα and CD95/Fas, while the intrinsic pathway is 
initiated by intracellular stresses, such as genotoxic or nutrient stress (Green, 
2005). Both apoptosis pathways are dependent on cysteine-dependent 
aspartate-specific proteases known as caspases. The extrinsic initiator caspase 
is caspase-8 while the intrinsic initiator caspase is caspase-9. In both pathways, 
the initiating caspases converge on the mitochondria leading to mitochondrial 
depolarization and activation of the executioner caspases, caspase-3 and 
caspase-7.  
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Figure 1. Morphologies of distinct programmed cell death pathways during 
infection.  
Apoptosis remains immunologically silent because the cell maintains membrane 
integrity while organelles are carefully degraded and sealed from the extracellular 
environment due to cell blebbing into apoptotic bodies. Necroptosis and 
pyroptosis are inherently inflammatory because of cytokine production and 
rupture of the plasma membrane, which leaks cytoplasmic contents known as 
danger associated molecular patterns (DAMPs). Apoptosis and pyroptosis both 
lead to nuclear condensation and DNA fragmentation, whereas the nuclei of 
necrotic cells swell. Apoptosis is characterized by mitochondrial depolarization 
and necroptosis is thought to lead to release of mitochondrial reactive oxygen 
species (ROS). Adapted from Ashida 2011. 
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 The executioner caspases are known as such because they are the final 
steps in apoptotic signaling transduction that leads to the apoptotic hallmarks of 
DNA degradation, cell shrinkage and membrane blebbing (Green, 2005). As the 
cell organelles are packaged into the apoptotic bodies, phosphatidyl serine from 
the phospholipid bilayer flips in orientation to face the extracellular environment. 
This acts as the “eat me” signal for macrophages and allows for silent 
phagocytosis of the damaged cell (Yoshida et al., 2005, Segawa et al., 2014). It 
is important to note that apoptosis is tightly regulated by a myriad of pro- and 
anti-apoptotic proteins. Changes in their balance allow the cell to adjust its 
course after apoptosis initiation and throughout the signaling cascades.  
Although apoptosis is often synonymous with programmed cell death, it is 
now recognized that both pyroptosis and necroptosis are also programmed cell 
death pathways. Pyroptosis is an inflammatory cell death pathway that has 
mostly been described in myeloid cells, whereas apoptosis and necroptosis has 
been reported in many cell types (Chen et al., 1996, Fink et al., 2008, 
Bergsbaken et al., 2009). Similar to apoptosis, pyroptosis is also the result of 
signaling cascades dependent on caspases, but the hallmark of pyroptosis is its 
dependency on caspase-1 (Bergsbaken et al., 2009). Caspase-1 is unique 
among the cell death caspases in that it is also responsible for processing of IL-
1β, a critical pyrogenic cytokine during infection. The fact that caspase-1 
activation is linked with the production of mature IL-1β renders pyroptosis an 
inherently inflammatory process. Caspase-1 does not lead to mitochondrial 
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depolarization or membrane blebbing; instead, it leads to the formation of 
membrane pores, which in turn lead to osmotic lysis of the cell. Cell rupture 
releases intracellular components, known as damage-associated molecular 
patterns (DAMPs) (Murakami et al., 2014, Van Crombruggen et al., 2013), that 
can further activate immune cells adding to inflammatory nature of pyroptosis. 
DNA damage also occurs during pyroptosis, however it is not mediated by the 
same factors as apoptosis (Bergsbaken and Cookson, 2007). Despite the 
pathological inflammatory consequence of pyroptosis, its induction protects the 
host from infection, as caspase-1 depletion often leads to enhanced intracellular 
replication of bacteria (Bergsbaken and Cookson, 2007, Bergsbaken et al., 
2009).  
The most recently described genetically programmed cell death 
mechanism is programmed necrosis, or necroptosis. Necrosis was classically 
thought of as “accidental” cell death in contrast to apoptosis, which was thought 
as “programmed” cell death. However, recent genetic evidence and the discovery 
of chemical inhibitors of necrosis have made it abundantly clear that necrosis is a 
programmed mechanism as well (Degterev et al., 2008, He et al., 2009). 
Necroptosis is morphologically characterized by swelling organelles, absence of 
DNA fragmentation, release of mitochondrial reactive oxygen species and 
eventual membrane rupture and cell lysis (Vandenabeele et al., 2010, 
Kaczmarek et al., 2013). Instead of caspases, necroptosis is dependent on the 
activation of receptor interacting protein kinases 1 and 3 (RIP1 and RIP3). 
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Although they have distinct outcomes, apoptosis and necroptosis share many of 
the same death receptors and intracellular factors. For example, after ligation to 
TNFα receptor, caspase-8 positively regulates apoptosis and inactive caspase-8 
leads to necroptosis (Kaiser et al., 2011). The commonalities between these two 
pathways have lead to the hypothesis that pathogen inhibition of apoptosis 
promotes necroptosis, or, pathogen inhibition of necroptosis promotes apoptosis 
(Sridharan and Upton, 2014).  
 
Cell death and microbial infection 
The timing of host cell death induced by microbial infection is a critical 
determinant of whether the host or pathogen ultimately prevails. A host cell may 
initially repress cell death pathways to produce antimicrobial peptides, initiate the 
activation of complement, and release cytokines for recruiting immune cells to 
clear the infection. However, if bacterial clearance fails, the host cell may 
undergo programmed cell death resulting in the loss of an intracellular niche for 
microbial replication (Ashida et al., 2011). To subvert the host immune response, 
pathogens may promote their own survival by initiating rapid host cell death, 
thereby preventing the immune cascade directed at their removal. Conversely, 
pathogens may also suppress host cell death to maintain an intracellular niche. 
The processes may be dependent on both the cell type and the specific microbe. 
Pathogen induced apoptosis has been extensively reported, particularly in 
phagocytic cells such as macrophages and PMNs (Ashida et al., 2011, Sridharan 
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and Upton, 2014, Bergsbaken et al., 2009). For example, Yersinia and Shigella 
both trigger rapid apoptosis in macrophages in response to phagocytosis, 
allowing the pathogens to escape (Weinrauch and Zychlinsky, 1999). On the 
other hand, many pathogens, such as Chlamydia trachomatis and Legionella 
pneumophila, block the apoptotic machinery to promote intracellular replication 
(Laguna et al., 2006, Losick et al., 2010). Microbes such as Salmonella, Yersinia 
and Francisella, also modulate pyroptosis (Bergsbaken and Cookson, 2007, 
Henry et al., 2007, Fink et al., 2008). Interestingly, in some cases the host cell 
shifts cell death from non-inflammatory apoptosis to the inflammatory pyroptosis. 
It is proposed that this shift leads to an enhanced immune response to promote 
bacterial clearance (Bergsbaken et al., 2009). Finally, the relationship between 
necroptosis and microbial pathogenesis has recently begun to be explored. 
Several bacteria, such as Mycobacterium tuberculosis, induce necroptosis as a 
means to escape one cell and infect the next (Yabal et al., 2014, Sridharan and 
Upton, 2014). Although there have been a few microbial species found to inhibit 
necrosis, the exact mechanisms remain unexplored (Sridharan and Upton, 
2014). Altering cell death is a common strategy utilized by many pathogens, but 
importantly, the mechanisms employed are pathogen and host cell specific. 
 
Modulation of cell death by N. gonorrhoeae 
Our laboratory and others reported that N. gonorrhoeae both induces or 
inhibits  cell death depending upon cell type (Table 2) (Müller et al., 1999, 
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Binnicker et al., 2003, Morales et al., 2006, Howie et al., 2008, Duncan et al., 
2009, Follows et al., 2009). The field of N. gonorrhoeae and apoptosis was 
controversial as some groups reported N. gonorrhoeae induced apoptosis while 
others declared the pathogen-inhibited apoptosis. Since then, numerous studies 
have demonstrated that programmed   
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Table 2. Summary of N. gonorrhoeae cell death studies 
Cell Type Outcome on cell death * 
 
Multiplicity 
of Infection 
(MOI) 
Citation 
Epithelial cell: 
immortalized 
endocervical 
Inhibits STS induced 
apoptosis: 48hpi 
MOI 10 and 
100 inhibits 
(Follows 
et al., 
2009) 
Epithelial cell: 
immortalized 
urethral 
Inhibits STS induced 
apoptosis: 8hpi 
MOI 10 and 
100 inhibits 
(Binnicker 
et al., 
2003) 
Epithelial cell: 
primary fallopian 
tube 
Inhibits TNFα induced 
apoptosis: 12hpi 
MOI 10 and 
100 inhibits, 
MOI 1 
induces 
(Morales 
et al., 
2006) 
Epithelial cell: T84 
human colon 
Inhibits STS induced apoptosis 
via downregulation of pro-
apoptotic proteins Bim and 
Bad: 6hpi 
MOI 50 (Howie et 
al., 2008) 
Epithelial cell: HeLa  Induces apoptosis: 15hpi MOI 1  (Müller et 
al., 1999) 
Epithelial cell: HeLa Induces apoptosis via Bim and 
Bmf: 15hpi 
MOI 1 (Kepp et 
al., 2009) 
PMN: Primary 
human PMNs 
Prolongs PMN survival and 
inhibits STS induced 
apoptosis: 2-12hpi 
MOI 1 (Simons 
et al., 
2006) 
PMN: HL-60 
myeloid leukemia 
cells differentiated 
to PMNs and 
primary PMN 
Inhibits STS induced 
apoptosis: 6hpi 
MOI 10 (Chen 
and 
Seifert, 
2011) 
Monocyte: human 
THP1 cell line 
Induces caspase-independent 
death: 4hpi 
MOI 0.2 (Duncan 
et al., 
2009) 
B cell: chicken B cell 
line 
Induces apoptosis: 2.5hpi MOI 25 (Pantelic 
et al., 
2005) 
B cell: primary B 
cells 
B cells less susceptible to 
apoptosis when infected: 6hpi 
MOI 10 (Criss 
and 
Seifert, 
2012) 
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*hpi = hours post infection 
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cell death extends beyond apoptosis to include pyroptosis and necroptosis, both 
of which have different molecular markers than apoptosis. Moreover, it is more 
widely recognized that the same pathogen can modulate different cell death 
mechanisms in different cell types (Clark and Maurelli, 2007, Suzuki et al., 2005, 
Lamkanfi and Dixit, 2010).  
To demonstrate that a pathogen induces cell death, one can simply 
measure cell death following microbial stimulation. However, to demonstrate that 
a pathogen inhibits cell death, one must exogenously induce cell death and show 
that the pathogen prevents the induction of cell death. Utilizing the natural short 
life span of PMNs and staurosporine (STS), a chemical inducer of apoptosis, it 
appears that N. gonorrhoeae inhibits apoptosis of PMNs (Simons et al., 2006, 
Chen and Seifert, 2011). These studies help explain how viable N. gonorrhoeae 
is recovered from patients’ PMNs. In monocytes, N. gonorrhoeae induces a lytic 
non-apoptotic form of cell death via inflammasome induction by gonococcal LOS 
(Duncan et al., 2009). For B cells and cell death, two contradicting reports have 
been published. One states that N. gonorrhoeae induces cell death (Pantelic et 
al., 2005) while the other claims N. gonorrhoeae prolongs B cell life span (So et 
al., 2012). It should be noted that Pantelic et al. utilized a chicken B cell line with 
no description of multiplicity of infection (MOI), while So et al. used primary 
human B cells and consistently used an MOI of 10. There have been limited 
studies addressing N. gonorrhoeae and cell death in T cells, however, no studies 
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have reported that N. gonorrhoeae induces T cell death (Boulton and Gray-
Owen, 2002, Yingru and Michael, 2011).  
Most studies examining cell death and N. gonorrhoeae have been 
performed in epithelial cells and have reached several conclusions. Using either 
immortalized urethral or endocervical cells, two groups demonstrated that N. 
gonorrhoeae protects cells from STS induced apoptosis (Binnicker et al., 2003, 
Follows et al., 2009). In primary fallopian tube cells, N. gonorrhoeae protected 
the cells from TNFα induced apoptosis (Morales et al., 2006). The inhibition of 
apoptosis has been linked to the upregulation of anti-apoptotic genes such as bfl-
1 and the cellular inhibitor of apoptosis protein-2 (cIAP2) (Binnicker et al., 2003, 
Follows et al., 2009) as well as the downregulation of pro-apoptotic proteins such 
as Bim and Bad (Howie et al., 2008). While gonoccocal porin has been shown to 
be factor that inhibits apoptosis (Massari et al., 2002, Follows et al., 2009), other 
studies have proposed that porins actually induce apoptosis. For example, in 
HeLa cells, incubation with live N. gonorrhoeae and purified gonococcal porin 
was reported to lead to mitochondrial depolarization and induction of apoptosis 
(Müller et al., 1999, Kepp et al., 2009). Discrepancies in epithelial cell death 
outcome between these studies is likely due to differences in HeLa cells versus 
immortalized cells and low MOIs versus high MOIs. Furthermore, of the various 
types of cell death, only apoptosis was examined with different assays and at 
different time points. Clearly more work is needed to understand the relationship 
of N. gonorrhoeae, cell death and epithelial cells. 
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The inhibitors of apoptosis proteins (IAPs) 
The inhibitors of apoptosis proteins (IAPs) are potent inhibitors of 
apoptosis, however their regulatory function extends beyond apoptosis. The IAPs 
regulate several forms of programmed cell death, each with distinct inflammatory 
outcomes. The IAPs also regulate NF-κB transduction, which is responsible for 
induction of genes necessary for inflammation, cell migration and cell survival. As 
recent studies have begun to clarify the signaling cascades in which cIAP1, 
cIAP2 and XIAP are involved, it is clear that these IAPs are uniquely situated at 
the junction of cell survival and inflammation. This position makes them important 
to innate immunity and host survival during microbial infection. 	  
The first identified IAP was a baculoviral protein that inhibited apoptosis of 
the host insect cell (Crook et al., 1993). To this day, IAP family proteins are 
defined by the presence of at least one baculoviral IAP repeat (BIR). Within this 
definition the human genome encodes 8 known IAPs (gene name/protein name): 
BIRC1/neuronal IAP (NAIP), BIRC2/cIAP1, BIRC3/cIAP2, BIRC4/X-linked IAP 
(XIAP), BIRC5/survivin, BIRC6/BIR repeat-containing ubiquitin-conjugating 
enzyme (BRUCE), BIRC7/melanoma IAP (ML-IAP) and BIRC8/IAP like protein-2 
(ILP2) (Deveraux and Reed, 1999). IAP members were originally thought to 
inhibit apoptosis by directly inhibiting activation of caspases (Deveraux et al., 
1998). However while this function has been established for XIAP, it remains 
unclear whether other IAP family members utilize the same mechanism to inhibit 
cell death (Eckelman and Salvesen, 2006). In addition to the BIR domain, several 
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IAP members also possess both an E3 ubiquitin ligase (RING domain) (Vaux and 
Silke, 2005) and a ubiquitin-binding domain (UBA) (Gyrd-Hansen and Meier, 
2010) (Figure 2). These domains allow IAP molecules to self-ubiquitylate, trans-
ubiquitylate and bind to polyubiquitin chains, which in turn make IAPs 
indispensible for ubiquitin-mediated immune signaling. For example, cellular 
IAP1 and IAP2 (cIAP1 and cIAP2) positively regulate NF-κB and mitogen 
activating protein kinases (MAPK) signaling downstream of the TNF receptor by 
conjugating a signaling scaffold of lysine (K)-63 polyubiquitin chains to receptor 
interacting protein (RIP)-1 kinase (Mahoney et al., 2008, Varfolomeev et al., 
2008). cIAP1 and cIAP2 also regulate signaling cascades by targeting proteins 
for proteasome degradation via addition of K48 polyubiquitin chains. Through 
their various ubiquitylation patterns, cIAPs and XIAP regulate signaling cascades 
downstream of a number of immune receptors including TLR2, TLR3, TLR4, 
NOD1/2, RIG1, TNF and TNF superfamily, and inflammasomes (Bauler et al., 
2008, Bertrand et al., 2009, Krieg et al., 2009, Weber et al., 2010, Tseng et al., 
2010, Mao et al., 2010, Lopez and Meier, 2010, Estornes and Bertrand, 2014).  
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Figure 2. Protein domains of the human inhibitor of apoptosis family 
Members of the human IAP gene family  (only 4 of 8 shown here) are defined by 
the presence of at least one baculoviral IAP repeat (BIR). The BIR domains are 
involved in protein–protein interactions with factors such as TNF receptor 
associated factors (TRAFs), NODs and caspases. IAPs also contain a really 
interesting new gene (RING) E3 ubiquitin ligase domain that ubiquitylates 
substrates, a ubiquitin associated domain (UBA) domain that binds to ubiquitin 
and polyubiquitylated chains, and a caspase recruitment domain (CARD) that 
suppresses the E3 ligase activity under steady-state conditions. Figure adapted 
from Beug 2012. 
	  32 
  Using antibodies against cIAP2 and human tissues, Vischioni et al. 
reported that cIAP2 protein is expressed in nearly all normal tissues of the 
human body, from epithelium to neurons to germ cells (Vischioni et al., 2006). 
While cIAP2 tissue expression mirrored that of cIAP1, XIAP expression was less 
ubiquitous. Unique to cIAP2 was its high expression in the basal layer of 
epithelial tissues where highly proliferative cells reside. Within the cell, cIAP2 
expression is mostly diffuse within the cytoplasm (Vischioni et al., 2004).  
The expression of cIAP2 is tightly regulated. Synthesis of cIAP2 is 
controlled at the transcriptional level by NF-κB and phosphatidyl inositol-3 kinase 
(PI3K) (Chu et al., 1997, Wang et al., 1998, Petersen et al., 2010) and the 
expression of cIAP2 can be induced by TNFα (Wang et al., 1998), protein kinase 
C (Wang et al., 2003), and environmental stress (Dong et al., 2003).  On the 
translational level, cIAP2 mRNA stability is controlled by the AU-rich element 
tristetraprolin (Chae et al., 2010). Once translated, cIAP2 stability is regulated by 
the anti-apoptotic factors second mitochondria-derived activator of caspase 
(SMAC) and the mitochondria-derived serine protease, Omi (Verhagen et al., 
2000, Yang et al., 2003). Autoubiquitylation and subsequent proteasome 
degradation also controls cIAP2 stability. It has also been proposed that cIAP1, 
cIAP2 and XIAP form a stabilizing heteromeric complex, and changes in 
expression of one IAP may alter the expression of the others via ubiquitylation 
(Rajalingam et al., 2006, Conze et al., 2005). Finally, cIAP2 activity can be 
regulated by subcellular localization: cIAP2 is found in the nucleus of an 
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unstimulated cells and then shuttled to the cytoplasm once the cells are activated 
(Vischioni et al., 2006). The highly regulated expression of cIAP2 reflects its 
importance in controlling immune signaling and cell fate. In fact, overexpression 
of cIAP2 is highly associated with several cancers and inflammatory bowel 
disease (Varfolomeev et al., 2007, Silke and Meier, 2013, Pedersen et al., 2014).  
Due to correlation between cancer, apoptosis resistance and high cIAP 
expression, small molecular IAP inhibitors were designed to mimic the intrinsic 
inhibitor of IAP, SMAC. SMAC is released from mitochondria and binds to the 
BIR domain of IAPs, thereby blocking the ability of IAPs to inhibit caspases. 
SMAC mimetics were originally designed to prevent XIAP from inhibiting 
caspase-3 and capase-7, however, it seems that many SMAC mimetics 
preferentially bind to cIAPs (Varfolomeev et al., 2007). Once bound, the SMAC 
mimetic initiates auto- and trans-ubiquitylation of the cIAPs, which then rapidly 
leads to proteasomal degradation. IAP degradation was originally observed to 
cause TNFα induced apoptosis, however, SMAC mimetics are now an 
indispensible tool for studying the various pathways IAPs regulate. 
 
Role for IAPs in the signaling networks of apoptosis and necroptosis 
Though it has been long understood that processes of cell death and 
inflammation are interconnected, these fields have further merged as these 
pathways have become molecularly defined (Blander, 2014). We now have a 
clear understanding that ubiquitin-mediated pathways drive both inflammation 
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and cell survival, particularly the pathways that regulate NF-κB. NF-κB signaling 
is central in the control of immune responses and function (Hayden and Ghosh, 
2011) and as mentioned above, cIAP1 and cIAP2 are key effectors of NF-κB 
signaling (Mahoney et al., 2008, Varfolomeev et al., 2007, Bertrand et al., 2008, 
Varfolomeev et al., 2008). The prototypic activator of NF-κB is the TNF receptor 
(Figure 3). After ligation, the BIR1 domain of cIAP1/2 associates with TNF 
receptor associated factor 2 (TRAF2) and TRAF5. TRAF2 and TRAF5 are 
bridging adaptors that couple cIAP1 and cIAP2 to the TNF receptor and, 
importantly, to the kinase RIP1 (Bertrand et al., 2008). To perpetuate signaling 
for NF-κB activation, cIAP utilizes its E3 ligase domain to ligate K63-ubiquitin 
chains to RIP1. The ubiquitin chains then act as scaffolds to recruit additional 
kinases. Eventually, dimers of NF-κB translocate to the nucleus and activate the 
transcription of proliferative, pro-survival and pro-inflammatory genes. For 
example, NF-κB activates genes coding for cyclin D1 (Guttridge et al., 1999), 
Bcl-2 and IAP anti-apoptotic proteins (Dutta et al., 2006), TNFα, IL-1, IL-6 and IL-
8 (Hoesel and Schmid, 2013). In the absence of cIAP1 or cIAP2, RIP1 is not 
ubiquitylated and the TNFα signaling leads to cell death pathways involving RIP3 
and necroptosis or caspase-8 and apoptosis (Moulin et al., 2012) (Figure 3). 
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Figure 3. Active IAPs promote NF-κB signaling  
A. Upon TNF receptor ligation, the active cIAPs are coupled to the TNF receptor 
by TRAF2 and TRAF5 and recruit RIP1. This complex is known as complex I and 
once formed, cIAPs utilize their E3 ligase domain to ligate K63-ubiquitin chains to 
RIP1 (blue chains). The formation of complex I eventually activates NF-κB, which 
promotes transcription of proliferative, pro-survival and pro-inflammatory genes. 
B. In the absence of cIAPs, RIP1 is not ubiquitylated and the TNFα signaling 
leads to cell death pathways in which RIP1 complexes with Fas-associated death 
domain (FADD) and caspase 8 or FADD and RIP3 to induce apoptosis or 
necroptosis, respectively. These complexes are known as complex II. Figure 
adapted from Estornes 2014. 
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Due to the pro-survival proteins regulated by NF-κB, a portion of cIAP2’s 
anti-apoptotic function indirectly derives from its ability to regulate NF-κB 
(Damgaard and Gyrd-Hansen, 2011, Piva et al., 2006). The original proposed 
function of cIAP2 was to directly block caspases in both intrinsic and extrinsic 
apoptosis, yet mounting evidence shows this role for cIAP2 is unlikely, and more 
likely specific to XIAP (Eckelman and Salvesen, 2006). What is becoming clear is 
the direct role of cIAP2 as an inhibitor of the extrinsic apoptosis pathway and 
necroptosis (Silke and Vucic, 2014). Despite the distinct outcomes, the same 
TNF family of receptors integrates both extrinsic apoptosis and necroptosis 
(Figure 3).  
The most extensively studied cell death signaling network is the TNF 
receptor and its associated complexes. The TNF receptor complex, complex II, 
can initiate both apoptosis and necroptosis (Figure 3). Complex II is comprised of 
the Fas-associated death domain (FADD), cellular FLICE-like inhibitory proteins  
(cFLIPs), RIP kinases, caspase-8 and cIAP1 or cIAP2 (Wang et al., 2008, 
Vandenabeele et al., 2010). Another similar complex coined “the ripoptosome”, is 
also regulated by cIAPs, nearly identical in its composition to complex II and can 
induce both apoptosis and necroptosis. The ripoptosome differs in that it forms 
spontaneously under genotoxic stress independent of the TNF receptor or the 
TNF receptor family (Imre et al., 2011). The formation of these complexes and 
the switch from survival to cell death is controlled by stabilization of the RIP 
kinases by IAP ubiquitylation (Bertrand et al., 2008, Geserick et al., 2009, Tenev 
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et al., 2011, Feoktistova et al., 2011). Once either complex II or the ripoptosome 
is formed, the switch from apoptosis to necroptosis occurs if there is insufficient 
caspase-8 activity, which can also be ubiquitylated and inactivated by IAPs 
(Kaiser et al., 2011, Tenev et al., 2011). Upon caspase-8 inactivation, RIP1 
activates RIP3 and induces the pseudokinase mixed lineage kinase domain-like  
(MLKL). MLKL activation leads to membrane lysis and caspase-independent 
necroptosis (Figure 4) (Sun et al., 2012, Chen et al., 2014).  
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Figure 4. IAPs in apoptosis, necroptosis and pyroptosis. 
A. Apoptosis can be induced by extracellular death receptors (extrinsic pathway) 
or by intracellular stress (intrinsic pathway). Both extrinsic and intrinsic pathways 
converge on caspase-3 and/or caspase-7, one of the final reversible steps in the 
apoptotic cascade. Here, XIAP can inhibit caspase-3,7 and block apoptosis. 
Furthermore, cIAPs can block the formation of the caspase-8 death complex 
initiated by the extrinsic pathway. B. Necroptosis can also be initiated by death 
receptors or intracellular stress. In contrast to apoptosis, necroptosis is caspase-
independent and instead RIP1/3-dependent. Both cIAPs and XIAP can block the 
formation of the caspase-8/RIP death complex and can promote necroptosis over 
apoptosis through modification of caspase-8. Mixed lineage kinase domain-like 
(MLKL) can lead to mitochondrial reactive oxygen species (ROS) and RIP3 can 
lead to activation of the inflammasome and release of IL-1β. C. Pyroptosis is only 
induced by intracellular detection of PAMPs or DAMPs by the inflammasome and 
is caspase-1 dependent. Inflammasome activation is enhanced through 
ubiquitylation (blue chain) of caspase-1 by the cIAPs, which leads to IL-1β 
release. Proteins required for execution of a specific cell death pathway are 
highlighted in green. Figure adapted from Ashida 2011. 
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IAPs in pyroptosis signaling 
Pyroptosis is an inflammatory cell death pathway dependent on caspase-
1. The activation of caspase-1 is coordinated by intracellular pattern recognition 
receptors known as inflammasomes (Bergsbaken et al., 2011). The 
inflammasome is a multiprotein intracellular sentinel of the host cell and 
recognizes various PAMPs and danger-associated molecular patterns (DAMPs). 
Upon recognition, NLRs begin assembly and recruit ASC and caspase-1. This 
complex can then cleave IL-1β and IL-18 into their active forms and initiate 
pyroptosis. 
Recently, cIAP1 and cIAP2 were demonstrated to play an important role in 
regulation of the inflammasome (Ciraci and Sutterwala, 2012) (Figure 4). Vince et 
al. demonstrated that with complete inhibition of cIAP1, cIAP2 and XIAP by the 
SMAC mimetic compound A, there was enhanced macrophage inflammasome 
activity following stimulation with LPS as measured by increased activation of 
caspase-1 and the generation IL-1β (Vince et al., 2012). The production of active 
IL-1β was independent of caspase-1, but dependent on the ripoptosome 
mediators caspase-8 and RIP 3. Thus connecting two complexes, Vince et al 
found that depletion of IAPs activate the inflammasome by the ripoptosome. In 
contrast, Labbé et al found that upon depletion of cIAP1 and cIAP2 by the SMAC 
mimetic BV6 in macrophages, there was reduced activation of the inflammasome 
and IL-1β activity (Labbé et al., 2011). These investigators also demonstrated 
that cIAP1 and cIAP2 ubiquitylate caspase-1 which enhances its association with 
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the inflammasome. Thus, one study proposes that depletion of IAPs enhances 
IL-1β production, while the other proposes that IAPs are necessary for sufficient 
IL-1β production. The differences between the two studies have yet to be 
reconciled and may be due to the many differences in experimental setups. 
Clearly more work is needed to understand how cIAP1 and cIAP2 regulate 
caspase-1 and pyroptosis. 
 
IAPs in immune signaling 
 IAPS are also involved in immune signaling outside of death 
receptors: they regulate NF-κB and MAPK signaling downstream of PRRs such 
as TLR4 and NLRs. Upon TLR4 recognition of LPS, the adaptor molecule TRAF6 
recruits cIAP1 and cIAP2 to the receptor. Instead of generating a scaffold of K63-
ubiqutin like TNFR signaling, cIAPs ligate a K48-ubiquitin chain to TRAF3, a 
negative regulator of MAPK activity. The K48-ubiquitin chain targets TRAF3 for 
proteasomal degradation and therefore promotes MAPK signaling. In the 
absence of cIAPs, TRAF3 is stabilized and MAPK activation of cytokines and 
chemokines is suppressed (Tseng et al., 2010, Damiano et al., 2006, 
Vandenabeele and Bertrand, 2012). TLR4 signaling can lead to two signaling 
cascades: the MyD88 pathway, which leads to MAPK and NF-κB or the TRIF 
pathway, which activates production of interferons (IFNs). Interestingly, cIAPs 
only regulate the MyD88 pathway and cIAP1/2 depletion does not change IFN 
levels (Tseng et al., 2010).  
	  42 
NLRs are intracellular PRRs that induce NF-κB and MAPK signaling 
through RIP2. The two NLRs, NOD1 and NOD2, recognize derivatives of 
peptidoglycan: a component of the cell wall in Gram-negative bacteria (Tattoli et 
al., 2007). Once NOD1 or NOD2 bind to their specific peptidoglycan, they 
oligomerize and recruit RIP2. Similar to TNF receptor signaling, cIAP1 and cIAP2 
form K63-ubiquitin chains on RIP2, which act as a scaffold to recruit more 
kinases and perpetuate NF-κB and MAPK signaling leading to production of 
cytokines, chemokines and antimicrobial peptides (Hasegawa et al., 2008). For 
example, in cIAP1 or cIAP2 null macrophages treated with NOD agonists, there 
is a significant reduction in NF-κB and MAPK activation. In vivo this reduced 
activation manifests as blunted serum cytokine and chemokine levels when 
challenged with NOD agonists (Bertrand et al., 2009).  
 
IAPS and microbial pathogenesis 
Many of the studies that have delineated the roles of cIAP2 in cell death 
and innate immune signaling originated in the cancer field. Yet it is easy to 
imagine that such integral roles in cell death and innate immunity would make 
cIAP2 an important factor during microbial pathogenesis as well.  There have 
been several in vitro and in vivo studies that have begun to show the importance 
of cIAP1 and cIAP2 during infection, which have been summarized in Table 2. 
Here, several in vivo mouse studies will be described.  
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Knockout mice and SMAC mimetics have been important tools in 
providing evidence that IAPs are critical for pathogen clearance and survival of 
the host. For example, cIAP1 and cIAP2 inhibit TNFα induced apoptosis, 
reducing the microbial burden in vivo. During lymphocytic choriomeningitis virus 
(LCMV) infection in mice treated with SMAC mimetics, T-cell expansion and 
survival is dampened. IAP depletion sensitizes T-cells to TNFα induced 
apoptosis and contributes to increased viral titers and dissemination to 
surrounding organs (Gentle et al., 2014). The immune signaling role of cIAP1/2 
has also been demonstrated to protect infected animals. When mice are infected 
with Chlamydia pneumoniae, cIAP1 knockout mice are more susceptible to 
infection than wild type and fail to clear the bacteria from the lungs. This is 
attributed to impaired recruitment of macrophages, increased IFN-γ and reduced 
TNFα in the lungs. Confirming the in vivo phenotype, ex vivo cIAP1 knockout 
macrophage experiments showed impaired cytokine response but no increase in 
apoptosis when challenged with C. pneumoniae (Prakash et al., 2009).  
The inhibition of necroptosis by cIAP1/2 has also been demonstrated to 
protect infected animals. During Listeria monocytogenes infection, SMAC 
mimetic treated mice had an increased bacterial burden due to necrosis of 
peritoneal macrophages (McComb et al., 2012). In a more recent study, 
Rodrigue-Gervais et al demonstrate that expression of cIAP2 protects mice from 
succumbing to a sub-lethal dose of mouse-adapted H1N1 virus. Although there 
were no differences in viral titers, inflammatory cytokines or immune cell 
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recruitment to the lungs between the wild type and cIAP2 deficient mice, cIAP2 
knockout mice succumbed to infection (Rodrigue-Gervais et al., 2014). 
Interestingly, it was found that while in vivo epithelial cells died primarily of 
apoptosis in the wild type mice, epithelial cells of the cIAP2 deficient mouse died 
in a caspase-independent manner.  Necroptosis of the lung epithelial cells was 
shown to be the cause of death and administration of a RIP1 inhibitor maintained 
the integrity of the lung and enhanced survival of the mouse. Both studies 
demonstrated that cIAP1/2 protect the host from microbial induced necroptosis, 
suggesting that these particular pathogens may utilize necroptosis as a means 
for dissemination (Robinson et al., 2012).  
Collectively, these studies indicate that cIAP1 and/or cIAP2 have a 
protective role in microbial pathogenesis. Whether other cIAPs have specific cell 
death functions in specific tissues or during certain infections has yet to be 
elucidated (Upton and Sridharan, 2014). 
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Table 3. Immune and cell death outcomes in IAP models during infection 
 
IAP 
investigated 
Infectious 
agent 
Model Outcome 
In vivo    
XIAP  
(Bauler et al., 
2008) 
L. 
monocytoge
nes 
XIAP KO mouse -Cell death not examined 
-Increased bacterial burden  
-Reduced proinflammatory 
cytokines in macrophages 
XIAP (Prakash 
et al., 2010)  
 
C. 
pneumoniae 
XIAP KO mouse - Increased macrophage 
apoptosis 
-Increased bacterial burden 
-Reduced macrophage iNOS 
levels 
-Increased TNFα in lungs 
cIAP2 
(Rodrigue-
Gervais et al., 
2014) 
Influenza cIAP2 KO mouse  
RIPK3 KO mouse 
RIPK inhibitor 
-Necroptosis in airway epithelial 
cells 
-Increased susceptibility to 
infection 
cIAP1  
(Prakash et al., 
2009) 
C. 
pneumoniae 
cIAP1 KO mouse - Necrosis of ex vivo 
macrophages. 
-Increased bacterial burden  
-Reduced macrophage 
recruitment 
-Increased INFγ, decreased 
TNFα 
cIAP1, cIAP2 
(McComb et 
al., 2012) 
L. 
monocytoge
nes 
cIAP1 KO cIAP2 
KO mice 
- Necroptosis of peritoneal 
macrophages 
-Increased bacterial burden 
cIAP1, cIAP2, 
XIAP  
(Gentle et al., 
2014) 
Lymphocytic 
choriomenin
gitis virus 
(LCMV) 
Mouse model 
with SMAC 
mimetics  and 
XIAP KO mouse 
- Apoptosis in CD8 and CD4 T 
cells 
-Increased viral titers 
-Impaired T cell expansion 
In vitro    
XIAP  
(Ashare et al., 
2007) 
P. 
aeruginosa 
Kupffer cells, 
overexpression of 
XIAP mutant 
-XIAP stabilized by PI3K and Akt 
- Apoptosis when XIAP unstable 
(bacteria stabilizes XIAP) 
XIAP  
(White et al., 
2011) 
Sendai virus HT1080 cell line  -XIAP stabilized by PI3K and Akt 
- Apoptosis when XIAP not 
stable (virus stabilizes XIAP) 
NAIP  
(Katagiri et al., 
2012) 
L. 
pneumophila 
Human NAIP 
expressed in 
murine 
macrophage 
-NAIP restricts growth of L. 
pneumophila 
- NAIP inhibits apoptosis, 
induces pyroptosis during 
infection 
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IAPs  
(Kominsky et 
al., 2002) 
Reovirus HEK cells -Immune response not 
examined 
- Apoptosis (virus degrades 
IAPs) 
cIAP1, cIAP2, 
XIAP  
(Rajalingam et 
al., 2006) 
C. 
trichomatis,  
HeLa cells, 
siRNA against 
IAPs 
-Immune response not 
examined 
- Apoptosis with siRNA against 
all three (C. trichomatis 
obstructs apoptosis) 
cIAP2  
(Li et al., 2011) 
H. pylori  Gastric cancer 
cell lines, siRNA 
against cIAP2 
-Decreased migration 
- Apoptosis with cIAP2 siRNA 
(H. pylori obstructs apoptosis) 
cIAP2  
(Yuan et al., 
2005) 
Human 
papillomaviru
s (HPV) 
Immortalized 
human oral 
keratinocytes, 
siRNA 
-Immune response not 
examined 
- Apoptosis with cIAP2 siRNA 
(HPV obstructs apoptosis) 
cIAP2  
(Kim et al., 
2008) 
B. fragilis 
enterotoxin 
Intestinal 
epithelial cell line, 
siRNA against 
cIAP2 
-MAPK  associated with 
induction of cIAP2 
Apoptosis with cIAP2 siRNA 
(toxin obstructs apoptosis) 	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Exosomes 
 Intercellular communication is a hallmark of multicellular organisms and 
can be mediated through direct cell-to-cell contact or secreted molecules. In the 
past 30 years, studies have revealed the exchange of extracellular vesicles as 
another means of intercellular communication (Harding et al., 2013). These 
extracellular vesicles, termed exosomes, are defined as 40-150 nm sized 
particles derived from endosomal multi-vesiclular bodies (MVBs) that have fused 
with the plasma membrane (Figure 5) (Raposo and Stoorvogel, 2013, Harding et 
al., 1984).  Exosomes facilitate communication by carrying cargo such as nucleic 
acid and protein from one cell to another. Exosomes were first discovered in 
reticulocytes in 1983, but it is now clear that many cells secrete exosomes 
including B cells, T cells, platelets, neurons and epithelial intestinal cells (Bobrie 
et al., 2011). Exosomes can be readily detected in bodily fluid such as semen 
(Ronquist and Brody, 1985), plasma (Caby et al., 2005), urine (Pisitkun et al., 
2004), saliva (Ogawa et al., 2011) and cerebrospinal fluid (Vella et al., 2007) 
making them excellent potential biomarkers for disease. 
 Due to their small size and low density, exosomes are typically isolated 
from body fluids or cell culture by ultracentrifugation. They can be identified and 
separated from cell debris and protein aggregates based on their unique 
characteristics. Exosomes originate from the endosome and thus are enriched 
with proteins found in the endosome such as flotilin, Alix, and tetraspanins CD9, 
CD63, and CD81 (Raposo and Stoorvogel, 2013). They are devoid of proteins 
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from other intracellular compartments such as the mitochondria, Golgi apparatus 
or endoplasmic reticulum (van Niel et al., 2006). Exosomes also have a lipid 
composition that differs from that of the plasma membrane: they are enriched in 
cholesterol and sphingomyelin instead of phoshpatidylcholine or 
phosphatidylethanolamine (Caroline et al., 2007).  
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Figure 5.	  	  Exosome formation and release 
Intraluminal vesicles bud into early endosomes, which then become 
multivesicular bodies (MVBs). The MVBs then fuse with the plasma membrane 
for release of the intraluminal vesicles, now termed exosomes. Other MVBs fuse 
with lysosomes.  The point of divergence between these MVBs is drawn at early 
endosomes. Figure adapted from Raposo 2013. 
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  Exosomes begin as intraluminal vesicles within the late endosome known 
as multvesicular bodies (MVBs). MVBs fuse with the lysosome for degradation of 
the vesicles but MVBs can also fuse with the plasma membrane for secretion of 
exosomes. Interestingly, their fate of degradation versus secretion can be 
distinguished by biochemical characteristics of the MVBs. For example, MVBs 
destined to release exosomes are cholesterol rich while MVBs targeted for the 
lysosome are cholesterol-poor and contain lysobisphosphatidic acid (Möbius and 
Ohno-Iwashita, 2002, Wubbolts et al., 2003). Once the MVBs of the late 
endosome bypass the lysosomal pathway, they are guided to the plasma 
membrane for direct fusion and release of exosomes into the extracellular space. 
The formation of the intraluminal vesicles and guiding of the endosome to the 
plasma membrane is a process that may vary from cell-to-cell and can be either 
endosomal sorting complex required for transport (ESCRT)-dependent or 
independent (Raposo and Stoorvogel, 2013). ESCRT is composed of four multi-
protein complexes, ESCRT 0, 1, 2 and 3 (Raiborg and Stenmark, 2009). ESCRT 
directs ubiquitylated proteins to late endosomes and assembles them into 
exosomes (Raiborg and Stenmark, 2009, Hwang, 2013). ESCRT-independent 
mechanisms involve the biogenesis of exosomes that are dependent on 
sphingomyelinase, an enzyme that produces ceramide, as well as the 
tetraspanins CD63 and CD9 (Trajkovic et al., 2008, Yuyama et al., 2012, Stuffers 
et al., 2009).  
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 How exosome cargo is selected is still not fully understood. Although 
some cytosolic proteins may be selected by the ESCRT machinery, it is clear that 
ubiquitylation of proteins is not required for exosome incorporation. Because of 
their abundance in exosomes and ability to complex with exosomal membrane 
proteins, it is also hypothesized that chaperones, such as Hsp70, may recruit 
proteins to exosomes (Raposo and Stoorvogel, 2013, Géminard et al., 2004). 
How RNA is sorted into exosomes is also unclear. There is some evidence that 
suggests RNA molecules targeted to exosomes have certain sequence motifs 
(Batagov et al., 2011) and some speculation that ESCRT 2 can form a complex 
with RNA (Irion and Johnston, 2007). In general, exosome formation and cargo 
selection remains poorly understood and more studies are needed.  
 The mobilization of MVBs to the plasma membrane for exosome release 
requires cytoskeleton components, such as actin and microtubules, as well as 
kinesins, myosins and small GTPases (Cai et al., 2007). Mounting evidence 
through screening indicates that Rab GTPases have an integral role in the 
release of exosomes, although their exact role is not well understood (Savina et 
al., 2002, Ostrowski et al., 2010, Riches et al., 2014). Once finally released, 
exosomes are stable in various physiological conditions and can fuse with either 
neighboring cells or travel to distal sites via plasma (Malik et al., 2013, Raposo 
and Stoorvogel, 2013). Adhesion molecules on the surface of exosomes may 
determine specificity of target cell binding, such as integrins or MHC 
components. For example, exosomes released from intestinal epithelial cells 
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have high MHC class II and preferentially bind to dendritic cells, rather than B 
cells or T cells (Denzer et al., 2000). Once attached to the plasma membrane, 
they may fuse with the assistance of the tetraspanins or become endocytosed 
into either an endosomal compartment or lysosomal compartment (Tian et al., 
2010).  Although exosomes were originally thought to only be cellular waste 
disposal, it is now known that exosome associated mRNA can be translated in 
target cells (Valadi et al., 2007) and exosome associated proteins can have 
effector functions in target cells (Khan et al., 2010). Over the past decade, a 
diverse array of biological functions has been attributed to exosomes and it 
widely accepted that exosomes represent an important mechanism of 
intercellular communication.  
 
Exosomes in the immune response 
 Many biological functions of exosomes have been discovered in the 
context of immunology; exosomes derived from immune and non-immune cells 
have a variety of roles in immune regulation. Exosomes can facilitate antigen 
presentation, modulate tumor immunity and drive inflammation (Bobrie et al., 
2011, Chaput and Théry, 2011). Interestingly, the composition of exosomes 
mostly reflects that of the parent cells, thus the transmembrane proteins found on 
exosomes are expressed in a cell-specific manner. For example, exosomes 
derived from T cells express T cell receptors and adhesion receptors, exosomes 
from B cells express B cell receptors and Fc receptors and exosomes from 
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dendritic cells express high levels of MHC I and MHC II. Futhermore, exosomes 
that originate from immune cells often carry inflammatory cytokines such as 
TNFα, IL-1β, and IL-18 (Hwang, 2013, Clayton et al., 2007, Turola et al., 2012). 
Exosome molecular composition may also change in response to the activation 
state of the cell of origin. For example, exosomes secreted by epithelial cells 
stimulated with IFN-γ are enriched with more MHC II molecules than 
unstimulated cells (Chaput and Théry, 2011). Thus cell specific composition of 
exosomes, as well as their ability to reflect cell activation, allow for targeted 
delivery and the ability to direct immune responses.  
 Exosomes can be immunostimulatory or immunosuppressive. Epithelial 
cells, endothelial cells, dendritic cells and macrophages have all been 
documented to release exosomes enriched in MHC II with the capacity to 
activate and perpetuate the adaptive immune response when loaded with 
antigens (Hwang, 2013, Robbins and Morelli, 2014). In fact, resting T cells 
incubated with exosomes derived from activated and antigen loaded dendritic 
cells led to full activation and proliferation of T cells (Bianco et al., 2007). In 
contrast, exosomes prepared from immature dendritic cells are 
immunosuppressive (Théry et al., 1999). Exosomes are also enriched with heat 
shock proteins that can be highly immunostimulatory when in contact with 
neighboring cells (Chalmin et al., 2010). Our knowledge of the 
immunosuppressive role of exosomes mainly derives from extensive work done 
in tumor biology, as exosomes have an impact on the tumor microenvironment. 
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Exosomes from tumor cell lines or tumor-bearing patients can subvert the anti-
tumor response through pleiotropic mechanisms: exosomes can inhibit T cell 
proliferation (Clayton et al., 2007), induce apoptosis (Huber et al., 2005), 
encourage Treg differentiation (Szajnik et al., 2010) and inhibit natural killer cell 
cytotoxicity (Aled et al., 2008). Tumor-derived exosomes can also disrupt the 
maturation of dendritic cells and macrophages via exosome associated TGFβ 
(Yu et al., 2013). The knowledge of exosome immune properties continues to 
expand and has lead to the development of exosomes as therapeutic agents for 
cancer, inflammatory and autoimmune diseases (Hwang, 2013, Chaput and 
Théry, 2011, Toro et al., 2015).  
 
Exosomes and microbial pathogens 
 There is extensive evidence that viruses, parasites and bacteria can 
influence the cargo and production of exosomes. Microbial pathogens can modify 
exosome cargo though incorporation of their own microbial proteins or by altering 
the composition of host proteins (Schorey et al., 2015, Fleming et al., 2014). For 
example, viruses such as HIV and hepatitis C depend on ESCRT proteins for 
viral packaging. Because ESCRT proteins facilitate exosome formation as well, 
the crosstalk may be responsible for the presence of viral proteins and viral RNA 
in (Lenassi et al., 2010, Dreux et al., 2012). While parasitic signatures from 
several parasites have been detected in exosomes, Cryptosporidium parvum 
infection alters host exosome composition. The parasite leads to increased 
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exosome production from intestinal epithelial cells and enriches exosome 
associated antimicrobial peptides (Hu et al., 2013). In bacteria, mycobacterial cell 
wall components as well as LPS from Salmonella typhimurium have been 
detected in exosomes secreted by infected macrophages (Bhatnagar et al., 
2007, Singh et al., 2011). It is not well understood how many of these pathogens 
incorporate microbial signatures into exosomes. Yet regardless of whether 
exosomes carry microbial factors or a modified set of host proteins, there 
appears to be consequences of exosome modification during infection. Viruses, 
parasites and bacteria modify the immune response via exosomes. Examples of 
such modifications by bacterial infection include exosomes derived from cells 
infected with Mycobacterium species, Salmonella typhimurium and 
Streptococcus pneumonia, all shown to induce proinflammatory responses in 
uninfected macrophages (Bhatnagar et al., 2007, Colino and Snapper, 2007, 
Bhatnagar and Schorey, 2007, Singh et al., 2011). Interestingly, exosomes from 
mycobacterial-infected cells can both promote and suppress the immune 
response. For example, when macrophages are treated with exosomes from 
Mycobacterium tuberculosis infected macrophages, they secrete chemokines 
that induce naïve macrophage and T cell migration in vitro (Singh et al., 2012). 
On the other hand, exosomes from M. tuberculosis infected cells suppress IFN-γ 
activation of naïve macrophages in a TLR2 dependent manner (Singh et al., 
2011). This suggests that the mycobacterial components within the exosomes 
act as PAMPs. Exosomes containing Salmonella LPS also act as PAMPs and 
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increase TNFα in naïve cells in a TLR4 dependent manner (Bhatnagar and 
Schorey, 2007). In addition to cell activation, mice injected with dendritic cell 
derived exosomes develop protective immunity against Streptococcus 
pneumonia and an increased immunoglobulin titer (Colino and Snapper, 2007). 
Collectively, these studies demonstrate a multifaceted role for exosomes during 
bacterial infection (Fleming et al., 2014).  
 
Hypothesis and Aims 
Previous studies report that N. gonorrhoeae stimulation increases cIAP2 
mRNA expression, a protein with known roles in cell death and immune 
signaling. We therefore hypothesize that changes in cIAP2 expression and 
exosome production, due to N. gonorrhoeae stimulation, will alter inflammation 
and cell death of infected epithelial cells and potentially, uninfected neighboring 
cells. These findings will provide further insight into how epithelial cells direct the 
female genital tract immune response during infection. To test this hypothesis we 
propose the following aims: (1) To characterize the expression and localization of 
cIAP2 induced by N. gonorrhoeae in human endocervical epithelial cells. (2) To 
define the role of cIAP2 in modulation of cell death and inflammation during N. 
gonorrhoeae infection of epithelial cells. (3) To characterize changes in exosome 
content and release due to N. gonorrhoeae stimulation of epithelial cells.  
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Chapter 2. Materials and Methods 
 
Epithelial cell cultures  
The endocervical epithelial cell line (End/E6E7) was immortalized with the 
E6 and E7 proteins from the human papillomavirus as described previously 
(Fichorova et al., 1997). Cells were maintained in flasks at 37°C in a 5% CO2 
incubator in keratinocyte serum-free medium (KSFM) supplemented with 50 
µg/mL of bovine pituitary extract, 0.1 ng/ml of epidermal growth factor, and 0.4 
mM CaCl2  (Invitrogen, Grand Island, NY). Media were changed every 2-3 days 
and cells were allowed to grow to 70-90% confluence. Cells were then 
trypsinized for 10 min with 1 mL of trypsin for every 25 cm2 of flask area (0.25% 
trypsin, 2.21 mM EDTA, Corning, Manassas, VA). Trypsin was inactivated with 
DMEM supplemented with 10% fetal bovine serum (FBS, HyClone Thermo 
Scientific, Logan, UT) (7 mL added to a 25 cm2 or 75 cm2 flask and 15 mL added 
to a 162 cm2 flask).  Cells were then centrifuged at 500 x g for 5 min and split 1:3 
into new flasks with fresh media.   
For some studies, the HeLa endocervical adenocarcinoma cell line was 
used.  HeLa cells were maintained in DMEM supplemented with 10% FBS. HeLa 
cells were maintained and split in a similar fashion to the End/E6E7 cells. 
Primary oral pharyngeal cells (OKP7 cells) were also utilized. OKP7 cells were 
maintained in KSFM in a similar fashion to End/E6E7 cells. 
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N. gonorrhoeae cultures  
N. gonorrhoeae strain FA1090B (provided by J.G. Cannon University of 
North Carolina), which expresses the OpaB adhesin protein in the absence of all 
other Opa proteins (Cole et al., 2010), was used to minimize variation in epithelial 
cell invasion due to Opa phase variation. Bacteria were plated on chocolate agar 
plates from frozen stocks and grown overnight at 37°C in a 5% CO2 incubator. 
The next day, colonies were inoculated in Chemically Defined Medium (CDM) 
and grown in liquid cultures for 2 to 3 h. To formalin fix the bacteria, cultures 
were centrifuged at 2000 x g for 10 min and resuspended in 0.4% formalin 
diluted in PBS (Sigma, St. Louis, MO). The bacteria remained in formalin solution 
for 2 h on a rocker at room temperature. The bacteria were then centrifuged at 
2000 x g for 10 min and washed in sterile phosphate buffered saline (PBS, 1x, 
Corning) 3 times before final resuspension in cell culture media (KSFM or 
DMEM). Formalin killed bacteria were stored at 4˚C for up to 2 months. 
 
Epithelial cell stimulation 
Epithelial cells (End/E6E7 cells, HeLa cells or OKP7 cells) were seeded in 
12 well plates (3.5 x 105/ml) and grown to confluency. Bacterial cultures grown in 
CDM were centrifuged at 2000 x g for 10 min and resuspended in KSFM at an 
optical density (OD600 nm) of 1.0 and diluted to obtain an appropriate multiplicity 
of infection (MOI) prior to addition to End/E6E7, HeLa or OKP7 cells for various 
time points. The number of colony forming units (CFU) for an OD of 1.0 was 
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determined the day before the experiment and ranged from 6-9 x 108 CFU/mL. 
For each experiment, the inoculum was diluted and plated to determine the 
number of CFU and actual MOI used. Cells were also incubated with TNFα (50 
ng/ml; BD Pharmigen, San Diego, CA) as a control for activation.  
 
Determination of bacterial CFU  
After incubation of N. gonorrhoeae with End/E6E7 cells, the number of 
intracellular, cell associated and extracellular bacteria were determined. To 
assess intracellular bacteria, infected cells were washed 3 times with PBS, 
followed by addition of fresh medium with gentamicin (50 µg/ml) (Sigma), and 
incubation of the cultures for an additional 90 min.  The cells were again washed 
3 times with PBS, followed by addition of a 1.0 mL saponin (1%; Sigma) in PBS 
(1x, Corning). Cells were incubated for 10 min to facilitate cell lysis, at which 
time, cells were scraped off the plate and cell lysates were collected in a 1.5 mL 
microcentrifuge tube. For cell-associated bacteria, infected cells were washed 3 
times with PBS without gentamicin treatment, followed by addition of a 1.0 mL 
1% saponin. After 10 min, cells were scraped off the plate and cell lysates were 
collected in a 1.5 mL microcentrifuge tube. To assess extracellular bacteria, cell 
culture supernatants were collected in sterile 1.5 ml microcentrifuge tubes.  For 
intracellular, cell-associated and extracellular bacteria, appropriate dilutions 
made in PBS were plated onto chocolate agar plates that were incubated at 37˚C 
in a 5% CO2 incubator overnight, and bacterial CFUs were counted to determine 
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the number of viable bacteria. CFUs were divided by the initial inoculum and data 
were presented as percent of initial inoculum. 
 
Protein preparation 
End/E6E7 cells were incubated as described above. Cell culture 
supernatants were collected, centrifuged at 10000 x g to remove cellular debris 
and the protein was precipitated with ethanol (80% v/v) at -80˚C overnight. The 
precipitated protein was resuspended in 50µL of Laemmli buffer (Bio-Rad, 
Hercules, CA). For whole cell lysates, cells were lysed by addition of RIPA buffer 
(25 mM Tris HCl, pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 
0.1% sodium dodecyl sulfate, Thermo Scientific, Waltham, MA) directly to the 
plate. Total protein concentration of whole cell lysates was determined by a 
bicinchoninic acid (BCA) protein assay (Sigma). Briefly, a protein standard curve 
of bovine serum albumin (BSA) was made in RIPA buffer.  Bicinchoninic acid 
was mixed with 4%(w/v) CuSO4 • 5H2O at a ratio of 5 mL to 100 µL to obtain the 
working reagent; 100 µL of this solution were added to each well of a 96-well 
plate, followed by the addition of 2 µL of protein sample.  The plate was 
incubated at 37˚C for 30 min and absorbance was read in a spectrophotometer 
at 562 nm. Protein concentrations were determined from the standard curve.  
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Western blot analysis and silver staining 
Aliquots of the protein from cell supernatants and cell lysates were diluted 
in Laemmli sample buffer (Bio-Rad, Hercules, CA) and examined by Western blot 
analysis. Proteins were separated by 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) in running buffer (25 mM Tris, 
192 mM glycine, 0.1% sodium dodecyl sulfate; Sigma) with molecular weight 
marker (Fisher EZ Run BP3603-1; Thermo Scientific) at 90 volts for 2 h. For 
silver staining, gels were stained with Bio-Rad silver staining kit per 
manufacturers instructions (Bio-Rad, Hercules, CA). Essentially, gels were 
washed in deionized water and then treated with fixative, oxidizer, silver stain 
and developer. For Western blot analysis, proteins were transferred to 
polyvinyldifluoride membranes (Bio-Rad, Hercules, CA), blocked with 5% milk in 
tris buffered saline with 1% tween (TBS-T) and probed with the following 
antibodies: cIAP2 (BD Pharmigen, clone F30-2285, San Diego, CA), ubiquitin, 
(Cell Signaling 3993, Beverly, MA), LC3A/B (Cell Signaling 4108, Beverly, MA), 
IκBα (Cell Signaling 9242), grp94 (Cell signaling 2104), CD9 (Santa Cruz C-4, 
Dallas, TX) and GAPDH (Cell Signaling 14C10, Beverly, MA), the latter as a 
loading control. Following overnight incubation with primary antibodies diluted 
1:1000 in blocking buffer at 4˚C, membranes were washed in TBS-T and 
incubated with secondary antibodies (goat anti-rabbit or anti-mouse IgG 
conjugated to horseradish peroxidase (Cell Signaling Technology, Danvers, 
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MA)), which were diluted 1:10000 in 5% milk in TBS-T and incubated with 
membranes for 1 h at room temperature.  The membranes were washed, with 
TBS-T and developed using chemiluminescent reagents (ECL Prime Western 
Blotting Detection Systems, GE Healthcare, Piscataway, NJ) and exposed to film 
(Thermo Scientific, Rockford, IL). Densitometry of protein bands was performed 
in ImageJ (NIH) to compare intensity values between experimental conditions. 
 
Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) 
RNA was isolated from End/E6E7 cells or HeLa cells using TRIzol reagent 
(Invitrogen, Grand Island, NY) as per manufacturer’s instructions. Glycogen was 
not used as an optional additive and RNA pellets were washed twice with 70% 
ethanol as opposed to once. RNA pellets were resuspended in 50 µL of RNAse 
free water. DNA was removed using the TURBO DNA-free Kit (Invitrogen, Grand 
Island, NY) as per manufacturer’s instructions and RNA concentration was 
assessed by measuring A260/280 spectrophotometrically (nanodrop) following 
DNA depletion. Reverse transcription was performed on 500 ng of total RNA in a 
final volume of 20 µL using the High-Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, Grand Island, NY) as per manufacturer’s instructions on a 
BioRad C1000 Thermal Cycler. The qPCR reactions were performed using 4 µL 
of cDNA, 10 µL of the TaqMan Gene Expression Master Mix and 1 µL of each 
TaqMan primer (BIRC2 Hs01112284_m1 and BIRC3 Hs00985031_g1) in a total 
volume of 20 µL (Applied Biosystems). Reactions were carried out in the Step 
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One Real Time PCR System with the following conditions: 50°C for 2 min, 95°C 
for 10 min followed by 40-45 cycles of 95°C for 15 sec and 60°C for 1 min, during 
which fluorescence was measured.  The relative levels of expression between 
control and treatment samples was calculated using the 2-ΔΔCt formula, where 
ΔCt= Ct target gene- Ct housekeeping gene and ΔΔCt= ΔCt treatment – ΔCt 
control.  The expression levels were then subjected to a log2 transformation to 
produce fold change. The control sample was untreated samples at 3 h. 
Reactions were performed in triplicate, averaged and normalized to the 
housekeeping gene β-actin (ACTB Hs01060665_g1) to quantify relative gene 
expression. A no template control was used for each primer as a negative 
control. 
 
cIAP2 degradation assays 
To inhibit the proteasome, cells were treated with 10 µM MG132 (Sigma) 
in DMSO for 3 h following 3 h of N. gonorrhoeae or TNFα stimulation. To inhibit 
lysosomes, cells were treated with 50 nM bafilomycin (LC Laboratories, Woburn, 
MA) in DMSO for 3 h following 3 h of N. gonorrhoeae or TNFα stimulation. To 
determine the half-life of the cIAP2 protein, End/E6E7 cells were treated with 50 
µg/mL of cycloheximide (Sigma) in DMSO for 30 min, 1, 3, 6, and 24 h. All 
controls were DMSO treated and all co-cultures were maintained at 37°C in a 5% 
CO2 incubator for indicated times. Cells were then washed with PBS (1x, 
Corning), lysed in RIPA buffer and analyzed by Western blot analysis as 
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described above. Changes in cIAP2 protein expression due to treatments were 
examined with anti-cIAP2 antibody.  
 
Caspase-3 activity assay 
End/E6E7 cells were unstimulated, stimulated with N. gonorrhoeae or 
TNFα for 12 h. Following cell incubation for 12 h, both adherent and non-
adherent cells were collected in PBS and lysed in RIPA buffer at -20˚C overnight. 
The following day, lysates were thawed and centrifuged at 10000 x g for 10 min 
to remove cell debris and caspase-3 activity was measured in the supernatants 
with the EnzChek Caspase-3 Assay Kit (Life Technologies, Carlsbad, CA) as per 
the manufacturer’s instructions. Essentially, the supernatants were incubated 
with the fluorogenic substrate Z-DEVD-AMC in a 96-well microplate for 30 min to 
measure fluorescence emission upon cleavage by active caspase-3.  The plate 
was read in a fluorescence microplate reader using an excitation wavelength of 
365 nm and emission at 465 nm. Data were expressed as raw fluorescence 
units.  
 
Cell death analysis by flow cytometry   
Cell death was examined by flow cytometry using annexin-V and 
propidium iodide (PI) staining. End/E6E7 cells (106 cells/well) were incubated 
with N. gonorrhoeae or TNFα for 12 h as described above. Adherent and non-
adherent cells were collected, washed in PBS/0.5% FBS (FACS buffer) and 
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resuspended in 100 µL Annexin-V Binding Buffer (BioLegend, San Diego, CA) 
containing Annexin-V-Pacific Blue (4 µg/mL; BioLegend) and PI (15 µg/mL; 
BioLegend). Cells were analyzed by flow cytometry on a LSRII SORP flow 
cytometer using FACSDiva™ acquisition and analysis software (Becton 
Dickinson, San Jose, CA). Gating was used to exclude cellular debris. Data were 
analyzed using Flowjo™ software. 
 
Cell lysis analysis by lactate dehydrogenase (LDH) release assay 
End/E6E7 cells were plated in 96-well plates and incubated with N. 
gonorrhoeae or TNFα for 24 h as described above. A lysis buffer was added to a 
positive control well 45 minutes prior to collection. Following stimulation, plates 
were centrifuged at 1000 x g for 5 min and the culture supernatants transferred to 
a fresh 96-well plate. LDH release was measured using the colorimetric CytoTox 
96 Non-Radioactive Cytotoxicity Assay (Promega, Madison, WI). The plate was 
read at 490 nm. The cyotoxicity percent for each sample was determined as a 
percentage of maximum lysis of the positive control.  
 
Cytokine enzyme-linked immunosorbent assay (ELISA) 
IL-6, IL-1β and TNFα secretion from EndE6/E7 cells was measured by 
ELISA of cell culture supernatants using an IL-6, IL-1β or TNFα kit (BD 
Bioscience, San Diego, CA) as specified by the manufacturer. Essentially, cell 
culture supernatant dilutions were determined such that experimental values 
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remained within the standard curve of each cytokine kit. From the standard 
curve, samples were expressed as pg/mL. 
 
Exosome and N. gonorrhoeae outer membrane bleb isolation and 
purification 
Exosomes were isolated as described (Théry et al., 2006). Briefly, culture 
supernatants were collected from 107 End/E6E7 cells or HeLa cells seeded in a 
10 cm dish incubated as described above. Supernatants were centrifuged at 500 
x g for 5 min to remove whole cells and then at 16000 x g for 20 min to remove 
cellular and bacterial debris. The clarified supernatants were filtered using 0.2 µm 
syringe filters and ultracentrifuged at 100000 x g at 4˚C overnight. To obtain N. 
gonorrhoeae blebs, FA1090B were grown in CDM for 3 h followed by 
centrifugation at 16000 x g for 20 min to remove the bacteria. The supernatant 
was filtered using a 0.2 µm syringe filter and ultracentrifuged at 100,000 x g at 
4˚C overnight. Aliquots of the resulting pellets containing either the exosome 
fraction or N. gonorrhoeae blebs were resuspended in 200 µL PBS for 
subsequent Western blot analysis. The exosomes were further immunopurified 
using CD9 coated magnetic beads from the Exo-FLOW™ kit (System 
Biosciences, Mountain View, CA) prior to lysis in RIPA buffer and Western blot 
analysis. Essentially, CD9 coated magnetic beads were incubated with 
exosomes overnight at 4˚C. Exosomes and beads were then washed with 
supplied washing buffer and magnetic stand 3 times. Using 50 µL of the supplied 
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elution buffer, exosomes were eluted from magnetic beads by gentle rocking for 
1 h and lysed by addition of 50 µL of RIPA buffer. Exosomes were then 
quantified by BCA protein assay as described above. 
 
Exosome quantification and size characterization 
To determine enzymatic activity of the isolated exosomes or N. 
gonorrhoeae blebs, exosomes were isolated by ultracentifugation and an aliquot 
of the exosome pellet was resuspended in PBS for quantification of exosomes by 
acetylcholinesterase activity (Savina et al., 2002). Briefly, 50 µL of the pellet were 
diluted in 243 µL PBS in a 96-well plate followed by addition of 0.1 mM 5,5′-
dithiobis(2-nitrobenzoic acid) and 1.25 mM acetylthiocholine (Sigma) in a final 
volume of 300 µL. Changes in absorbance at 412 nm were monitored at 10 min 
intervals for 80 min.  To determine if exosome formation in End/E6E7 cells was 
sphingomyelinase dependent, End/E6E7 cells were unstimulated or stimulated 
with N. gonorrhoeae at an MOI 10 as described above. After 2 h, cells were 
treated with DMSO (vehicle control) or 15 µM GW4869 (Cayman Chemicals, Ann 
Arbor, MI). Conditioned media were collected after 20 h and exosomes were 
isolated and quantified by acetylcholinesterase activity as described above. 
To directly count and size exosomes and N. gonorrhoeae bleb particles on 
the NanoSight particle counter, exosomes or blebs were isolated by 
ultracentrifugation and resuspended in 200 µL PBS. Resuspended particles were 
further diluted 10 times in PBS and injected into the NanoSight instrument. 
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Exosome concentration was quantified as particles/mL. Particle diameter was 
determined for both exosomes and isolated N. gonorrhoeae blebs. Nanoparticle 
tracking analysis (NTA) was performed using a NanoSight instrument. The 
NanoSight system was calibrated with polystyrene nanobeads prior to analysis.  
To directly count and size exosome and N. gonorrhoeae bleb particles on 
the ZetaView™ particle counter, exosomes or blebs were isolated by 
ultracentrifugation and resuspended in 200 µL PBS. The exosomes were further 
immunopurified using CD9 coated magnetic beads from the Exo-FLOW™ kit 
(System Biosciences, Mountain View, CA), as described above but without the 
addition of lysis buffer. Eluted exosomes were diluted 10 times in PBS and 
injected into the ZetaView™ instrument. Exosome concentration was quantified 
as particles/mL. Particle diameter was determined for both exosomes and 
isolated N. gonorrhoeae blebs.  
  
Exosome transmission electron microscopy  
Exosomes were pelleted as described above and fixed by layering 4% 
paraformaldehyde in 0.1 M sodium phosphate buffer at pH 7.4 (PFA) onto the 
exosome pellet for 2 h at room temperature. PFA was replaced with PBS and 
pellets were infiltrated with 2.3 M sucrose in PBS containing 0.2 M glycine for 15 
min prior to freezing in liquid nitrogen. Frozen samples were sectioned at -120°C 
and 60-80 nm sections were transferred to formvar-carbon coated copper grid. 
Sections were contrasted and embedded in methyl cellulose by floating the grids 
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on a mixture of 0.3% uranyl acetete in 2% methyl cellulose for 5 min. Excess 
liquid was blotted on a filter paper and the grids were examined in a JEOL 
1200EX transmission electron microscope and images were recorded with an 
AMT 2k CCD camera.  
 
Exosome treatment of End/E6E7 cells 
 Exosomes from unstimulated End/E6E7 cells or End/E6E7 cells 
stimulated with formalin killed N. gonorrhoeae were isolated as described above 
and quantified by bicinchoninic acid protein assay (Sigma). For cytokine analysis, 
5 x 105 End/E6E7 cells were untreated or treated with exosomes for 24 h (µg 
exosomes used are specified in each figure legend). For caspase-3 analysis, 5 x 
105 End/E6E7 cells were untreated or treated with 50 µg exosomes from 
unstimulated cells for 24 h prior to 3 µM STS treatment for 6 h. Cells were lysed 
and analyzed for caspase-3 activity as described above. Finally, for FACs 
analysis, cells were untreated or treated with 50 µg exosomes from unstimulated 
cells for 24 h prior to stimulation with N. gonorrhoeae for 6 h. Cells were 
collected, stained and analyzed for PI and annexin V staining as described 
above. 
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Statistical analysis 
Data were analyzed by T tests or ANOVA with Bonferroni's posttest. A p-
value of .05 was considered statistically significant. All data were analyzed with 
GraphPad Prism software (GraphPad Software, Inc., San Diego, CA). 
 
Medium, Buffers and Reagents 
All reagents were obtained from Sigma Chemical Corp. (St. Louis, MO) unless 
stated otherwise. 
 
Chemically Defined Medium (CDM) 
Amino acids 
L-cysteine (0.15 mM, catalog # C 4424), L-hypoxanthine (0.37 mM, catalog # T 
8941), uracil (0.45 mM, catalog # U 0750) were dissolved in 100 ml of 1.0 N 
NaOH. 
L-alanine (1.1 mM, catalog # A 5824), L-arginine-HCl (0.71 mM, catalog # A 
5131), L-asparagine.H20 (0.17 mM, catalog # A 8381), L-aspartic acid (3.8 mM, 
catalog # A 6558), L-cysteine HCl (0.35 mM, catalog # C 1276), L-glutamic acid 
(8.8 mM, catalog # G 1626), L-glutamine (0.34 mM, catalog # G 3126), 
Glutathione reduced (0.15 mM, catalog # G 1404), Glycine (0.33 mM, catalog # 
G 7403), DL-histidine HCl-H2O (0.12 mM, catalog # H 7875), DL-isoleucine (0.23 
mM, catalog # J 5393), DL-leucine (.69 mM, catalog # L 7875), DL-lysine HCl 
(0.27 mM, catalog # L 6001), DL-methionine (0.1 mM, catalog # M 9500) DL-
	  71 
phenylalanine (0.15 mM, catalog # P1876), L-proline (0.43 mM, catalog # P 
8449), DL-serine (0.48 mM, catalog # S 4375), DL-threonine (0.42 mM, catalog # 
T 8375), and L-valine (0.51 mM, catalog # V 0500) were dissolved in 2000 ml 
double distilled water (ddH2O). 
Amino acids in acid and base (from above) were added and made up to a 
volume of 2700 ml with ddH2O. 
 
Vitamins/Biotin 
Thiamine HCl (0.0059 mM, catalog # T 4625). co-carboxylase  (0.001 mM, 
catalog # C 8754), biotin (0.012 mM, catalog # B 4501), D-pantothenic acid 
(0.004 mM catalog # P 2250 were dissolved in 300 ml of 95% ethanol and made 
up to a volume of 600 ml with ddH2O. 
 
Phosphate Buffer 
KH2PO4 (4 mM, catalog # P 0662), K2HPO4 (4 mM, catalog # P 8281) were 
dissolved in 200 ml of ddH2O and made up to a volume of 400 ml with ddH2O. 
 
HEPES buffer 
HEPES (20 mM, catalog # H 3375) was dissolved in 200 ml ddH2O and made up 
to a volume of 400 ml with ddH2O. 
 
Salt Solution 
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NaCl (58.45 g, catalog # S 3014), K2SO4 (10 g, catalog # P 9458), MgCl2-6H2O 
(2.18 g, catalog # M 2670), NH4Cl (2.2 g, catalog # A 9434), EDTA (30 mg, 
catalog # E 5134) were dissolved in 150 ml of ddH2O and made up to a volume 
of 250 ml with ddH2O. 
 
Glucose 
(20% stock in ddH2O, catalog # D16-500) 
 
Calcium Chloride 
(0.25 mM in ddH2O, catalog # C 3881) 
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Chapter 3. Neisseria gonorrhoeae induces a transient increase of 
intracellular cIAP2, followed by production of exosome-associated cIAP2 in 
human endocervical epithelial cells 
Our laboratory demonstrated that N. gonorrhoeae protects human 
endocervical epithelial cells from apoptosis, thereby maintaining an intracellular 
niche and evading immune clearance (Follows et al., 2009). Our laboratory also 
reported that N. gonorrhoeae stimulation of human endocervical epithelial cells 
significantly increases expression of cIAP2 (Follows et al., 2009). A role for 
cIAP2 has been postulated in this function, but has not been examined in detail. 
cIAP2 is part of a family of proteins known as the IAPs. IAPs are potent inhibitors 
of apoptosis, however their regulatory functions extend beyond apoptosis. The 
IAPs regulate several forms of programmed cell death, each with distinct 
inflammatory outcomes. The IAPs also regulate NF-κB transduction, which is 
responsible for induction of genes necessary for inflammation, cell migration and 
cell survival.  
Expression of cIAP2 is tightly regulated through transcription (Wang et al., 
1998), translation (Chae et al., 2010) and sub-cellular localization (Vischioni et 
al., 2006). The stability of cIAP2 is also regulated by anti-apoptotic factors as well 
as autoubiquitylation and subsequent proteasome degradation. In this section, 
we report on changes in cIAP2 expression and localization following N. 
gonorrhoeae stimulation of End/E6E7 cells.  
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cIAP2 mRNA expression 
To determine if cIAP2 expression was induced by formalin killed bacteria 
or TNFα as had been demonstrated with live N. gonorrhoeae, qRT-PCR of cIAP2 
was performed on End/E6E7 cells f 3, 6 and 24 h post-stimulation. TNFα was 
used because of its known ability to induce cIAP2 expression (Gaur and 
Aggarwal, 2003, Furusu et al., 2007, Wang et al., 1998). TNFα induced cIAP2 
transcript levels as early as 6 h with sustained induction over time (Figure 6A). 
Live N. gonorrhoeae at an MOI of both 10 and 100 increased cIAP2 expression 
starting at 6 h and significantly increased expression at 24 h. Formalin killed 
bacteria (MOI 100) did not significantly induce cIAP2 mRNA expression in 
End/E6E7 cells. The expression of cIAP2 mRNA was also examined in HeLa 
cells. Similar cIAP2 expression patterns were observed in HeLa cells as 
End/E6E7 cells: TNFα and live bacteria induced expression while formalin killed 
bacteria did not (Figure 6B). Both MOI of 10 and 100 induced significantly more 
cIAP2 expression at 24 h when compared to 3 h of stimulation or compared to 24 
h of unstimulated cells. 
Because of their similar functions, the literature describing cIAP2 often 
investigated cIAP1 simultaneously. However, several studies have demonstrated 
cIAP1 and cIAP2 to be induced independently under certain conditions 
(Rajalingam et al., 2006, Damiano et al., 2006). To determine if N. gonorrhoeae 
or TNFα induced cIAP1 mRNA in End/E6E7 cells, levels of cIAP1 and cIAP2 
mRNA expression were examined at 3, 6 and 24 h post-stimulation. When 
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compared to unstimulated cells at each time point, both TNFα and N. 
gonorrhoeae significantly induced cIAP2 but not cIAP1 expression (Figure 7). It 
should be noted that y-axis scales are different between cIAP2 and cIAP1; 
N.gonorrhoeae and TNFα induced cIAP2 nearly 100 fold at 24 h while cIAP1 is 
never induced more than 3 fold.  
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Figure 6. N. gonorrhoeae stimulation induces an increase in cIAP2 mRNA 
expression in both End/E6E7 cells and HeLa cells.  
End/E6E7 cells (A) or HeLa cells (B) were either unstimulated (black bars) or 
incubated with 50 ng/mL TNFα (grey bars), formalin killed N. gonorrhoeae (white 
bars) or live bacteria at an MOI of either 10 (blue bars) or 100 (red bars) for 
indicated times. RNA was isolated from whole cells using TRIzol and mRNA 
expression was determined as described in Material and Methods. Fold change 
is compared to unstimulated cells at 3 h. Graph depicts the mean ± SEM of 
triplicate wells of one experiment. Two-way ANOVA (**p < 0.01. ***p<0.001). 
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Figure 7. N. gonorrhoeae stimulation induces an increase in cIAP2, but not 
cIAP1, mRNA expression in End/E6E7 cells over time.  
End/E6E7 cells were either unstimulated, treated with 50 ng/mL of TNFα (white 
bars) or treated with N. gonorrhoeae at an MOI of 100 (grey bars) for indicated 
times. RNA was isolated from whole cells using TRIzol and analyzed for either 
cIAP2 (A) or cIAP1 (B) mRNA expression. Fold change is compared to 
unstimulated cells at 3 h. Graph depicts the mean ± SEM of three independent 
experiments. Two-way ANOVA (*p < 0.05, ***p<0.001). 
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cIAP2 protein expression 
To examine whether the increase in cIAP2 mRNA corresponded to 
increased levels of cIAP2 protein, Western blot analysis of whole cell lysates 
(WCL) was performed. Following epithelial cell incubation with N. gonorrhoeae 
FA1090B strain at MOI 10 and MOI 100, a time-dependent increase of 
intracellular cIAP2 levels was observed. Expression of cIAP2 peaked at 6 h post-
stimulation but was followed by a decrease in detectable protein after 24 h 
stimulation (Figure 8A). Formalin killed bacteria also induced cIAP2 protein 
expression, and it was maintained at 24 h post-stimulation (Figure 8B).  A similar 
early increase in cIAP2 expression pattern was observed following stimulation 
with TNFα (50 ng/ml) (Figure 8C), with sustained expression at all time points 
examined. No detectable cIAP2 protein was evident in response to simultaneous 
stimulation of End/E6E7 cells with both N. gonorrhoeae and TNFα for 24 h 
(Figure 8D). Interestingly, the decrease in cIAP2 protein levels observed after a 
24 h incubation with N. gonorrhoeae (MOI 100) did not correspond to a decrease 
of cIAP2 mRNA, as determined by qPCR (Figure 7A). Both TNFα and N. 
gonorrhoeae induced sustained cIAP2 mRNA levels over the course of 
stimulation. 
We next sought to determine if the observed transient cIAP2 protein 
expression was unique to End/E6E7 cells or could be replicated in other 
epithelial cells. Because cIAP2 expression can be dysregulated in cancer cells or 
by the E6/E7 proteins (Wu 2010), cIAP2 expression was examined in primary 
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oral pharyngeal cells (OKP7 cells). Similar to End/E6E7 cells, TNFα induced 
sustained cIAP2 expression from 3 to 24 h while live N. gonorrhoeae induced 
cIAP2 expression that peaked at 6 h post-stimulation and decreased by 24 h in 
OKP7 cells (Figure 9A). Expression of cIAP2 protein was also examined in HeLa 
cells, which were found to be less responsive to TNFα or N. gonorrhoeae 
stimulation than either End/E6E7 cells or OKP7 cells (Figure 9B).  
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Figure 8. N. gonorrhoeae induces a transient increase of intracellular cIAP2 
in End/E6E7 cells.  
A. End/E6E7 cells were either unstimulated (Un), treated with 50 ng/mL of TNFα 
for 24 h or treated with N. gonorrhoeae at an MOI of 10 or 100 for indicated 
times. Representative of 5 separate experiments. B. End/E6E7 cells were 
unstimulated (Un) or stimulated with formalin killed N. gonorrhoeae at an MOI of 
100 for the indicated times. Representative of 3 separate experiments. C. 
End/E6E7 cells were unstimulated (Un) or treated with 50 ng/mL of TNFα for the 
indicated times. Representative of 5 separate experiments. D. End/E6E7 cells 
were unstimulated (Un), treated with 50 ng/mL of TNFα, treated with N. 
gonorrhoeae (MOI 10 or MOI 100) or both simultaneously for 24 h. 
Representative of 3 separate experiments. For A-D, whole cell lysates were 
collected from End/E6E7 cells at the indicated time points and examined by 
Western blot analysis using antibodies against cIAP2 and GAPDH. Changes in 
protein levels were compared to cells left unstimulated for 24 h.  
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Figure 9. N. gonorrhoeae induces a transient increase of intracellular cIAP2 
in primary oral pharyngeal cells and HeLa cells.  
A. Primary oral pharyngeal cells were either unstimulated (Un), treated with 50 
ng/mL of TNFα or treated with N. gonorrhoeae at an MOI of 10 or 100 for 
indicated times. B. HeLa cells were either unstimulated (Un), treated with 50 
ng/mL of TNFα or treated with N. gonorrhoeae at an MOI of 100 for indicated 
times. For A-B, whole cell lysates were collected from oral pharyngeal or HeLa 
cells at the indicated time points and examined by Western blot analysis using 
antibodies against cIAP2 and GAPDH. Changes in protein levels were compared 
to cells left unstimulated for 24 h. Representative of 3 separate experiments. 
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Due to the observed differences between expression of cIAP2 mRNA and 
protein levels, the potential for cIAP2 degradation was investigated. We sought to 
determine the half-life of cIAP2 protein using the translational inhibitor 
cyclohexamide (CHX). Cells were left untreated or treated with 50 µg/mL CHX. 
Whole cell lysates were collected at 0.5, 1, 3, 6 and 24 h post treatment and 
cIAP2 expression was analyzed by Western blot analysis. Interestingly, cIAP2 
expression increased during CHX treatment whereas IκBα, a protein with a 
known short half-life, decreased over time indicating that CHX was 
pharmacologically active (Figure 10). These results indicated that cIAP2 protein 
half-life could not be determined over 24 h using CHX. 
To further explore the potential for cIAP2 degradation, End/E6E7 epithelial 
cells were stimulated with TNFα or N. gonorrhoeae (MOI 100) prior to 4 h 
treatment with the either the proteasome inhibitor MG132 or the lysosome 
inhibitor bafilomycin (Figure 11). Cell lysates were examined by Western blot 
analysis. Because proteins targeted for the proteasome are ubiquitylated, a 
ubiquitin smear was used as a positive control for proteasome inhibition and was 
found to increase with addition of MG132. Similarly, an increase in a protein on 
autophagosomes targeted for the lysosome, LC3II, was detected following 
bafilomycin treatment, indicating lysosome suppression. No change was 
detected in cIAP2 following proteasome or lysosome inhibition in unstimulated 
cells, TNFα or N. gonorrhoeae stimulated cells (Figure 11). Collectively, these 
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results indicate that N. gonorrhoeae induces a transient increase in cIAP2 
expression that is neither proteasome- nor lysosome-mediated.   
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Figure 10. Expression of cIAP2 following cycloheximide treatment.  
A. End/E6E7 cells were left unstimulated (Un) for 24 h or incubated with 50 
µg/mL CHX for the time indicated. Whole cell lysates were collected from 
End/E6E7 and examined by Western blot analysis using antibodies against 
cIAP2, IκBα and GAPDH. B. From two separate experiments performed in 
duplicate, densitometry of cIAP2 and IκBα were normalized to GAPDH over time. 
Graph depicts the mean of duplicate wells and is representative of two 
independent experiments. 
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Figure 11. N. gonorrhoeae does not induce cIAP2 degradation via the 
proteasome or lysosomes.  
A. End/E6E7 cells were either unstimulated (Un), or stimulated with 50 ng/mL 
TNFα or with N. gonorrhoeae at an MOI 100 for 20 h before treatment with 10 
µM MG132 for 3 h. B. End/E6E7 cells were either unstimulated (Un), or 
stimulated with 50 ng/mL TNFα or with N. gonorrhoeae at an MOI 100 for 4 h 
before treatment with 10 nM bafilomycin (BAF) for 4 h. Protein levels were 
determined by Western blot analysis using antibodies against cIAP2, GAPDH, 
ubiquitin and LC3II. GAPDH served as the protein loading control, while the 
ubiquitin smear served as a positive control for MG132 and LC3II served as a 
positive control for BAF. Images are representative of 3 separate experiments. 
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cIAP2 localization 
Since the observed loss of intracellular cIAP2 induced by N. gonorrhoeae 
in End/E6E7 cells at 24 h was not due to either lack of mRNA expression or 
increased protein degradation, we next examined if cIAP2 was being released 
from epithelial cells. End/E6E7 cells were incubated with TNFα or N. 
gonorrhoeae (MOI 100) for 3, 6, and 24 h and whole cell lysates and cell culture 
supernatants were collected for electrophoretic analysis. Prior to SDS-PAGE and 
Western blot analysis, supernatants were cleared of cell debris and the proteins 
were concentrated by ethanol precipitation. As shown in Figure 12, cIAP2 was 
consistently detected in the cell supernatant fractions from unstimulated cells and 
from cells stimulated with TNFα at all time points (Figure 12A), suggesting that a 
constitutive release of cIAP2 may be occurring and that this was not influenced 
by cell activation via TNFα. In contrast, we observed increased amounts of 
extracellular cIAP2 following N. gonorrhoeae stimulation, which was maximal at 
24h (Figures 12A and 12B).  To determine if this resulted from lysis of End/E6E7 
cells, the presence of extracellular LDH (indicative of compromised cell 
membrane integrity) was determined by an LDH assay. As shown in Figure 10C, 
no increase in LDH release was observed 24h after either TNFα or N. 
gonorrhoeae stimulation of End/E6E7 cells, suggesting that extracellular cIAP2 
was not due to cell lysis (Figure 12C).  
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Figure 12. N. gonorrhoeae induces extracellular cIAP2 released from 
human endocervical epithelial cells.  
End/E6E7 cells were either unstimulated (Un), treated with 50ng/mL of TNFα or 
N. gonorrhoeae at an MOI of 100. A. Cell culture supernatants were examined 
for cIAP2 by Western blot analysis at the indicated time points using an antibody 
against cIAP2. B. Densitometry of extracellular cIAP2 from 3 independent 
experiments (TNFα dotted line, MOI 100 solid line). Fold change was compared 
to supernatants from unstimulated cells after 24 h. C. LDH release after 24 h, 
depicting the mean ± SEM of four independent experiments. One-way ANOVA  
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It has been reported that survivin, another member of the IAP family, is released 
from cells and is enriched in secreted exosomes	   (Khan et al., 2010). Exosomes 
are 40-100 nm lipid vesicles released for delivery of protein, RNA and other 
intracellular products to proximal and distal cells (Raposo and Stoorvogel, 2013). 
To examine if the extracellular localization of cIAP2 induced by N. gonorrhoeae 
was due to shuttling via exosomes, we isolated exosome fractions from 
End/E6E7 cells stimulated with N. gonorrhoeae (MOI 10 and 100) and TNFα for 
24 h. Cell culture supernatants were cleared of cell and bacterial debris by 
centrifugation and filtration prior to ultracentrifugation for exosome isolation. 
Exosome fractions were examined by Western blot analysis with an anti-CD9 
antibody, an exosome marker. As shown in Figure 13A, this analysis confirmed 
exosome enrichment.  Grp94 is a marker for Golgi apparatus; testing its 
expression confirmed that this intracellular organelle was not contaminating the 
samples. Furthermore, cIAP2 protein was detectable in the exosome fractions as 
measured by Western blot analysis (Figure 13B), with the highest level of cIAP2 
in exosome fractions isolated from N. gonorrhoeae stimulated cells. The 
expression of cIAP2 protein was also evident in exosomes isolated from N. 
gonorrhoeae stimulated HeLa cells (Figure 13C). 
These results indicate that N. gonorrhoeae induced cIAP2 localization to 
exosomes, however, it was unclear if there was more detectable cIAP2 in 
exosomes from gonococcal stimulated cells because more cIAP2 was being 
shuttled to exosomes or if there was a general increase in exosome production. 
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An additional concern was that the fractions tested contained both exosomes 
from End/E6E7 cells as well as small blebs shed from the outer membrane of N. 
gonorrhoeae (Zielke et al., 2014, Dorward and Garon, 1989). In order to separate 
exosomes derived from stimulated End/E6E7 cells from N. gonorrhoeae blebs, 
the exosomes were immunopurified with anti-CD9 coated magnetic beads from 
the Exo-FLOW™ kit (Figure 14). After the anti-CD9 magnetic beads captured the 
exosomes, they were stained with a membrane FITC dye and sorted by flow 
cytometry. The anti-CD9 magnetic beads incubated with N. gonorrhoeae blebs 
did not have FITC staining indicating that the CD9 magnetic beads were specific 
to exosomes (Figure 14). 
Exosomes were thus immunopurified using the anti-CD9 magnetic beads 
to separate them from potential large, membrane-associated protein aggregates 
and from N. gonorrhoeae blebs. The bead-associated fraction was washed, the 
exosomes were eluted from the beads and equivalent total protein amounts were 
examined by Western Blot analysis for cIAP2 expression. As shown in Figure 15, 
the presence of cIAP2 in the exosome-enriched fractions from cells stimulated 
with N. gonorrhoeae at MOI 10 and MOI 100 was confirmed.  
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Figure 13. N. gonorrhoeae promotes cIAP2 association with exosome 
fraction released from End/E6E7 cells.  
A. Exosomes (Exo) and whole cell lysates (WCL) were harvested from 
unstimulated End/E6E7 cells and examined by Western blot analysis using 
antibodies against the exosome marker CD9 and the Golgi marker grp94. B. 
End/E6E7 cells or C. HeLa cells were either unstimulated (Un), stimulated with 
TNFα (50 ng/mL), or with N. gonorrhoeae at an MOI of 100 for 24 h. Exosomes 
were isolated by ultracentrifugation and examined by Western blot analysis using 
antibodies against cIAP2 and the exosome marker CD9. Images from End/E6E7 
cells (A-B) are representative of 5 separate experiments while image from HeLa 
cell (C) is representative of 2 separate experiments. 
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Figure 14. Exosomes released by End/E6E7 can be separated from N. 
gonorrhoeae blebs.  
Cells were unstimulated or stimulated with TNFα (50 ng/mL) or live N. 
gonorrhoeae at an MOI of 10 for 24 h. Exosomes were isolated by 
ultracentrifugation and then resuspended in PBS for Exo-Flow™ as described in 
Materials and Methods. N. gonorrhoeae blebs were also isolated and 
resuspended in PBS. The resuspended exosome or N. gonorrhoeae bleb fraction 
was incubated with CD9 coated magnetic beads per Exo-Flow™ instructions. 
Vesicles attached to CD9 beads were stained with a removable FITC dye and 
sorted on a BD FACSARIA II SORP. A. Plot depicts CD9 coated beads without 
exosomes that were stained with FITC. B. Plot is representative of CD9 coated 
beads with exosomes from unstimulated cells that were stained with FITC. C. 
The histogram represents each condition: CD9 beads without exosomes (Red), 
CD9 beads with N. gonorrhoeae blebs (black), CD9 beads with exosomes from 
unstimulated cells (blue), CD9 beads with exosomes from TNFα stimulated cells 
(orange), CD9 beads with exosomes from N. gonorrhoeae stimulated cells 
(purple). This experiment was performed 2 separate times. 
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Figure 15. N. gonorrhoeae promotes release of cIAP2 in exosomes from 
End/E6E7 cells.  
End/E6E7 cells were unstimulated (Un), stimulated with TNFα (50 ng/mL), or 
with N. gonorrhoeae at an MOI of 10 or 100 for 24 h. Exosomes were isolated by 
ultracentrifugation and then immunopurified with CD9 coated beads. Exosomes 
were released from the beads and protein was quantified prior to Western blot 
analysis using antibodies against cIAP2. Representative of 2 separate 
experiments. 
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Chapter 3 Summary 
An important observation from our studies was that N. gonorrhoeae 
stimulation of epithelial cells modulates expression and localization of cIAP2.  
Previous studies have detected upregulation of cIAP2 mRNA following N. 
gonorrhoeae stimulation and have suggested cIAP2 may contribute to inhibition 
of apoptosis during gonococcal stimulation (Binnicker et al., 2003, Follows et al., 
2009). Induction of cIAP2 mRNA in response to N. gonorrheoae was confirmed 
by qPCR. In both End/E6E7 cells and HeLa cells, live N. gonorrhoeae 
continuously induced cIAP2 expression over time. Similar increases in cIAP2 
mRNA were observed for cells stimulated with TNFα, but not cells stimulated by 
formalin killed N. gonorrhoeae. When investigating cIAP1, we found that cIAP1 
expression was unresponsive to either TNFα or N. gonorrhoeae stimulation in 
End/E6E7 cells. This finding supports other studies demonstrating that both 
pathogen ligands and live bacteria induce cIAP2, but not cIAP1 (Damiano et al., 
2006, Rajalingam et al., 2006, Kim et al., 2008, Li et al., 2011).  
When examining cIAP2 protein, we found that N. gonorrhoeae stimulation 
induced a transient increase in cIAP2 protein levels in End/E6E7 cells. High early 
induction of cIAP2 protein reflected the induction of cIAP2 transcripts, however, 
the significant decrease of cIAP2 protein at later time points was contrary to the 
corresponding high levels of cIAP2 transcript. The discrepancy in cIAP2 
transcript and protein levels was not observed in TNFα treated cells: TNFα 
continuously induced both transcript and protein over time. The depletion of 
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intracellular cIAP2 at later time points was not due to proteasome of lysosome 
degradation. Instead, the intracellular depletion due to N. gonorrhoeae 
corresponded to increasing levels of extracellular cIAP2. Furthermore, the 
extracellular cIAP2 was found to be exosome associated. Although cIAP2 could 
be detected in exosomes from unstimulated and TNFα stimulated cells, N. 
gonorrheoae stimulation significantly enriched cIAP2 in isolated exosomes. 
Collectively, our studies describe a potential mechanism of cIAP2 regulation via 
exosome export during N. gonorrhoeae stimulation. 
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Chapter 4. Neisseria gonorrhoeae induction of cIAP2 modulates cell death 
in human endocervical epithelial cells 
The cIAPs are critical regulators of cell death pathways and the 
expression of cIAP2 is tightly regulated (Wang 2003, Kim 2010, Vaux 2005). The 
original proposed function of cIAP2 was to directly block caspases in both 
intrinsic and extrinsic apoptosis, yet mounting evidence shows this role for cIAP2 
is unlikely, and more likely specific to XIAP (Eckelman and Salvesen, 2006). It is 
now understood that cIAP2’s anti-apoptotic function indirectly derives from its 
ability to regulate NF-κB, due to the pro-survival proteins regulated by NF-κB 
(Damgaard and Gyrd-Hansen, 2011, Piva et al., 2006). However, it is also 
evident that cIAP2 has a direct role as an inhibitor of the extrinsic apoptosis 
pathway and necroptosis (Silke and Vucic, 2014).  
Studies have utilized knockout mice and SMAC mimetics to demonstrate 
that cIAP2 has a protective role for the host during microbial infection (Upton and 
Sridharan, 2014, Rodrigue-Gervais et al., 2014). Here, we utilized SMAC 
mimetics to determine the role of cIAP2 in cell death during N. gonorrhoeae 
stimulation of End/E6E7 cells. We explored the potential role of cIAP2 in both 
apoptosis and necroptosis. 
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N. gonorrhoeae and cell death  
To determine if there were functional consequences to the exosome 
export of cIAP2, cell death of End/E6E7 cells following stimulation with N. 
gonorrhoeae was examined. Following stimulation with N. gonorrhoeae (MOI 10 
and 100) and TNFα (50 ng/ml), cells were collected at 6,12 and 24 h, stained 
with annexin-V and PI and analyzed by flow cytometry. Two examples of flow 
cytometry plots, MOI 10 at 6 and 24 h, are shown in Figure 16A. To examine 
changes in cell death, the percentage of cells positive for annexin-V and PI was 
determined and then normalized to unstimulated cells for each time point. 
Following 24 h of N. gonorrhoeae stimulation, when intracellular cIAP2 was 
depleted (Figure 8A), we observed increased cell death compared to that 
observed following 6 h of stimulation, as measured by increased PI and annexin-
V co-staining. In contrast, TNFα stimulated cells did not undergo changes in cell 
death (Figure 16B). These data suggest a correlation between cIAP2 export and 
N. gonorrhoeae induced cell death. These results seemed contrary to our 
previous findings that N. gonorrhoeae does not induce apoptosis and instead 
prevents exogenous induction of apoptosis by STS, a chemical inducer of 
apoptosis (Binnicker et al., 2003, Follows et al., 2009). However, previous 
studies only examined markers of apoptosis while here, PI and annexin-V co-
staining, were examined. PI and annexin-V are general cell death markers, and 
can detect multiple types of cell death (Holler et al., 2000, Tenev et al., 2011). 
For example, an increase in PI and annexin-V co-staining can be the result of 
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late-stage apoptosis or any stage of necrosis (Vermes et al., 1995, Tenev et al., 
2011). To determine if cell death was due to apoptosis, we next examined 
changes caspase-3 activity, a hallmark of apoptosis. Following stimulation with 
N. gonorrhoeae (MOI 10 and 100) and TNFα (50 ng/ml), epithelial cells were 
lysed and collected at 6, 12 and 24 h. As a positive control for apoptosis, cells 
were also treated with 3 µM STS for 6 h. Whole cell lysates were examined for 
caspase-3 activity. While the addition of STS significantly increased caspase-3 
activity, N. gonorrhoeae at an MOI of 10 or 100 did not increase caspase-3 
activity at any of the time points examined (Figure 16C). As expected, TNFα had 
no effect on caspase-3 activity in End/E6E7 cells (Figure 16C). The caspase-3 
results were consistent with previous findings in which workers from our 
laboratory reported that N. gonorrhoeae stimulation did not induce apoptosis in 
End/E6E7 cells (Follows et al., 2009).  
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Figure 16. N. gonorrhoeae stimulation induces increased PI and annexin-V 
staining, but not caspase-3 activity, in human endocervical epithelial cells.  
End/E6E7 cells were either unstimulated, or stimulated with 50 ng/mL of TNFα or 
N. gonorrhoeae MOI 10 or MOI 100 for indicated times. A. Whole cells were 
stained for annexin-V (Y axis) and propidium iodide (PI, X axis) prior to FACS 
analysis. Plots represent MOI 10 from 6 h to 24 h. B. Graphical representation of 
dead cells of quadrant 1-3 (Q1-Q3) from FACs analysis. Fold change was 
compared to unstimulated cells (black bars) for each respective time point. Cells 
were stimulated with TNFα (grey bars) or N. gonorrhoeae MOI 10 (white bars) or 
MOI 100 (red bars). Graph depicts the mean ± SEM of three independent 
experiments. C. End/E6E7 cells were unstimulated (black bars) or stimulated 
with TNFα (grey bars) or N. gonorrhoeae MOI 10 (white bars) or MOI 100 (red 
bars). for 12 h. Cells were also treated with 3 µM staurosporine (STS, striped 
bar) for 6 h as a control for apoptosis. Whole cell lysates were analyzed for 
caspase-3 activity. Graph depicts the mean ± SEM of triplicate wells and is 
representative of two independent experiments. All graphs analyzed by two-way 
ANOVA (*p<0.05, ***p < 0.001). 
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A role for cIAP2 in cell death  
It is well established that N. gonorrhoeae prevents exogenous induction of 
apoptosis by STS of treatment in epithelial cells (Binnicker et al., 2003, Follows 
et al., 2009). A role for cIAP2 has been postulated in this function, but has not 
been examined in detail. This was examined here using BV6, a compound that 
rapidly ubiquitylates cIAP1 and cIAP2, targeting these proteins for proteasome 
degradation (Varfolomeev et al., 2007) (Figure 17). End/E6E7 cells were 
pretreated with 5 µM BV6 for 2 h prior to stimulation for 12 h with N. gonorrhoeae 
(MOI 10 and 100), with medium alone as a negative control, or with TNFα (50 
ng/ml) [as it requires IAP expression for NF-κB pro-survival signaling (Mahoney 
et al., 2008)]. To examine changes in cell death, adherent and non-adherent cells 
were collected, stained with annexin-V and PI and analyzed by flow cytometry. 
To elucidate the type of cell death, annexin-V and PI staining were analyzed 
separately (Figure 18A). Annexin-V is a marker for phosphatidylserine exposure 
signifying apoptosis and PI is indicative of membrane permeability and therefore 
a general cell death marker. STS (3 µM for 6 h) was used as a positive control for 
induction of apoptosis. Contrary to our previous findings when only apoptosis 
was examined, N. gonorrhoeae at an MOI 100 significantly increased PI staining 
(Figure 16B), but not annexin-V staining (Figure 18C), compared to unstimulated 
cells. TNFα alone did not induce cell death (Figure 18B). When End/E6E7 cells 
were treated with TNFα or N. gonorrhoeae in the presence of BV6, we observed 
a significantly higher percent of PI-positive cells as compared to vehicle control 
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(Figure 18B) suggesting that the presence of cIAP2 was important for 
maintaining membrane permeability and consequently cell viability.  We did not 
observe significant differences in annexin-V staining in cells treated with BV6 
(Figure 18C) suggesting that cells did not increase exposure of 
phosphatidylserine in the absence of cIAP2. 
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Figure 17. The SMAC mimetic BV6 inhibits cIAP2 expression in End/E6E7 
cell.  
End/E6E7 cells were pretreated with 5 µM BV6 or DMSO control vehicle for 2 h 
and then either unstimulated (Un), or stimulated with 50 ng/mL TNFα or with N. 
gonorrhoeae at an MOI 100 for 6 h. Whole cell lysates were analyzed by 
Western blot analysis using antibodies against cIAP2 and GAPDH. 
Representative of 3 separate experiments. 
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Figure 18. N. gonorrhoeae induction of cIAP2 modulates cell death as 
measured by FACs analysis in End/E67 cells.  
End/E6E7 cells were pretreated with DMSO control vehicle (white bars) or 5 µM 
BV6 (grey bars) for 2 h. Cells were either unstimulated (Un), or stimulated with 
50 ng/mL of TNFα, formalin killed N. gonorrhoeae (FK GC) or live N. 
gonorrhoeae for 12 h. Cells were also treated with 3 µM STS for 6 h as a control 
for apoptosis. A. Whole cells were stained for annexin-V (y-axis) and PI, x-axis 
prior to FACS analysis. First panel plot represents MOI 10 and second 
represents MOI 10 with BV6. B. Graphical representation of PI staining for four 
separate experiments and fold change compared to unstimulated cells with 
vehicle control. B. Graphical representation of annexin-V staining for four 
separate experiments and fold change compared to unstimulated cells with 
vehicle control. All bar graphs depict the mean ± SEM with two-way ANOVA, (**p 
< 0.01, ***p<0.001). 
  
	  111 
To further examine the cell death pathway regulated by cIAP2, we 
measured changes in caspase-3 enzyme activity, a critical marker of apoptosis. 
N. gonorrhoeae alone did not induce caspase-3 activity in End/E6E7 cells at 12 h 
post stimulation, consistent with earlier studies (Follows et al., 2009), and no 
changes in caspase-3 activity were observed in the presence of BV6, suggesting 
that cIAP2 did not play a role in this process (Figure 19). We next examined cell 
lysis, an indicator of non-apoptotic cell death. In cells stimulated with both TNFα 
and N. gonorrhoeae, BV6 treatment significantly increased cell lysis as measured 
by LDH release (Figure 20).  
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Figure 19. N. gonorrhoeae induction of cIAP2 does not modulate caspase-3 
activity in End/E67 cells.  
End/E6E7 cells were pretreated with DMSO control vehicle (white bars) or 5 µM 
BV6 (grey bars) for 2 h. Cells were either unstimulated (Un), or stimulated with 
50 ng/mL of TNFα or N. gonorrhoeae for 12 h. Cells were also treated with 3µM 
STS for 6 h as a control for apoptosis. Whole cell lysates were analyzed for 
caspase-3 activity. Graph depicts the mean ± SEM of triplicate wells with two-
way ANOVA and is representative of two independent experiments (***p<0.001). 
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Figure 20. N. gonorrhoeae induction of cIAP2 modulates cell lysis in 
End/E67 cells.  
End/E6E7 cells were pretreated with DMSO control vehicle (white bars) or 5 µM 
BV6 (grey bars) for 2 h. Cells were either unstimulated (Un), or stimulated with 
50 ng/mL of TNFα or N. gonorrhoeae for 12 h. Cells were also treated with 3 µM 
STS for 6 h as a control for apoptosis. Cell culture supernatants were analyzed 
for LDH release. Graph depicts the mean ± SEM of triplicate wells and is 
representative of two independent experiments. Two-way ANOVA was used (**p 
< 0.01, ***p<0.001). 
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We next examined whether BV6 treatment induced necroptosis, a lytic 
form of programmed cell death that occurs under cIAP depletion. Necroptosis is 
induced by activation of receptor interacting kinase 3 (RIP3) following formation 
of the cell death complex containing caspase-8 and receptor interacting kinase 1 
(RIP1) (Feoktistova et al., 2010, McComb et al., 2012). After cell treatment with 
BV6 and N. gonorrhoeae stimulation (12 h), cells were lysed and caspase-8 was 
immunoprecipitated and probed for the presence of RIP1 by Western blot 
analysis. BV6 treatment alone caused spontaneous formation of caspase-8 and 
RIP1 complex. Interestingly, cell stimulation with N. gonorrhoeae alone (MOI 10 
and 100) also resulted in complex formation (Figure 21). These results suggest 
that N. gonorrhoeae induced depletion of intracellular cIAP2 may lead to 
caspase-8 and RIP1 complex formation.  
One consequence of active caspase-8/RIP1/RIP3 complex is the induction 
of IL-1β cleavage (Tenev et al., 2011, Vince et al., 2012). As an indirect measure 
of complex formation, changes in IL-1β production due to BV6 were also 
measured. Treatment with BV6 alone did not alter IL-1β production at 6 or 12h 
(Figures 22A and 22B). TNFα alone did not induce IL-1β and N. gonorrhoeae 
(MOI 10 and 100) stimulation alone induced low levels of IL-1β. However, a 
significant increase of IL-1β release was observed following 12 h TNFα and N. 
gonorrhoeae stimulation in the presence of BV6 (Figure 22B). We next 
determined if the observed increase in IL-1β due to BV6 was specific to the 
unique processing of IL-1β by caspase-8/RIP1/RIP3 or a general trend in 
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cytokine expression during BV6 treatment. When the cytokine IL-6 was 
measured following BV6 treatment and N. gonorrhoeae stimulation, it was found 
that IL-6 was increased by 6 h of N. gonorrhoeae stimulation alone and 
significantly dampened by BV6 treatment (Figure 22C). This trend continued at 
12 h post stimulation, but was most pronounced at an MOI 10 (Figure 22D). 
These results demonstrate that BV6 treatment has opposite effects on IL-6 and 
IL-1β expression. It is possible that BV6 treatment interferes with IL-6 
transcription because of the role of cIAP2 in NF-κB signaling, while cIAP2 
depletion increases IL-1β processing by caspase-8/RIP1/RIP3, thus increasing 
secretion. We also measured TNFα production to verify that the observed cell 
death was not due to TNFα autocrine signaling. TNFα was not detectable in 
End/E6E7 cells following 12 h or 24 h of N. gonorrhoeae stimulation (data not 
shown), suggesting that this mechanism of cell death is TNFα-independent. 
  
	  116 
 
 
Figure 21. N. gonorrhoeae or BV6 stimulation induces caspase-8 and RIP1 
complex in End/E6E7 cells.  
End/E6E7 cells were pretreated with DMSO control vehicle or 5µM BV6 for 2 h. 
Cells were either unstimulated (Un), or stimulated with 50 ng/mL of TNFα or N. 
gonorrhoeae for 12 h. Whole cell lysates were collected from End/E6E7 cells and 
subjected to coimmunoprecipitation (IP) with agarose beads and anti-caspase-8 
antibody. The caspase-8 complex was examined by Western blot analysis using 
antibodies against RIP1. Representative of 2 separate experiments. 
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Figure 22. N. gonorrhoeae induction of cIAP2 modulates cytokine release.  
End/E6E7 cells were pretreated with DMSO control vehicle (white bars) or 5 µM 
BV6 (grey bars) for 2 h. Cells were either unstimulated (Un), or stimulated with 
50 ng/mL of TNFα or N. gonorrhoeae for 6 h (A, C first column) or 12 h (B, D 
second column). Cell culture supernatants were analyzed by ELISA for IL-1β 
(A, B first row) or IL-6 (C, D first row). Graphs depict the mean ± SEM of 
triplicate wells and is representative of two independent experiments. Two-way 
ANOVA was used (*p < 0.05, **p < 0.01, ***p<0.001). 
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 Previous studies found that N. gonorrhoeae induced cIAP2 transcript 
levels and hypothesized that the increased cIAP2 prevented apoptosis and 
therefore permitted the bacteria time to replicate within the cell (Binnicker et al., 
2003, Follows et al., 2009). The hypothesis suggests that cIAP2 expression is 
beneficial for N. gonorrhoeae survival. Although this is difficult to concretely 
ascertain, we sought to determine if BV6 treatment modulated survival of N. 
gonorrhoeae in End/E6E7 cells. At 12h post-stimulation, the number of cell-
associated bacteria (both intracellular and cell attached) was determined by 
plating cell lysates on chocolate agar plates and determining CFU. Intracellular 
CFU were also determined following incubation with gentamicin for 90 min. BV6 
treatment significantly increased cell associated CFU suggesting that cIAP2 
depletion lead to enhanced N. gonorrhoeae growth (Figure 23A). Conversely, 
BV6 treatment reduced intracellular N. gonorrhoeae CFU (Figure 23B). This is 
likely due to cell lysis induced by BV6 (Figure 20) and therefore the cells may 
have been more permeable to gentamicin. To rule out any effect of BV6 on the 
bacteria itself, N. gonorrhoeae was grown in cell culture media with DMSO or 
BV6 for 12 h. Bacteria were plated and there was no significant difference in CFU 
between DMSO and BV6 media, indicating that changes in cell associated CFU 
were due to changes in BV6-mediated degradation of cIAP2 (Figure 23C).  
  
	  120 
 
 
 
 
 
 
 
 
C 
DM
SO BV
6
0
500
1000
1500
DMSO
BV6
%
 v
ia
bl
e 
re
la
tiv
e 
to
 in
pu
t
ns
A associated cfu
DM
SO BV
6
0
20
40
60
80
DMSO
BV6
*
%
 v
ia
bl
e 
re
la
tiv
e 
to
 in
pu
t
Intracellular cfu
DM
SO BV
6
0.00
0.01
0.02
0.03 *
%
 v
ia
bl
e 
re
la
tiv
e 
to
 in
pu
t
B 
	  121 
Figure 23. Induction of cIAP2 decreases cell lysis and survival of N. 
gonorrhoeae in End/E6E7 cells.  
End/E6E7 cells were pretreated with DMSO control vehicle (white bars) or 5µM 
BV6 (grey bars) for 2 h. Cells were stimulated with N. gonorrhoeae at an MOI of 
10 for 12 h. A. Cell-associated bacteria (both intracellular and bacteria attached 
to endocervical epithelial cell surface) were counted as CFUs and were 
normalized to the inoculum. B. Intracellular bacteria were recovered after 
gentamicin treatment, were counted as CFU and normalized to inoculum. C. N. 
gonorrhoeae was grown in cell media without End/E6E7 cells with DMSO control 
vehicle (white bars) or 5µM BV6 (grey bars) for 12 h. Recovered CFU were 
normalized to inoculum. Graphs depict the mean ± SEM of three individual 
experiments. Student t-test was used (*p < 0.05). 
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Chapter 4 Summary 
Previous studies examining the ability of N. gonorrhoeae to modulate cell 
death in epithelial cells have primarily focused on the apoptosis pathway	  
(Binnicker et al., 2003, Morales et al., 2006, Howie et al., 2008, Follows et al., 
2009). In this chapter we demonstrated that N. gonorrhoeae does not induce 
apoptosis in End/E6E7 cells as measured by changes in phosphatidylserine and 
caspase-3 activity, confirming previous work performed in End/E6E7 cells 
(Follows et al., 2009). However, cell death as measured by changes in cell 
membrane permeability was significantly increased 24 h post gonococcal 
stimulation. Interestingly, N. gonorrhoeae induced cell death correlated with 
intracellular depletion of cIAP2.  
In the absence of cIAPs, cellular stress can lead to apoptosis and/or 
necroptosis (Moulin et al., 2012, Wang et al., 2008). By using the SMAC mimetic 
BV6, an inhibitor of cIAP2, we found exacerbated cell death following stimulation 
of N. gonorrhoeae as measured by changes in cell permeability and cell lysis. 
The BV6 induced cell death was independent of caspase-3 activity. We also 
observed increased production of IL-1β in the presence of BV6 following N. 
gonorrhoeae stimulation. Furthermore, we found both N. gonorrhoeae alone and 
BV6 treatment lead to formation of the RIP1-caspase complex. These results are 
consistent with literature describing cIAP inhibition of the ripoptosome complex, a 
complex that processes IL-1β and leads to a caspase-independent cell death 
known as necroptosis (Feoktistova et al., 2010, Tenev et al., 2011, Vince et al., 
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2012, Kaczmarek et al., 2013). Collectively, these results suggest that 
intracellular cIAP2 is important in the protection of epithelial cell death induced by 
N. gonorrhoeae via a lytic, necroptotic pathway as opposed to an apoptotic 
pathway.  
Finally, we investigated if cIAP2 expression in the epithelial cells is associated 
with gonococcal survival by treating the cells with BV6. We determined that BV6 
did not impair N. gonorrhoeae growth and therefore any changes in bacterial 
survival were due to changes in the host cell environment. We found cells treated 
with BV6 had reduced intracellular survival but increased cell associated survival. 
These results indicated that cIAP2 depletion led to enhanced gonococcal survival 
in End/E6E7 cells. These experiments did not address whether these changes in 
gonoccocal survival were directly due to the role of cIAP2 in host cell death. 
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Chapter 5. Neisseria gonorrhoeae exosome release and content  
Exosomes are defined as 40-150 nm sized particles derived from 
endosomal multi-vesiclular bodies (MVBs) that have fused with the plasma 
membrane for extracellular release (Harding et al., 1984, Raposo and 
Stoorvogel, 2013). They are released from many cell types and facilitate 
communication by carrying cargo such as nucleic acid and protein from one cell 
to another. Exosomes derived from immune and non-immune cells have a variety 
of roles in immune regulation and have been found to have a role during 
microbial pathogenesis. Interestingly, microbial pathogens can modify exosome 
cargo though incorporation of their own microbial proteins or by altering the 
composition of host proteins (Bobrie et al., 2011, Chaput and Théry, 2011).  
We demonstrated that N. gonorrhoeae enriches cIAP2 in exosomes 
released from End/E6E7 cells (Figure 15). In this section we aim to determine if 
N. gonorrhoeae can also alter exosome release, which would contribute to levels 
of extracellular cIAP2. We also begin to address whether exosomes have a 
functional role in cytokine production or cell death in naïve End/E6E7 cells. 
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Exosome and N. gonorrhoeae bleb characterization and quantification 
 To isolate exosomes from End/E6E7 cell cultures, conditioned media from 
unstimulated and stimulated cells were collected and centrifuged to remove 
whole cells and cell debris/bacteria. The centrifuged supernatants were then 
filtered (0.22 µm) prior to ultracentrifugation. Although this process removed a 
majority of cellular debris, ultracentrifugation does not result in a purified 
exosome pellet. To confirm the presence of exosomes, we sought to characterize 
size and morphology of the exosome fraction isolated from ultracentrifugation. 
Exosomes from unstimulated cells were isolated by ultracentrifugation and 
resuspended in 4% PFA. To collect N. gonorrhoeae blebs, the supernatant of 
FA1090B grown in CDM for 3 h was ultracentrifuged and blebs were 
resuspended in 4% PFA. Suspensions of exosomes from unstimulated cells and 
N. gonorrhoeae blebs were analyzed by TEM (Figures 24A and 24B). Whole 
suspensions demonstrated that individual exosomes were approximately 100 nm 
and blebs were approximately 80 nm, corresponding to sizes described in the 
literature (Kulp and Kuehn, 2010, Raposo and Stoorvogel, 2013). End/E6E7 cells 
stimulated with N. gonorrhoeae at an MOI 100 were also analyzed by TEM. To 
distinguish exosomes from N. gonorrhoeae blebs, the ultracentifuged pellets 
were fixed in 4% PFA, sectioned and stained with gold-labeled anti-CD9. 
However, the gold-labeling was unsuccessful and we were unable to distinguish 
exosomes from N. gonorrhoeae blebs (Figure 24C). The sectioned TEM did 
confirm that the ultracentrifuged pellet contained vesicles with a lipid bilayer 
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consistent with exosomes. It should be noted that TEM was only performed one 
time on suspensions and two times on sections, thus data presented are 
preliminary. 
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Figure 24. Transmission electron microscopy of exosome and N. 
gonorrhoeae bleb preparations 
A. Exosomes from unstimulated End/E6E7 cells were isolated by 
ultracentrifugation and resuspended in 4% PFA. Suspensions were then 
mounted and contrasted on formvar-carbon coated copper grids. B. Blebs from 
N. gonorrhoeae grown in CDM were isolated by ultracentrifugation and 
resuspended in 4% PFA. Suspensions were then mounted and contrasted on 
formvar-carbon coated copper grids. C. End/E6E7 cells were stimulated with N. 
gonorrhoeae at an MOI of 10 for 24 h. The exosome/N. gonorrhoeae bleb 
fraction was isolated from stimulated End/E6E7 cells by ultracentrifugation, fixed 
in 4% PFA and frozen. Frozen pellets were then sectioned at 60-80 nm and 
contrasted on formvar-carbon coated copper grids. Images are preliminary and 
represent one experiment. 	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To further characterize size and determine changes in exosome 
production, exosomes from unstimulated and stimulated cells (TNFα and N. 
gonorrhoeae MOI 100) as well as N. gonorrhoeae outer membrane blebs were 
isolated and characterized by NanoSight, an instrument that characterizes 
nanoparticles. Through tracking of Brownian motion, the NanoSight measured 
the diameter of each particle counted. There was no difference in exosome 
diameter between unstimulated, TNFα stimulated and N. gonorrhoeae (MOI 100) 
stimulated exosomes; the exosomes ranged in size from 50-160 with an average 
size of 85 nm (Figures 25A and 25B). Gonococcal stimulation of End/E6E7 cells 
results in release of exosomes from End/E6E7 cells and N. gonorrhoeae blebs 
from the bacteria, thus exosome preparations contain both N. gonorrhoeae blebs 
and exosomes. We measured the size of N. gonorrhoeae blebs isolated from 
cultures of bacteria and found significant overlap in diameter between N. 
gonorrhoeae blebs and exosomes (Figures 25A and 25B). Therefore, we could 
not measure changes in exosome production from stimulated versus 
unstimulated epithelial cells. 
We next characterized exosome size and concentration after using 
exosome specific immunopurification to separate the exosomes from N. 
gonorrhoeae blebs. Exosomes from unstimulated and N. gonorrhoeae stimulated 
cells (MOI 100) were isolated and immunopurified with anti-CD9 coated magnetic 
beads from the Exo-FLOW™ kit (Figure 14). Eluted exosomes were then 
characterized by another nanoparticle counter called ZetaView™. Similar to 
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NanoSight, the ZetaView instrument found exosomes and N. gonorrhoeae outer 
membrane blebs to be indistinguishable by size (Figures 26A and 26B). The 
median size of exosomes was 75 nm while the median size of N. gonorrhoeae 
blebs was 71 nm. Because exosomes were immunopurified by CD-9 beads 
before ZetaView analysis, changes in exosome concentration between 
unstimulated and N. gonorrhoeae stimulated cells could be determined. 
Interestingly, it was found that N. gonorrhoeae approximately doubles exosome 
release compared to unstimulated cells (Figure 26C).  
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Figure 25. N. gonorrhoeae outer membrane blebs are similar in size to 
exosomes released from End/E6E7 cells.  
Epithelial cells were either unstimulated (Un), or stimulated with 50 ng/mL of 
TNFα or N. gonorrhoeae (MOI 100) for 24 h. Exosomes were isolated from 
End/E6E7 cells by ultracentrifugation and resuspended in 200 µL PBS. N. 
gonorrhoeae outer membrane blebs were isolated and resuspended in 200 µL 
PBS. A. Exosome and N. gonorrhoeae bleb preparations were analyzed by 
NanoSight. B. Graph depicts size of NanoSight analyzed particles as mean ± 
SEM of two biological samples. 
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Figure 26. N. gonorrhoeae stimulation of End/E6E7 cells increases 
exosome release. 
Epithelial cells were left unstimulated (Un) or stimulated with N. gonorrhoeae 
(MOI 100) for 24h. Exosomes were isolated by ultracentrifugation and then 
immunopurified by CD9 coated beads. A. Exosomes were released from the 
beads and prepared for particle size analysis by ZetaView®. B. Graph depicts 
size of ZetaView® analyzed particles as median ± SEM of three biological 
samples C. Concentration of particles was simultaneously analyzed by 
ZetaView®. Graph depicts particle count mean ± SEM of three biological 
samples. Student t-test was used (***p < 0.001).  
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To confirm that N. gonorrhoeae stimulation increases exosome release, 
we measured the enzymatic activity of acetylcholinesterase. Acetylcholinesterase 
is an enzyme enriched in exosomes and previously used to quantify exosomes 
(Savina et al., 2002, Khan et al., 2010, Honegger et al., 2013). Increased 
acetylcholinesterase activity was observed in epithelial cells stimulated with N. 
gonorrhoeae (MOI 100) as compared to unstimulated, or TNFα-treated cells 
(Figure 27A). Since the exosome pellet also contained N. gonorrhoeae outer 
membrane blebs, acetylcholinesterase activity was measured in isolated blebs. 
N. gonorrhoeae outer membrane blebs had no detectable acetylcholinesterase 
activity and therefore increased enzymatic activity observed from N. gonorrhoeae 
stimulated cells was most likely due to the activity in exosomes (Figure 27A).  To 
verify that the increased production of exosomes was not due to increased cell 
proliferation induced by N. gonorrhoeae stimulation, the acetylcholinesterase 
activity was normalized to the number of epithelial cells at the time of collection 
(Figure 25B). Similar results were obtained in epithelial cells stimulated with N. 
gonorrhoeae at MOI 10 (Figure 27C). To confirm the increase in exosome 
release was not unique to End/E6E7 cells, acetylcholinesterase activity was 
measured in HeLa cells. HeLa cells were treated identically to End/E6E7 cells: 
exosomes were collected by ultracentrifugation from conditioned media of 107 
cells that were unstimulated or stimulated with N. gonorrhoeae (MOI 100) or 
TNFα. Similar to End/E6E7 cells, we also observed increased release of 
exosomes when HeLa cells were stimulated with N. gonorrhoeae (Figure 28). A 
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limitation of this study is that the number of epithelial cells was not determined at 
the time of exosome collection from HeLa cells as done for End/E6E7 cells. 
However, cell numbers were later determined to remain unchanged due to TNFα 
or N. gonorrhoeae stimulation (data not shown). Together, these data 
demonstrate that N. gonorrhoeae stimulation of epithelial cells results in 
increased exosome release.  
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Figure 27. N. gonorrhoeae stimulation of End/E6E7 cells increases 
exosome enzymatic activity. 
A. End/E6E7 cells were either unstimulated (Un, blue squares), stimulated with 
TNFα (50 ng/mL, grey triangles), or with N. gonorrhoeae at an MOI of 100 for 
24h (MOI 100, red triangles). Isolated exosomes were analyzed for 
acetylcholinesterase activity at the indicated time points (black circles indicate 
cell media as a control). N. gonorrhoeae blebs were also isolated and analyzed 
for acetylcholinesterase activity (black dotted line). B. Changes in 
acetylcholinesterase activity (AchE) from graph A at 80 min were normalized to 
cells counted at the time of collection. Graph depicts the mean ± SEM of three 
independent experiments, one-way ANOVA (*p < 0.05). C. End/E6E7 cells were 
either unstimulated or stimulated with N. gonorrhoeae at an MOI of 10 and 100. 
Isolated exosomes were analyzed for acetylcholinesterase activity (AchE) every 
10 min over 80 min. Changes in acetylcholinesterase activity were normalized to 
cells counted at the time of collection. Graph depicts the mean ± SEM of three 
independent experiments, one-way ANOVA (*p < 0.05). 
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Figure 28. N. gonorrhoeae stimulation of HeLa cells increases exosome 
enzymatic activity. 
HeLa cells were either unstimulated (grey), stimulated with TNFα (50 ng/mL, 
blue), or with N. gonorrhoeae at an MOI of 10 for 24h (red). Isolated exosome 
fractions were analyzed for acetylcholinesterase activity at the indicated time 
points. N. gonorrhoeae blebs were also isolated and analyzed for 
acetylcholinesterase activity (black dotted line). 
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The formation of exosomes is a process that may be cell specific as the 
formation of exosomes can be either ESCRT-dependent or independent (Raposo 
and Stoorvogel, 2013). In the more common ESCRT-independent mechanism, 
the biogenesis of exosomes is dependent on sphingomyelinase, an enzyme that 
produces ceramide (Trajkovic et al., 2008, Yuyama et al., 2012, Stuffers et al., 
2009). To determine if exosome formation from End/E6E7 cells during N. 
gonorrhoeae stimulation was dependent on sphingomyelinase, cells were treated 
with 15 µM GW4869, an inhibitor of sphingomyelinase. Exosomes were isolated 
and quantified by acetylcholinesterase activity and the number of cells was 
quantified at the time of collection. In unstimulated cells, GW4869 decreased 
acetylcholinesterase activity per cell nearly 5 fold (Figures 27A and 27B). The N. 
gonorrhoeae induced increase in acetylcholinesterase activity per cell was 
mitigated by the addition of GW4869 (Figures 29A and 29B). These results 
suggest that exosome formation in End/E6E7 cells is dependent on 
sphingomyelinase and the enhanced release of exosomes due to N. 
gonorrhoeae relies on the same pathway. 
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Figure 29. Neutral sphingomyelinase regulates exosome production in 
End/E6E7 cells.  
A. End/E6E7 cells were either unstimulated (Un, grey triangle) or stimulated with 
N. gonorrhoeae (MOI 10, red circle) for 2 h prior to addition of DMSO (solid lines) 
or 15 µM of GW4869 (dotted lines) and incubation for an additional 22 h. Isolated 
exosomes were analyzed for acetylcholinesterase activity at the indicated time 
points. B. Changes in acetylcholinesterase activity from graph A at 40 min were 
normalized to cells counted at the time of collection. Graph depicts a 
representative experiment of two separate experiments.  
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Changes in exosome content 
 
 It has been reported that exosome content reflects the specific cell from 
which it is derived, however, the relative abundance of individual proteins may 
differ from cytoplasm to exosome (Henderson and Azorsa, 2011). Furthermore, 
bacterial pathogens have been reported to significantly alter the protein content 
of exosomes following infection (Hu et al., 2013, Honegger et al., 2013, Oehmcke 
et al., 2013). To determine if the protein signature of exosomes was altered due 
to cell stimulation with N. gonorrhoeae, exosomes were collected and subjected 
to SDS-PAGE followed by silver staining. Exosomes from unstimulated cells did 
not reflect the same protein composition as whole cell lysates from unstimulated 
cells, suggesting that exosomes were enriched with different proteins than the 
whole cell (Figure 29). Exosome composition from TNFα stimulated cells 
resembled exosomes from unstimulated cells, however, exosomes from cells 
stimulated with N. gonorrhoeae had a different protein signature. 
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Figure 30. Exosome protein content differs from whole cell lysate  
End/E6E7 cells were unstimulated (Un), stimulated with TNFα (50 ng/mL), or 
with N. gonorrhoeae (MOI of 100) for 24 h. Exosomes were isolated by 
ultracentrifugation. Exosomes were then immunopurified by CD9 coated beads 
as described in Materials and Methods. Exosomes were released from the beads 
and quantified by protein content so equal amounts of protein were loaded in 
each lane. Samples were subjected to SDS-PAGE and silver staining. An 
unstimulated whole cell lysate (WCL) was loaded as a control. Image is 
representative of two separate experiments.  
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Isolated exosomes induce inflammatory response  
 N. gonorrhoeae modulates both exosome production and content in 
End/E6E7 cells. Exosomes can carry nearly 200 unique proteins and 100 coding 
and 130 non-coding transcripts (Jenjaroenpun et al., 2013, Kalra et al., 2013, 
Duijvesz et al., 2013), all of which can modulate the immune response in 
neighboring cells. To begin to understand how exosomes isolated from 
End/E6E7 cells alter inflammation in naïve cells, exosomes from unstimulated 
End/E6E7 cells were first examined in a preliminary experiment. Exosomes were 
added in increasing amounts to naïve End/E6E7 cells at 5, 10, 25, 50 and 100 µg 
of protein. After 24 h of stimulation, IL-6 was found to increase in an exosome 
dose-dependent manner, suggesting that exosomes from unstimulated cells can 
elicit an inflammatory response in neighboring cells (Figure 30). It should be 
noted that although the unstimulated exosomes elicited IL-6, the amount of IL-6 
was low as compared to other studies performed (300 pg/mL in Figure 30 versus 
2000 pg/mL in Figure 22). 
 We next investigated whether exosomes from stimulated cells would alter 
cytokine production in naïve cells differently than exosomes isolated from 
unstimulated cells. To exclude the changes in cytokine production due to N. 
gonorrhoeae outer membrane blebs, formalin killed N. gonorrhoeae was used. 
End/E6E7 cells seeded for exosome collection were unstimulated or stimulated 
with formalin killed bacteria at an MOI 100 or TNFα (50 ng/mL) for 24 h. 
Exosomes were then isolated, quantified and added to naïve End/E6E7 cells for 
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24 h. Cell supernatants were analyzed for both IL-6 and IL-1β by ELISA. 
Exosomes from both unstimulated and stimulated cells induced production of IL-
6 in naïve cells, however exosomes from stimulated cells induced greater 
concentrations of IL-6 (Figure 31A). Exosomes from cells stimulated with formalin 
killed N. gonorrhoeae induced nearly 3000 pg/mL of IL-6, almost 10 times more 
than exosomes from unstimulated cells. Only exosomes from cells stimulated 
with formalin killed bacteria significantly induced IL-1β production compared to 
unstimulated cells (Figure 31B). A major limitation to consider is that this 
experiment was performed once. Although preliminary, these data suggest that 
different stimuli can produce exosomes with varying effects on inflammation in 
neighboring cells.  
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Figure 31. Exosomes derived from unstimulated cells induce IL-6 in 
End/E6E7 cells.  
Exosomes were isolated from unstimulated cells, quantified by protein content 
and added to End/E6E7 cells in increasing amounts. After 24 h, supernatants 
were harvested and analyzed for IL-6 by ELISA. Graph depicts the mean ± SEM 
and represents one experiment performed in triplicate.  
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Figure 32. Exosomes derived from stimulated cells induce cytokines in 
End/E6E7 cells.  
Cells were left unstimulated (Un), stimulated with TNFα (50ng/mL), or formalin 
killed N. gonorrhoeae for 24 h. Exosomes were isolated from the conditioned 
media using ultracentrifugation (120,000 x g for 12 h). Fifty µg of exosomes were 
then added to End/E6E7 cells. After 24 h, supernatants were harvested and 
analyzed by ELISA for IL-6 and IL-1β. Graph depicts the mean ± SEM and is 
representative of two experiments performed in triplicate, one-way ANOVA (**p < 
0.01, ***p < 0.001). 
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It has been reported that survivin, an IAP family member, has both 
intracellular and extracellular roles in inhibiting apoptosis and promoting 
proliferative and metastatic potential in neighboring cells when secreted (Khan et 
al., 2010). We therefore aimed to determine if exosomes containing cIAP2 could 
also modulate cell death in neighboring cells. Although exosome associated 
cIAP2 was enhanced during N. gonorrhoeae stimulation, cIAP2 was detected in 
exosomes from unstimulated cells (Figure 15). Thus to begin to understand how 
exosomes isolated from End/E6E7 cells alter cell death in naïve cells, exosomes 
from unstimulated cells were first examined. End/E6E7 cells were treated with 50 
µg of exosomes for 24 h followed by 6 h of 3 µM STS to induce apoptosis. Cell 
lysates were quantified for caspase-3 activity and it was found that the exosomes 
from unstimulated cells had no effect on caspase-3 activity. Furthermore, pre-
treating cells with exosomes did not suppress STS induced apoptosis (Figure 
32). These preliminary data suggest that exosomes from unstimulated cells do 
not protect against STS induced apoptosis, however, it remains to be determined 
if exosomes from N. gonorrhoeae stimulated cells do protect from STS induced 
apoptosis. 
Because cIAP2 appears to protect End/E6E7 cells from N. gonorrhoeae 
induced cell death, not STS induced apoptosis, the effect of exosomes from 
unstimulated cells was examined in gonococcal stimulated cells. End/E6E7 cells 
were pre-treated with 50 µg of exosomes from unstimulated cells for 24 h prior to 
N. gonorrheoae (MOI 10 and 100) stimulation for 12 h. Cells were collected and 
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stained for PI and annexin-V prior to FACs analysis. Exosomes from 
unstimulated cells alone had no effect on cell death, however, cells pre-treated 
with exosomes prior to N. gonorrhoeae stimulation had reduced levels of PI 
staining (Figure 33A). This was only observed in cells stimulated with an MOI 
100, not MOI 10. There were no changes in annexin-V (data not shown). To 
determine if exosomes from unstimulated cells increased levels of cIAP2, either 
exogenously or endogenously produced cIAP2, cells from the same wells were 
also lysed and analyzed via Western blot analysis. Interestingly, exosomes from 
unstimulated cells increased cIAP2 expression in cells either unstimulated or N. 
gonorrhoeae stimulated (Figure 33B). Although these preliminary results suggest 
exosomes may inhibit gonococcal cell death, much more work is needed to 
clarify if this is specific to cIAP2 and if so, whether the increase in cIAP2 is due 
exosomal transfer or exosomal stimulation of the target cell. 
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Figure 33. Exosomes derived from unstimulated cells do not inhibit 
apoptosis in End/E6E7 cells.  
Exosomes were collected from unstimulated cells and quantified for protein. 
End/E6E7 cells were first pretreated with either PBS (white bars) or 50 µg of 
exosomes (grey bars) for 20 h. Cells were then left untreated (Un) or treated with 
3 µM STS for 6 h. Whole cell lysates were collected and analyzed for caspase-3 
activity. Graph depicts the mean ± SEM of on experiment performed in triplicate, 
two-way ANOVA.  
 
 
  
	  151 
 
 
 
 
 
 
 
 
 
 
A 
cIAP2 
GAPDH 
+e
xo
 
+ P
BS
 
+e
xo
 
+ P
BS
 
MOI 100 Un B 
72 
34 
	  152 
Figure 34. Exosomes derived from unstimulated cells induce cIAP2 and 
reduce N. gonorrhoeae associated cell death.  
Exosomes were collected from unstimulated cells and quantified for protein. 
End/E6E7 cells were first pretreated with either PBS (white bars) or 50 µg of 
exosomes (grey bars) for 20 h. Cells were then left untreated (Un) or stimulated 
with N. gonorrhoeae (MOI 10 and 100) for 12 h. A. Whole cells were stained for 
propidium iodide (PI) prior to FACS analysis. Graphical representation of PI only 
staining for one experiment and fold change compared to unstimulated cells with 
vehicle control. B. Cells from the same wells as those analyzed for FACs 
analysis were lysed and analyzed by Western blot using antibodies against 
cIAP2 and GAPDH. Represents one experiment performed in duplicate. 
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Chapter 5 Summary 
 In this chapter we began to explore how N. gonorrhoeae alters exosomes 
beyond cIAP2 enrichment. Here, we demonstrated that the exosomes isolated by 
serial ultracentrifugation were intact and clear of debris as determined by TEM. 
Exosomes had a characteristic lipid bilayer and characteristic size. N. 
gonorrhoeae outer membrane blebs were also visualized by TEM and had no 
distinguishing characteristics from exosomes. We went on to more precisely 
analyze size by nanoparticle tracking and found exosomes from N. gonorrhoeae 
or TNFα stimulated cells and unstimulated cells had similar size distributions 
ranging from 50 – 160 nm while N. gonorrhoeae outer membrane blebs spanned 
35-125 nm. Nanoparticle tracking confirmed TEM analysis: N. gonorrhoeae outer 
membrane blebs and exosomes couldn’t be separated by size. 
 Studies presented here are the first to show that N. gonorrhoeae induced 
exosome release. Both nanoparticle counts and acetylcholinesterase activity (an 
enzyme enriched in exosomes) were found to be significantly increased in cells 
stimulated with N. gonorrhoeae. Together, these data support two mechanisms 
by which N. gonorrheoae stimulation increased extracellular cIAP2: gonococcal 
stimulation induced cIAP2 exosome association and increased exosome 
production.  
In step with several reports that demonstrate microbial pathogens alter both 
content and production of exosomes (Hu et al., 2013, Honegger et al., 2013), we 
have demonstrated that N. gonorrhoeae enriches cIAP2 within the exosome and 
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increases exosome release. In this chapter we also demonstrate that N. 
gonorrhoeae modifies exosome protein composition as analyzed by silver stain. 
We show that exosomes from unstimulated cells can modify cytokine release and 
cell death in neighboring cells. We propose that exosomes from N. gonorrhoeae 
stimulated cells may elicit different responses in neighboring cells due to their 
altered exosome protein content. 
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Chapter 6. Discussion 
 
Within the FGT, epithelial cells are the orchestrators of the early innate 
immune response during mucosal infection with pathogenic bacteria or viruses. 
N. gonorrhoeae is a mucosal pathogen and, in females, initiates infection in 
epithelial cells of the ectocervix and endocervix. Similar to other bacterial 
pathogens, N. gonorrhoeae can induce or inhibit host cell death to persist and 
survive in the host cell. It has been postulated that N. gonorrhoeae’s modulation 
of cell death and inflammation in epithelial cells impacts the innate immune 
response (Fichorova et al., 2001, Binnicker et al., 2003, Follows et al., 2009). To 
further understand how N. gonorrhoeae alters cell death and inflammation in 
epithelial cells, we examined how N. gonorrheoae modulates cIAP2, a protein at 
the signaling crossroads of cell death and immune signaling. In the present 
study, we demonstrated that N. gonorrhoeae stimulation induced a transient 
increase in cIAP2 protein levels in human cervical epithelial cells. High 
intracellular protein levels were observed during early N. gonorrhoeae 
stimulation, followed by an intracellular decrease and a corresponding increase 
in extracellular cIAP2. Our results suggest that the latter was due to cIAP2 
association with exosomes that were released from the epithelial cells as well as 
an overall increase in exosome production following prolonged N. gonorrhoeae 
stimulation. Inhibition of cIAP2 in N. gonorrhoeae stimulated epithelial cells 
resulted in increased cell death and IL-1β production. Finally, we demonstrated 
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that N. gonorrhoeae altered the cargo and production of exosomes released from 
epithelial cells, which in turn, modulated inflammation in neighboring cells 
As sentinels of the FGT, epithelial cells contribute to the immune response by 
acting as a physical barrier, producing antimicrobials, secreting chemokines and 
cytokines and in some cases, presenting antigens (Quayle, 2002, Wira et al., 
2005). Studies presented here demonstrated that N. gonorrhoeae induced cIAP2 
protected against an inflammatory cell death, which may impact neighboring 
cells, and that N. gonorrhoeae modulated exosome release, which may also 
impact intercellular communication. Thus, these studies highlight an additional 
mechanism for epithelial cells to orchestrate the immune response in the FGT 
during infection.  
 
Expression and localization of cIAP2 
An important observation from these studies was that N. gonorrhoeae 
stimulation of epithelial cells modulated expression and localization of cIAP2. It 
was previously shown that N. gonorrhoeae upregulated cIAP2 mRNA in 
immortalized epithelial cells and PMNs (Binnicker et al., 2003, Simons et al., 
2006, Follows et al., 2009); these studies suggest that cIAP2 contributes to the 
inhibition of apoptosis during gonococcal stimulation. In both End/E6E7 cells and 
HeLa cells, live N. gonorrhoeae induced cIAP2 mRNA expression with time. 
Similar results were obtained for TNFα, a known inducer of cIAP2, but not for 
formalin killed N. gonorrhoeae.  Despite their similar functions, mounting 
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evidence supports that cIAP1 and cIAP2 expression are regulated differently. 
While cIAP2 can be induced by NF-κB, MAPK and PI3K signaling pathways (Chu 
et al., 1997, Wang et al., 1998, Kim et al., 2008, Petersen et al., 2010), the 
pathways that induce cIAP1 expression are less understood. We found cIAP1 
mRNA expression levels did not respond to either TNFα or N. gonorrhoeae, in 
agreement with other studies (Damiano et al., 2006, Rajalingam et al., 2006, Li et 
al., 2011).  
The stability of cIAP2 is regulated by ubiquitylation and subsequent 
proteasome or lysosome degradation (Vaux and Silke, 2005, Rajalingam et al., 
2006). In epithelial cells infected with Chlamydia trachomatis, inhibition of the 
lysosome or proteasome stabilized cIAP2 (Rajalingam et al., 2006). Our studies, 
however, found no change in cIAP2 depletion after inhibiting the proteasome or 
lysosome during gonococcal stimulation. 
Because cIAP2 activity can be regulated by cellular localization (Vischioni et 
al., 2006), we investigated if cIAP2 could be detected extracellularly. Indeed, 
cIAP2 protein was detectable in cell supernatants and increased throughout N. 
gonorrhoeae stimulation. Extracellular cIAP2 was highest at later time points, 
precisely when intracellular cIAP2 was depleted. Extracellular cIAP2 was 
detected in unstimulated cells, and there was no change with TNFα. cIAP2 has 
no known secretion signaling sequence suggesting it is not secreted through a 
traditional pathway. Notably, we detected cIAP2 in the exosomal fraction and 
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found N. gonorrhoeae stimulation significantly enriched cIAP2 in exosomes 
released from End/E6E7 cells.  
These studies describe a potential mechanism of cIAP2 regulation via 
exosome export, however they do not describe the functional consequence of 
exosome-associated cIAP2. Exosome cargo sorting mechanisms have yet to be 
fully elucidated and it remains unclear why some proteins are and some are not 
secreted in exosomes. Although exosome content often reflects the cell type 
from which they were secreted, protein content of exosomes is not necessarily 
similar to the protein milieu found in the cell cytoplasm (Henderson and Azorsa, 
2011). From these studies and others, it is unclear whether all proteins (including 
cIAP2) that are sorted to the exosome have a function in neighboring cells or 
whether this is a cellular waste management program (Harding et al., 2013). 
However these two functions are not mutually exclusive. Khan et al. has 
demonstrated a functional role for exosome associated survivin in neighboring 
cells (Khan et al., 2009, Khan et al., 2010), however these studies were 
performed using overexpression assays and it remains poorly understood how 
much of exosome survivin is required for function. Although it is unclear whether 
cIAP2 specifically, amongst the myriad of other proteins in an exosome, has 
functional consequences in a neighboring cell, there does seem to be a 
functional consequence to intracellular depletion of cIAP2  
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Cell death and cIAP2 during infection 
Although it is recognized that pathogens can modulate programmed cell 
death pathways, including apoptosis, pyroptosis and necroptosis (Ashida et al., 
2011, Blander, 2014), previous studies examining N. gonorrhoeae have primarily 
focused on the apoptosis pathway (Binnicker et al., 2003, Morales et al., 2006, 
Howie et al., 2008, Follows et al., 2009). In this study, we examined apoptosis 
and general cell death markers at 6, 12 and 24 h post N. gonorrhoeae 
stimulation. N. gonorrhoeae did not induce apoptosis in End/E6E7 cells as 
measured by changes in phosphatidylserine and caspase-3 activity at any time 
point. This confirms previous studies completed in our laboratory (Follows et al., 
2009). However, general cell death, as measured by changes in cell membrane 
permeability, was observed at later time points. Interestingly, N. gonorrhoeae 
induced cell death correlated with intracellular depletion of cIAP2. This is the first 
report of non-apoptotic cell death in epithelial cells stimulated with N. 
gonorrhoeae. 
IAP members were originally thought to inhibit apoptosis by directly binding 
and inhibiting activation of caspases (Deveraux et al., 1998). Over the past 15 
years studies have confirmed that XIAP does indeed inactivate caspases, 
however, cIAP1 and cIAP2 do not appear to use this same anti-apoptotic 
mechanism (Eckelman and Salvesen, 2006). Instead, cIAP1 and cIAP2 utilize 
their ubiquitin ligase activity to positively regulate NF-κB and MAPK signaling, 
which in turn transcribe a host of anti-apoptotic genes (Dutta et al., 2006). 
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Specifically, cIAP1 and cIAP2 conjugate polyubiquitin chains to RIP1, an 
important TNF receptor kinase (Bertrand et al., 2008). In the presence of cIAP2, 
RIP1 propagates signaling that leads to NF-κB activation and the induction of 
anti-apoptotic proteins. In the absence of cIAP2, RIP1 is not ubiquitylated and 
TNFα signaling leads to cell death pathways involving RIP1 and necroptosis or 
caspase-8 and apoptosis (Wang et al., 2008, Moulin et al., 2012).  
Although the previous studies suggested cIAP2 inhibits apoptosis during N. 
gonorrhoeae stimulation (Binnicker et al., 2003, Simons et al., 2006, Follows et 
al., 2009), recent literature describing a role for cIAP2 in multiple types of cell 
death lead us to expand our investigation beyond apoptosis. By using the SMAC 
mimetic BV6, a small molecule that ubiquitylates and degrades cIAP2, the role of 
cIAP2 in cell death was examined. We found exacerbated cell death in the 
presence of BV6 following 12 h of stimulation of N. gonorrhoeae as measured by 
membrane permeability and cell lysis. The increase in cell death was 
independent of apoptosis markers: there was no change in phosphatidylserine or 
caspase-3 activity. These results indicate that cIAP2 depletion during N. 
gonorrhoeae stimulation did not lead to apoptosis.  
Apoptosis has well known markers such as caspase-3 activity, 
phosphatidylserine exposure and mitochondrial depolarization, but because of 
their recent discovery, other forms of cell death are not as well characterized. 
Cell death other than apoptosis used to be termed “accidental” and only noted to 
result in cell lysis (Sridharan and Upton, 2014). Numerous recent studies have 
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characterized the necroptosis signaling pathway, and therefore have 
distinguished necroptosis from so-called accidental necrosis. A hallmark of 
necroptosis is the activity of RIP1 and RIP3 due to formation of RIP1/caspase-
8/FADD/FLIP complex. This complex then induces apoptosis or RIP3-dependent 
necroptosis, depending on the activation status of caspase-8, which can also be 
modified by IAPs (Kaiser et al., 2011, Tenev et al., 2011). A final indicator of 
necroptosis under cIAP depletion is an increase in IL-1β: activated caspase-
8/RIP1/RIP3 is capable of direct IL-1β processing and secretion (Vince et al., 
2012).  
cIAP2 depletion during N. gonorrhoeae stimulation did not lead to 
apoptosis in our studies and thus we next investigated the possibility of 
necroptosis. We found BV6 treatment alone caused spontaneous formation of 
caspase-8 and RIP1 complex due to cIAP2 degradation. Cell stimulation with N. 
gonorrhoeae alone (and no BV6 treatment) also resulted in complex formation. 
These results suggest that depletion of intracellular cIAP2, by either BV6 or N. 
gonorrhoeae, may lead to caspase-8 and RIP1 complex formation. We also 
observed increased production of IL-1β in the presence of BV6 following N. 
gonorrhoeae stimulation, another indicator of necroptosis. Finally, we measured 
TNFα production to determine if the observed cell death was due to TNFα 
autocrine signaling. Although it was originally reported that the End/E6E7 cells 
did not secrete TNFα in response to N. gonorrhoeae (Fichorova et al., 2001), the 
microarray performed by Follows et al. reported increased TNFα mRNA 
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(secreted protein was not measured) (Follows et al., 2009). TNFα was not 
detected in the End/E6E7 cells stimulated with N. gonorrhoeae, suggesting that 
the mechanism of cell death observed in this study is TNFα-independent. 
Collectively, our results indicate that N. gonorrhoeae induction of cIAP2 protects 
human cervical epithelial cells from cell death. We speculate that the high levels 
of cIAP2 induced at relatively early time points during infection protects cells from 
necroptotic death. At later time points, export of cIAP2 via secretion of exosomes 
may be a mechanism that depletes intracellular cIAP2 and initiates host cell 
death. 
Our observations are consistent with the findings of Vince et al. who found 
cIAP depletion via the SMAC mimetic “compound A” leads to enhanced IL-1β 
secretion following formation of caspase-8/RIP1/RIP3 (Vince et al., 2012). Our 
observations were in contrast to Labbé et al. who found cIAP depletion by the 
SMAC mimetic BV6 dampens IL-1β secretion (Labbé et al., 2011). Both studies 
used macrophages primed with LPS, however Ciraci et al. suggested that 
differences may be due to the different SMAC mimetic: compound A inhibits 
cIAP1, cIAP2 and XIAP while BV6 does not inhibit XIAP (Ciraci and Sutterwala, 
2012). Although we utilized BV6, our findings were more consistent with the 
group that used compound A and observed increased IL-1β. It is important to 
note that our studies were performed in epithelial cells and with live bacteria, not 
a sterile ligand, thus direct comparisons are difficult to make. Future studies 
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should closely monitor the expression of XIAP, RIP3 and caspase-8 during N. 
gonorrhoeae stimulation. 
An important observation from this work was that cIAP2 depletion induced 
cell death resembling necroptosis instead of apoptosis during N. gonorrhoeae 
stimulation. Due to the distinct inflammatory outcomes of apoptosis and 
necroptosis, the type of cell death is important to microbial pathogenesis, which 
is highlighted in a study by Rodrigue-Gervais et al.. When given a sub-lethal 
dose of mouse-adapted H1N1 virus, WT mice survive while cIAP2 knockout mice 
succumbed to infection. It was also reported that lung epithelial cells underwent 
cell death in both the WT and cIAP2 knockout mouse, however, the WT epithelial 
cells underwent apoptosis while the cIAP2 knockout epithelial cells underwent 
necroptosis (Rodrigue-Gervais et al., 2014). Therefore, in the absence of cIAP2, 
there was a switch from apoptosis to necroptosis that resulted in death for the 
mice. Because there was no difference in viral titer, immune cell activation or 
cytokine levels between the WT and cIAP2 knockout mouse, cIAP2 knockout 
mice likely succumbed to infection because of tissue damage, signifying that 
necroptosis of mucosal epithelial cells was more disruptive to the epithelial 
barrier than apoptosis. The authors suggest the enhanced pathology was due to 
the release of cell death ligands of the necroptotic infected epithelial cells that in 
turn, induced necroptosis in uninfected bystander cells. 
Cell death, whether apopotosis or necroptosis, is not an event isolated to 
the dying cell and can have a profound impact on neighboring cells. Cell death 
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used to be thought of as a consequence of inflammation, however more recently 
the concept has evolved to consider that cell death may precede, trigger or 
amplify the inflammatory response (Pasparakis and Vandenabeele, 2015). 
Apoptosis is known to be a non-lytic, non-inflammatory cell death, however, an 
apoptotic cell still communicates with neighboring cells in order to facilitate its 
silent removal. Apoptotic cells release anti-inflammatory cytokines, such as IL-10 
and TGFβ, and can also induce macrophages to release anti-inflammatory 
cytokines (Green et al., 2009). Conversely, necroptotic cells release inflammatory 
cytokines, such as IL-1β, which induce an inflammatory response in bystander 
cells. The lytic nature of necroptosis also leads to the release of immunogenic 
intracellular components known as DAMPs, which are inflammatory as well 
(Kaczmarek et al., 2013). Together, DAMPs and cytokines released from 
necroptotic cells can lead to an inflammatory environment. 
Mucosal sites such as the FGT have resident macrophages, dendritic cells 
and PMNs. Thus, necroptosis of an infected mucosal epithelial cell can activate 
immune cells that can enhance tissue damage and pathology. However, cell 
death by necroptosis can still be an effective mechanism to contain pathogen 
replication and facilitate in the uptake of infected cells by phagocytes (Sridharan 
and Upton, 2014). In fact, the acute release of DAMPS and cytokines can quickly 
recruit phagocytic cells, such as macrophages and PMNs, to engulf the exposed 
pathogen. Thus, the induction of necroptosis could be an important mechanism 
to elicit an immune response and eradicate a pathogen that is subverting the 
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immune response by inhibition of apoptosis. Although not adequately supported 
by studies presented here, the export of cIAP2 may be a mechanism employed 
by the epithelial cell to induce cell death and to recruit phagocytes in response to 
N. gonorrhoeae inhibiting apoptosis (Figure 34).  
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Figure 35. Proposed role for N. gonorrhoeae induced extracellular cIAP2.  
A. N. gonorrhoeae induces production of intracellular cIAP2 through activation of 
NF-κB at early time points. B. High levels of intracellular cIAP2 prevent formation 
of cell death complex. cIAP2 shuttles to exosomes for export. C. Through export 
via exosomes, intracellular cIAP2 is depleted and cannot prevent formation of 
cell death complex that induces necroptosis. Necroptosis releases DAMPs and 
inflammatory cytokines such as IL-1β. D. Exosomes, DAMPs and cytokines 
released from infected epithelial cells may alter cell death and immune 
responses in uninfected epithelial cells, macrophages, dendritic cells or PMNs.  
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Earlier studies of the inhibition of apoptosis by N. gonorrhoeae in epithelial 
cells suggested that N. gonorrhoeae upregulation of cIAP2 prevented apoptosis 
and therefore permitted the bacteria time to replicate within the cell (Follows et 
al., 2009). Although our studies show that cIAP2 protected against necroptosis 
instead of apoptosis, one can deduce that cIAP2 is beneficial for host survival 
and host survival is beneficial for pathogen replication. BV6 did not impair N. 
gonorrhoeae proliferation and therefore any changes in bacterial survival were 
due to changes in the host cell environment. End/E6E7 cells treated with BV6 
had reduced intracellular survival. This was consistent with our observation that 
BV6 enhanced cell permeabilization and therefore allowed for gentamicin 
penetration. Conversely, BV6 increased cell associated bacteria, suggesting that 
cIAP2 protected against gonococcal replication. Increased cell associated 
bacteria in the absence of cIAP2 could be due to dampened NF-κB signaling and 
therefore reduced antimicrobial peptide production, or, increased cell lysis 
allowing the bacteria to more quickly escape the host cell after replication. It 
should be noted that these data are preliminary and should be interpreted only in 
the context of epithelial cells. For example, during gonococcal infection in vivo, 
increased cell lysis due to BV6 could expose the bacteria to resident 
macrophages or PMNs, leading to pathogen clearance and decreasing cell 
associated bacteria.  
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N. gonorrhoeae and exosome production 
Upon finding cIAP2 to be associated with exosomes, we sought to further 
characterize exosomes released from the End/E6E7 cells. Exosomes are very 
small (50-150 nm) bilayered vesicles that originate from the endosome, 
incorporate cytosolic components and then are secreted into the extracellular 
environment. Currently, there is no standardization for exosome isolation, 
however, ultracentrifugation is the most well studied method (Jan et al., 2014). In 
our studies, we utilized serial ultracentrifugation and verified exosome structure 
and size by TEM and nanoparticle analysis.  
It should be noted that the study of exosomes in the context of a bacterial 
infection is complicated by the fact that both the microbe and the host release 
vesicles into the extracellular environment. Gram-negative pathogens, such as N. 
gonorrhoeae, are notorious for “blebbing” their outer membrane (L. et al., 2005, 
Lai et al., 2015). As confirmed by our TEM analysis, Gram-negative blebs are 
bilayered and similar in size to exosomes (Kulp and Kuehn, 2010). Moreover, 
exosomes and N. gonorrhoeae blebs have similar densities; 1.13-1.19 g/mL for 
exosomes and 1.12 g/mL for blebs (Schorey et al., 2015, Dorward and Garon, 
1989). In contrast to exosomes, which are formed within the cell, blebs are 
formed when the outer membranes bulge away from the cell and pinch off (Lai et 
al., 2015). It is thought that N. gonorrhoeae blebs function in intercellular 
communication, horizontal gene transfer and biofilm formation (Dorward and 
Garon, 1989, L. et al., 2005). Blebs contain protein cargo from the outer 
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membrane and periplasm as well as immunogenic factors such as LPS and 
peptidoglycan (Kulp and Kuehn, 2010, Lai et al., 2015). Although it has never 
been demonstrated with N. gonorrhoeae, outer membrane blebs from other 
Gram-negative species can activate the innate and adaptive immune responses. 
It is proposed that the blebs from N. gonorrhoeae may also have 
immunomodulatory functions because the bleb’s constituents largely reflect 
factors expressed on the outer membrane, such LOS, lipoproteins and porin 
(Zielke et al., 2014).  
N. gonorrhoeae stimulation enriched cIAP2 within exosomes, but we also 
wanted to determine if N. gonorrhoeae increases the release of exosomes thus 
further increasing the concentration of extracellular cIAP2. We found that N. 
gonorrhoeae stimulated cells increased the number of exosomes. This is in line 
with several other studies reporting that epithelial cells increase exosome release 
in response to infectious agents (Honegger et al., 2013, Hu et al., 2013).  
 
Potential functional consequences of exosomes following N. gonorrhoeae 
stimulation 
Gonococcal stimulation of exosome production is interesting outside the 
scope of cIAP2 as well; exosomes can carry nearly 200 unique proteins and 100 
coding and 130 non-coding transcripts (Jenjaroenpun et al., 2013, Kalra et al., 
2013, Duijvesz et al., 2013). Although the regulation of exosome production is 
not fully understood, studies suggest an increase in exosome production may be 
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related to a stress response: ATP, intracellular Ca2+ influx, receptor ligation and 
p53 have all been found to induce exosome release (Wilson et al., 2004, Savina 
et al., 2005, Obregon et al., 2006, Blanchard et al., 2002, Yu et al., 2006). In 
addition to N. gonorrhoeae, other microbes have also been found to increase 
exosome production. The parasite Cryptosporidium parvum increases exosome 
release in intestinal epithelial cells via TLR4, which in turn promotes exosome 
release at the plasma membrane (Hu et al., 2013). Interestingly, the released 
exosomes carry antimicrobial peptides that decrease the viability of the parasite 
and thus enhance exosome production, which is likely a host cell defense 
mechanism. On the other hand, the E6/E7 proteins of HPV reduce exosome 
release in HeLa cells (Honegger et al., 2013). The observed decrease in 
exosome release correlated with reduced expression of p53, which E6/E7 
proteins are known to degrade. In fact, studies have found p53 induces gene 
expression of tumor suppressor-activated pathway 6 (TSAP6), a protein thought 
to regulate exosome production (Yu et al., 2006). Although the E6/E7 proteins 
dampened the release of exosomes, they enhanced the concentration of 
survivin, a IAP family member known to be associated with tumor progression 
(Khan et al., 2010).  
Studies presented here are the first to show that N. gonorrhoeae induces 
exosome production. An earlier study described the release of small host 
vesicles carrying CD46 in response to N. gonorrhoeae, however these vesicles 
appeared to be microvesicles budding from the plasma membrane in contrast to 
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vesicles released from the endosome (exosomes) (Gill et al., 2005). Interestingly, 
CD46 is a receptor for gonococcal pilus and upon ligation, CD46 vesicles were 
shed from the surface of the epithelial cell, clearing various receptors on the cell 
surface. The studies presented here do not address the mechanism by which N. 
gonorrhoeae induces exosome production. The End/E6E7 cells do not express 
TLR4, however, it is feasible that exosomes could be produced upon ligation of 
other TLRs expressed by End/E6E7 cells such as TLR2. Intracellular PRRs could 
also induce exosome release, although this has not been documented in present 
literature. Interestingly, several reports have suggested that N. gonorrhoeae 
interferes with lysosome fusion (Lin et al., 1997, Ayala et al., 1998, Edwards and 
Butler, 2011). Thus, it is possible that the increase in exosome release is due to 
N. gonorrhoeae redirecting multivesicular bodies (MVBs) away from the 
lysosome and to the plasma membrane for exosome release.  
Inhibition of exosome secretion to study their biological function has been a 
challenge in the field (Schorey et al., 2015). Firstly, not all exosome formation 
seems to follow the same pathway, and secondly, the few targets known for 
inhibition also likely affect other vesicular pathways within the cell. However, 
several studies have had success inhibiting exosomes with the neutral 
sphingomyelinase inhibitor, GW4869 (Yuyama et al., 2012, Dreux et al., 2012, 
Guo et al., 2015). Sphingomyelinases release ceramide from sphingomyelin and 
therefore GW4869 should only inhibit exosomes generated via the ceramide 
pathway (Yuyama et al., 2012). Using this inhibitor, we found marked reduction in 
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released exosomes in both unstimulated and N. gonorrhoeae stimulated cells, 
suggesting that exosomes formed in End/E6E7 cells are dependent on the 
ceramide pathway. Interesting, it has been demonstrated that N. gonorrhoeae 
induces ceramide expression in Chang epithelial cells (Faulstich et al., 2015). 
The increase in ceramide may be a potential mechanism by which the bacteria 
increase exosome release as observed in our studies. Furthermore, the study 
found that neutral sphingomyelinase, which generates ceramide, is necessary for 
PorB invasion of the gonococcus (Faulstich et al., 2015). This finding would 
suggest that we observed a decrease in exosome release following GW4869 
treatment because there was reduced invasion.  Although we do not know if 
enhanced exosome release is dependent on N. gonorrhoeae invasion, we do not 
observe an increase in exosome release when End/E6E7 cells are stimulated 
with formalin killed N. gonorrhoeae (data not shown), suggesting that increased 
exosome release is dependent on invasion.  
In line with several reports that demonstrate microbial pathogens alter both 
content and production of exosomes (Hu et al., 2013, Honegger et al., 2013), N. 
gonorrhoeae enriched cIAP2 within the exosome and increased exosome 
release. While studies typically cite changes in one or a few altered proteins 
during infection, two recent studies have used proteomic profiling of exosomes to 
demonstrate that bacterial pathogens can significantly alter exosome 
composition following infection. In macrophages, Leishmania mexicana altered 
44 exosomal proteins and in human peripheral blood monocytes, Streptococcus 
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pyogenes induced exosome localization of several immunomodulatory proteins 
including fibrinogen-binding integrins CD18 and CD11b, as well as antimicrobials 
lysozyme and neutrophil defensin 1 (Oehmcke et al., 2013). From these studies, 
it is clear that the content of exosomes varies depending upon the infectious 
agent.  
We have begun to study how exosomes from N. gonorrhoeae stimulated cells 
alter cellular responses in neighboring epithelial cells. Because N. gonorrhoaea 
blebs are also abundantly present in exosome samples, verifying detected 
responses in neighboring cells is due to exosomes, not blebs, is difficult. Yet 
blebs should not be seen only as contaminants of exosome studies, as both 
microbial and host derived vesicles likely play a role in shaping the immune 
response (Schorey et al., 2015). In preliminary studies presented here, 
exosomes from unstimulated cells induced cytokine responses that may protect 
End/E6E7 cells from N. gonorrhoeae induced cell death. Furthermore, when cells 
were treated with formalin killed bacteria (thus samples should be free of blebs), 
stimulated cells produced exosomes that elicited greater cytokine production 
than unstimulated cells. Future studies should address the effect of live bacteria 
on exosomes as well as the role cIAP2 may or may not have in modulating 
neighboring cell responses. 
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Clinical relevance 
Collectively, our results indicate that N. gonorrhoeae induction of cIAP2 in 
human cervical epithelial cells protects these cells from cell death. We speculate 
that the high levels of cIAP2 induced at relatively early time points during 
infection, protects cells from necroptotic death. At later time points, export of 
cIAP2 via secretion of exosomes may deplete intracellular cIAP2 and initiate host 
cell death (Figure 34). Because the observed cell death is lytic in nature, the cell 
is likely to release pro-inflammatory molecules that could aid in the recruitment of 
phagocytic cells that clear the bacteria. It should be noted that experiments 
describing cIAP2 depletion and necroptosis utilized high MOIs, thus lytic cell 
death of epithelial cells during natural infection may occur in later stages of 
infection. The induction of necroptosis in later stages of infection may be a 
mechanism that leads to recruitment of phagocytes.  
The secretion of cIAP2 via exosomes is a novel finding. Although studies 
described here do not adequately address if cIAP2 is bioactive in neighboring 
cells, the presence of cIAP2 in exosomes could lead to a new diagnostic or 
prognostic strategy for cancers. High cIAP2 expression has been documented in 
cancers from cervical cancer, to colorectal cancer to leukemia (Pei-Hui et al., 
2012, Dagenais et al., 2015, Opel et al., 2015). Nearly all cells, particularly tumor 
cells, secrete exosomes (Kahlert and Kalluri, 2013) and thus detecting cIAP2 
from tumor sites is potentially feasible. Indeed, a recent study described cIAP1, 
cIAP2 and XIAP in exosomes from four tumor cell lines (Valenzuela et al., 2015). 
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Thus the presence of cIAP2 in exosomes could be a very promising diagnostic or 
prognostic tool for cancer patients. For example, isolation of exosomes from 
cervico-vaginal lavages would be much less invasive procedure than a biopsy for 
diagnosis of cervical cancer or for monitoring treatment.  
The role of exosomes in the FGT has had little attention, but the potential 
importance of these vesicles was shown in a report that vaginal cells can uptake 
exosomes from semen, reducing HIV transmission (Madison et al., 2015). 
Another study demonstrated that exosomes from the placenta induce apoptosis 
in immune cells, thereby protecting the fetus from the maternal immune system 
(Stenqvist et al., 2013). Exosomes can fuse with cells that are direct neighbors, 
but they can also traverse epithelium to resident macrophages, dendritic cells or 
PMNs (Hu et al., 2013). Thus, modified exosomes from N. gonorrhoeae infected 
epithelial cells may enable epithelial cells to orchestrate the immune response in 
the FGT. 
.  
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Chapter 7. Future Directions and Ongoing Studies 
 
 In this study, N. gonorrhoeae altered expression and localization of cIAP2, 
a protein integral to maintaining host cell survival. N. gonorrhoeae induced high 
levels of intracellular cIAP2 that were later exported via exosomes and 
corresponded to depleted intracellular levels. Through chemical inhibition of 
cIAP2, we found that cIAP2 protected against an inflammatory cell death in N. 
gonorrhoeae stimulated cells. N. gonorrhoeae induced production of exosomes 
that may potentially effect cell death and cytokine production in uninfected 
bystander cells. Collectively, these studies highlight an additional mechanism by 
which epithelial cells direct the immune response during N. gonorrheoae 
infection. However, these studies also raise a number of unanswered questions 
that are mentioned below. 
 
Functional consequences of cIAP2 export via exosomes  
 N. gonorrhoeae alone induced cell death as measured by increased cell 
permeabilization at late time points post-infection. Increased cell death correlated 
with the time at which intracellular cIAP2 was depleted, presumably due to 
exosome export of cIAP2. A limitation of this study was the inability to directly 
attribute the intracellular depletion of cIAP2 due to exosome export, to the 
observed cell death when cIAP2 was chemically inhibited. Future studies should 
confirm if the cell death from N. gonorrhoeae stimulation alone and cell death 
from BV6 inhibited cIAP2 undergo the same cell death pathway. Ideally, a 
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mechanism to inhibit exosome secretion without affecting cIAP2 expression 
during N. gonorrhoeae stimulation could demonstrate that retention of 
intracellular cIAP2 reduces N. gonorrhoeae induced cell death. This direct link 
would concretely reveal a new mechanism for intracellular cIAP2 regulation and 
its importance in regulating cell death. 
 We demonstrated that cIAP2 was associated with exosomes, and as 
described above, we hypothesize this to be a mechanism whereby intracellular 
cIAP2 is depleted and cell death initiated in response to infection. We did not 
address whether exosome associated cIAP2 has a biological function in 
neighboring cells. For example, it has been reported that cells treated with 
exosomes enriched with survivin, an IAP family member, were resistant to 
apoptosis induction (Khan et al., 2010). Future studies should address activity of 
exosomal cIAP2 by overexpressing cIAP2 and treating uninfected cells with 
cIAP2 enriched exosomes. However, because exosomes may contain up to 200 
different proteins, studies should also examine cell death and inflammation in 
uninfected cells as a result of the whole exosome, and not only the presence of 
cIAP2.  
 
Functional consequences of cell death during N. gonorrhoeae infection 
In this study, cIAP2 protected against a lytic cell death known as 
necroptosis. The lytic nature of necroptosis leads to the release of immunogenic 
intracellular components known as DAMPs, which may alter inflammatory 
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responses in neighboring cells. Future studies should investigate if DAMPs 
released from cIAP2 depleted epithelial cells during N. gonorrhoeae stimulation 
either induce or repress cell death in neighboring uninfected epithelial cells. Such 
studies may shed light on how necroptosis affects the epithelial barrier during 
infection. These studies were performed in epithelial cells, however, within the 
FGT, epithelial cells may communicate with immune cells including 
macrophages, dendritic cells and PMNs. Currently, a member of the laboratory is 
investigating cell death in macrophages stimulated with N. gonorrhoeae. In the 
near future we plan to determine how cell death of macrophages and/or epithelial 
cells may alter cell death and inflammation of macrophages and/or epithelial 
cells.  
 
Changes in exosomes following N. gonorrhoeae stimulation 
 Live N. gonorrhoeae stimulation enhanced the release of exosomes from 
epithelial cells. As other microbial pathogens such as human papilloma virus and 
the parasite Cryptosporidium induce exosome release (Honegger et al., 2013, Hu 
et al., 2013), future studies should address the mechanism by which N. 
gonorrhoeae induces exosome release including the role of invasion as well as 
isolated N. gonorrhoeae ligands including porins, opa proteins and lipoproteins.  
 Our results regarding the functional consequences of exosomes are 
preliminary, however, ongoing studies are examining how exosomes from N. 
gonorrhoeae stimulated epithelial cells alter cell death, inflammation and 
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gonococcal survival in uninfected neighboring cells. Because N. gonorrhoeae 
outer membrane blebs, as well as exosomes, are present during natural 
infection, future studies should address how gonococcal outer membrane blebs 
alter immune responses in uninfected epithelial cells. Future studies will also 
determine how exosomes from epithelial cells and N. gonorrhoeae outer 
membrane blebs modulate cell death, inflammation and gonococcal survival in 
macrophages. These studies may reveal how epithelial exosomes and 
gonococcal blebs prime macrophages for their encounter with bacteria. 
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Abstract  
Gonorrhea is a highly prevalent disease resulting in significant morbidity 
worldwide, with an estimated 106 cases reported annually. Neisseria gonorrhoeae, 
the causative agent of gonorrhea, colonizes and infects the human genital tract 
and often evades host immune mechanisms until successful antibiotic treatment is 
used. The alarming increase in antibiotic-resistant strains of N. gonorrhoeae, the 
often asymptomatic nature of this disease in women and the lack of a vaccine 
directed at crucial virulence determinants have prompted us to perform 
transcriptome analysis to understand gonococcal gene expression patterns during 
natural infection. We sequenced RNA extracted from cervico-vaginal lavage 
samples collected from women recently exposed to infected male partners and 
determined the complete N. gonorrhoeae transcriptome during infection of the 
lower genital tract in women. On average, 3.19% of total RNA isolated from female 
samples aligned to the N. gonorrhoeae NCCP11945 genome and 1750 
gonococcal ORFs (65% of all protein-coding genes) were transcribed. High 
expression in vivo was observed in genes encoding antimicrobial efflux pumps, 
iron response, phage production, pilin structure, outer membrane structures and 
hypothetical proteins. A parallel analysis was performed using the same strains 
grown in vitro in a chemically defined media (CDM).  A total of 140 genes were 
increased in expression during natural infection compared to growth in CDM, and 
165 genes were decreased in expression.  Large differences were found in gene 
expression profiles under each condition, particularly with genes involved in DNA 
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and RNA processing, iron, transposase, pilin and lipoproteins. We specifically 
interrogated genes encoding DNA binding regulators and iron-scavenging proteins, 
and identified increased expression of several iron-regulated genes, including 
tbpAB and fbpAB, during infection in women as compared to growth in vitro, 
suggesting that during infection of the genital tract in women, the gonococcus is 
exposed to an iron deplete environment. Collectively, we demonstrate that a large 
portion of the gonococcal genome is expressed and regulated during mucosal 
infection including genes involved in regulatory functions and iron scavenging.  
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Introduction 
The sexually transmitted infection (STI) gonorrhea, caused by the Gram-negative 
bacterium Neisseria gonorrhoeae, is the second most common reportable 
disease in the U.S. In 2014, there were 331,000 reported cases and the total 
annual number is estimated to be 800,000 due to underreporting (Centers for 
Disease Control and Prevention). Gonorrhea is also prevalent worldwide with an 
estimated 106 million cases annually (1).  The relatively straightforward 
therapeutic approaches to treat gonococcal infections have been complicated 
recently by the emergence of antibiotic resistance (2, 3). In 2013, the CDC 
reported that antibiotic-resistant N. gonorrhoeae was a major cause for concern 
in the US and abroad, and a recent study has described cephalosporin-resistant 
N. gonorrhoeae in the United States (4).   
Like many other human pathogens, N. gonorrhoeae must adapt to the 
environment encountered during infection. Control of gene expression results 
from a number of distinct mechanisms, including DNA binding proteins and 
regulatory sRNAs that bind to target mRNAs to control their translation and 
stability (5-8). DNA binding proteins that are important in infection include sigma 
factors, such as RpoH, shown to increase transcription of genes involved in 
stress response and adherence to epithelial cells (9, 10), and OxyR, which 
regulates expression of genes such as catalase, involved in resistance to 
bactericidal reactive oxygen species (11).  Another well-known factor crucial for a 
successful host infection is Fur, which regulates intracellular iron levels (12, 13). 
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Targets of Fur include the ferric-binding protein (FbpA), transferrin binding 
proteins (TbpAB) and lactoferrin binding proteins (LbpAB).   
Despite numerous studies that have examined gonococcal gene expression in 
vitro, little is known about how this pathogen regulates gene expression during 
natural infection.  In the female genital tract, N. gonorrhoeae is exposed to 
unique conditions, such as low pH (14, 15), varying oxygen and iron levels (16-
19), and the presence of additional microbes and host cells (20).  In this 
environment, free iron is scarce and is usually complexed to host iron binding 
proteins, including transferrin and lactoferrin, thus making the female genital tract 
an iron-deplete environment (17). However, during menses iron levels can rise 
and N. gonorrhoeae responds to these changes via expression of the Fur protein 
(17). Previous work from our group has shown that gonococcal genes encoding 
the tbpAB genes and the fur gene itself are differentially regulated during in vivo 
infection (16, 17). However, these studies were carried out using a combination 
of subset microarrays and qRT-PCR and thus were limited in their sensitivity and 
detection. 
Here, we present the first study based on an RNA deep sequencing (RNA-seq) 
analysis of N. gonorrhoeae RNA samples derived directly from cervico-vaginal 
lavage specimens of infected women. The gonococcal strains isolated from these 
samples were also grown in vitro and the resulting transcriptomes were 
compared to those expressed during natural infection to define infection-specific 
gene expression profiles. This analysis has identified gonococcal genes that are 
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highly expressed during cervical infection in women and other genes that are 
differentially regulated during infection compared to growth in vitro. 
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Results  
Global analysis of gonococcal gene expression during natural mucosal 
infection in women  
Following RNA extraction and sequencing from four cervico-vaginal 
lavage samples, cDNA reads were aligned to the three fully sequenced strains of 
N. gonorrhoeae in the NCBI database: N. gonorrhoeae FA1090, NCCP11945 
and TCDC-NGO8107, using Rockhopper software (21).  Gonococcal RNA 
isolated from all subjects aligned most closely to the NCCP11945 strain, a strain 
isolated from a vaginal specimen in 2008 in Korea (22). On average, 3.19% of 
the total RNA from each sample aligned to the N. gonorrhoeae NCCP11945 
genome and ~45% aligned to the human genome.  To be considered expressed, 
a gene had to have a reads per kilobase per million reads (RPKM) value of at 
least 10. Our analysis detected expression of 1750 gonococcal genes, 
representing ~ 65% of the gonococcal genome. The level of expression of all 
genes, regardless of RPKM level in each subject and infecting strain, is 
summarized in S1 Table . High expression of several similar genes was detected 
in each of the vaginal samples (Table 1).  These similarities in gene expression 
occurred despite temporal differences in the exposure of female subjects to the 
infected partner(s), menstrual cycle and degree of cervico-vaginal neutrophilia 
(Table 2). This core set of similar genes included those encoding outer 
membrane (omp3, NGK_0749) housekeeping (elongation factor P, Tu), stress 
response (groES), phage associated (NGK_1145) and hypothetical proteins 
(NGK_0472, NGK_2043) (Table 1). In addition to ORFs, 75 short non-coding 
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transcripts representing regulatory small RNAs (described in detail below), were 
also expressed.   It is important to note that several of these highly expressed 
genes showed similar high expression in vitro during growth in CDM.  Specific 
analysis of genes showing changes in expression as a result of infection is 
discussed below. 
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Table 1.  Gonococcal genes* that exhibited the highest expression levels 
during infection of the female genital tract. 
Gene Product 
Expression 
Subject 
1*** 
Expression 
Subject 
2*** 
Expression 
Subject 
3*** 
Expression 
Subject 
4*** 
**NGK_0225 
16S rRNA-
processing 
protein RimM 546 596 566 712 
NGK_0472 
Hypothetical 
protein 1085 1142 1554 1737 
NGK_0749 
Outer 
membrane 
protein 653 361 372 955 
NGK_0861 
Elongation 
factor P 1675 1074 685 1311 
NGK_0873 Glutaredoxin 3711 1994 2460 4432 
NGK_0946 
Putative 
secreted 
protein 643 451 375 1284 
NGK_1099 DbhA 1301 1091 722 3655 
NGK_1145 
Putative phage 
associated 
protein 1462 1063 1343 1717 
NGK_1876 Omp3 2001 1229 1279 3718 
NGK_2043 
Hypothetical 
protein 657 387 371 985 
NGK_2298 
Hypothetical 
protein 10792 23821 12739 17690 
NGK_2415 
Elongation 
factor Tu 2983 1698 1704 3233 
NGK_2431 
Elongation 
factor Tu 2903 1341 1262 2407 
NGK_2459 Glutaredoxin 3186 1887 730 2060 
NGK_2520 
Acyl carrier 
protein 975 2203 1787 4170 
NGK_2558 
Co-chaperone 
GroES 1647 2317 609 979 
NGK_2621 
F0F1 ATP 
synthase 
subunit C 1186 567 1424 758 
*    Cervico-vaginal lavage samples were examined separately and genes that 
were in the top 50 most highly expressed genes in all 4 subjects are indicated.  
rRNA, tRNA, and ribosomal protein coding genes have been removed. 
	  	  190	  
**  Locus Tag is shown according to N. gonorrhoeae, NCCP11945 genome 
*** Expression levels shown as Reads per Kilobase per Million Reads (RPKM). 
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Table 2. Characteristics of female subjects with uncomplicated gonorrhea  
  
Subject Age 
Days 
Since 
Last 
Menstr
ual 
Cycle 
Days 
Since 
Last 
sex-
contact 
with 
Infected 
Male 
Cervical 
Culture for 
N. 
gonorrhoea
e (Ng)* 
Other 
Microbes 
Present 
(Method of 
Detection) 
Vaginal 
Wet 
Mount 
Cervi
cal 
PMN
s** 
1 29 27 10 Pos. None Normal ++ 
2 35 26 4 Pos. 
C. 
trachomati
s (PCR) U. 
urealyticum 
(Culture), 
M. hominis 
(Culture) 
Clue cells 
(BV+) ++ 
3 21 16 11 Pos. None Clue cells (BV+) + 
4 23 8 1    Neg.*** 
U. 
urealyticum 
(Culture) 
Normal None 
 
*  Thayer–Martin media; Ng confirmed by colonial morphology, Gram’s stain and 
oxidase testing 
** Number of cervical polymorphonuclear leukocytes (PMNs) indicated: +, 1-4 
PMNs/oif (oil immersion field); ++, >10  PMNs/oif under light microscopy at 
X1000  
*** Subject 4 was negative for N. gonorrhoeae by culture but positive by PCR 
+   (BV) Bacterial vaginosis  
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To gain information on general trends of gonococcal responses to 
infection in women, we categorized and organized the top 100 gonococcal genes 
that were most highly expressed when RPKM values from all subjects were 
averaged together.  These genes were categorized based on their gene 
annotation according to strain NCCP11945, which was chosen because 
sequences aligned most closely to that strain (22).  To determine the ratio of 
enrichment, these highly expressed genes were first categorized by function. 
Then, the percentage of genes in each functional category was compared to the 
percentage of genes within the same functional category in the whole gonococcal 
genome.  The resulting ratio was defined as the “ratio of enrichment”. The most 
commonly represented enriched categories that were highly expressed included 
genes associated with pilin, membrane and stress response as well as traditional 
housekeeping genes such as those involved in translation, replication and energy 
metabolism (Fig. 1).  Expression of these genes showed variable levels in each 
of the cervico-vaginal samples, but all were expressed at high levels and, as a 
whole, reflected the profile of the most highly expressed gonococcal genes 
during natural infection.  As above, several of these genes were also highly 
expressed in vitro.  A specific analysis of genes that showed changes in 
expression relative to in vitro growth is presented below. 
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Fig 1.  Categorization of top 100 expressed N. gonorrhoeae genes during 
natural mucosal infection in women.  The top 100 gonococcal genes 
expressed in 4 infected subjects were categorized based on gene categories 
using NCBI information from the NCCP11945 strain.  Categories are shown on 
the y-axis with the ratio of enrichment (percentage of genes of a given functional 
category in the RNA-seq dataset/percentage of genes of that functional category 
in the whole gonococcal genome) shown on the x-axis. Ribosomal protein, tRNA, 
and rRNA genes were removed for clarity. 
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Expression of N. gonorrhoeae antimicrobial resistance genes during 
natural mucosal infection in women 
N. gonorrhoeae strains isolated recently worldwide have shown increased 
resistance to antibiotics (2-4). The infecting strains in our study also were 
resistant to several antibiotics (S2 Table). Thus, we examined expression of 
genes encoding the mtrCDE efflux pump (23-26), a system that exports toxic, 
host-derived compounds and hydrophobic antibiotics from gonococci.  MtrR, the 
regulatory protein which represses transcription of mtrCDE genes (27), was also 
examined.  Expression of all genes within the mtrCDE locus was found in all 4 
cervico-vaginal lavage samples (Fig. 2). We observed lower levels of expression 
of the regulatory mtrR gene as compared to the efflux pump components for all 4 
infecting strains. In Subjects 2, 3 and 4, the mtrR gene was not detected at an 
RPKM level of at least 10.  Expression of mtrR in Subject 1 was higher than in 
other subjects, corresponding to a higher expression of the mtrCDE genes.  
Expression of the mtrA gene, which activates the mtrCDE locus (28), was also 
detected in Subjects 1, 2 and 4 with RPKM values of 67, 31 and 167 respectively 
(S1 Table-Line 262). It should be noted that many of the genes in the mtr locus 
also showed high expression in vitro, and that mtr genes were not specifically 
regulated by infection but rather showed a pattern of expression in vivo 
consistent with low levels of the repressor and high levels of the efflux pump 
genes (Fig. 2). 
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Fig. 2. Expression of the Gonococcal mtrR / mtrCDE genes.  Expression 
levels, reads per kilobase per million reads, (RPKM), of each of the three genes 
in the mtrCDE operon and the mtrR gene are shown for each of the 4 cervico-
vaginal lavage samples examined as well as in the corresponding strain grown in 
CDM for three of subjects. 
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Gonococcal gene expression during natural mucosal infection relative to 
expression during growth in CDM 
The majority of studies aimed at characterizing the response of the 
gonococcus to different environmental stimuli have examined N. gonorrhoeae 
cultured in vitro (i.e. during incubation in media or with host cells) conditions that 
do not completely replicate the environment encountered in the human host 
during infection. Therefore, gonococcal genes that are expressed during natural 
infection may differ markedly from those expressed in vitro. Thus, we cultured 
gonococcal isolates from Subjects 1, 2, and 3 (Subject 4 was diagnosed by PCR 
only; no isolate was recovered) in a chemically defined medium (CDM) with 
added ferric nitrate (100 µM final concentration) and compared the resulting 
transcriptome to that expressed during infection in the female genital tract.  We 
did not observe differences in the growth rates between the 3 strains in CDM 
plus ferric nitrate (data not shown). Expression levels for all genes detected 
under in vitro conditions are shown in S1 Table.  
Regulated genes were those that showed a difference in expression of at 
least 3-fold (up or down) in natural infection compared to growth in CDM.  On 
average, 397 gonococcal genes, representing 20% of the genome, were 
regulated in each subject.  Functional enrichment analysis, performed on genes 
showing differences in expression during natural infection compared to growth in 
CDM, showed enrichment of genes encoding for tRNA, iron, membrane, 
transposase and lipoproteins among genes whose expression was increased in 
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vivo compared to growth in CDM.  In contrast, metabolism, growth and 
housekeeping functions were enriched in genes showing decreased expression 
in vivo compared to CDM (Fig. 3).  Subject-specific gene expression patterns 
appeared overall remarkably similar, although subtle differences were also noted 
between subjects.  For example, in the comparison between in vivo gene 
expression and growth in CDM, pilin-related genes were enriched among genes 
showing increased expression in Subject 2, enriched among genes showing 
decreased expression in Subject 3 and not enriched at all in Subject 1.  A similar 
variability was observed for stress response genes, where enrichment among 
genes with increased expression was observed in Subjects 2 and 3 but not in 
Subject 1.  Finally, genes encoding lipoproteins were enriched among genes with 
increased expression in Subject 1 and 3 but not in Subject 2.  Overall, we 
observed general trends and a core set of genes differentially expressed in all 
subjects regardless of the specifics of infection.  However, the subtle differences 
in regulation and expression of gonococcal genes, for example those involved in 
pilin and stress response, indicate that the genital tract of each subject was 
unique.  
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Fig. 3. Subject-specific comparisons between transcriptomes of N. 
gonorrhoeae in natural infection vs. growth in CDM.  N. gonorrhoeae 
transcriptomes observed for each subject compared with transcriptomes of 
corresponding infecting strains grown in CDM.  Genes that showed at least a 3-
fold change in expression were categorized based on gene function.  (A) 
Functional enrichment of genes showing at least a 3-fold change in expression 
during infection of Subject 1 compared to growth of the infecting strain in CDM.  
Gene categories are shown in the y-axis and ratio of enrichment is shown on the 
x-axis.  Blue bars indicate functional enrichment of genes showing increased 
expression during natural infection in vivo compared to growth in CDM. Red bars 
indicate functional enrichment of genes showing decreased expression during 
natural infection in vivo compared to growth in CDM. (B) Identical analysis for 
Subject 2 (C) Identical analysis for Subject 3.   
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Regulation of N. gonorrhoeae genes encoding DNA binding proteins during 
natural mucosal infection relative to growth in CDM 
 Regulatory proteins that bind DNA appear to play a prominent role in N. 
gonorrhoeae infection of the genital tract in women.  Among the 3 subjects, each 
examined individually, 14 DNA-binding regulators were differentially expressed 
during natural infection as compared to growth in CDM, with increased 
expression of 6 and decreased expression of 8 regulatory protein genes. Certain 
genes that encode DNA binding proteins were regulated in multiple subjects, for 
example an AraC-like regulator (NGK_2588) was increased in Subjects 1 and 2, 
a two-component regulator (NGK_2403) was decreased in Subjects 2 and 3, and 
a CysB-like regulator decreased (NGK_1878) in Subjects 1 and 2 (Table 3).  The 
fur gene also showed lower levels in RNA isolated from Subjects 2 and 3 
compared to growth in CDM.   
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Table 3.  Gonococcal regulators differentially expressed in vivo versus in 
vitro. 
Locus Tag Gene 
Subject # or 
Composite 
View** 
Increased Expression* 
NGK_0127 transcriptional regulator NrdR 1 
NGK_0157 protein BasS 2 
NGK_1125 NarL/NarP 2, Comp. 
NGK_1256 Regulator of cell morphogenesis and NO signaling 2 
NGK_1277 
Putative HTH-type transcriptional regulator 
NMB1378 1 
NGK_1600 MtrR protein 1 
NGK_2588 AraC family transcriptional regulator 1, 2, Comp. 
      
Decreased Expression* 
NGK_0289 GntR family transcriptional regulator 1 
NGK_0454 integration host factor subunit alpha 1, 2, 3 
NGK_0729 recombination regulator RecX 1 
NGK_0935 putative ATP-binding protein 2 
NGK_1099 protein DbhA 2, 3 
NGK_1653 Regulatory protein NosR 1 
NGK_1662 transcriptional regulator, AsnC family 3 
NGK_1685 putative transcriptional regulator, repressor 3 
NGK_1878 transcriptional regulator CysB-like protein 1, 2 
NGK_2333 BolA/YrbA family protein 3 
NGK_2403 Putative two-component response regulator 2, 3 
NGK_2458 OxyR 1, 3 
NGK_2495 Fur family ferric uptake regulator 2, 3  
* Gonococcal regulators that showed increased or decreased expression (> 3-
fold) in vivo,   
compared to expression of corresponding N. gonorrhoeae  grown in vitro in CDM 
+ ferric nitrate  
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# Transcriptome of N. gonorrhoeae in the cervico-vaginal lavage (CVL) samples 
from Subjects 
   1, 2 or 3 compared to the transcriptome of the corresponding strain of N. 
gonorrhoeae isolated from Subjects 1, 2 or 3 (no strain was isolated from subject 
4) 
** Composite view: Expression of designated gene from CVLs from any of the 4 
subjects   
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Composite analysis of gonococcal gene expression during natural mucosal 
infection relative to expression during growth in CDM 
 Several gonococcal genes were regulated in a similar fashion in each 
subject, suggesting that a common response of the gonococcus may be 
dependent on intrinsic features of the human female genital tract.  Thus, we next 
examined the combined results from the 4 cervico-lavage samples to define an 
‘average’ expression of each gonococcal gene during infection (Table S3). As a 
comparison, we also combined the data resulting from the in vitro growth of the 3 
available infecting strains, and lastly, used these averages to compare in vivo 
and in vitro gene expression.   We identified 305 genes with statistically 
significant changes in expression, defined as a q-value of <0.05 and > than a 2-
fold change in expression. A total of 140 genes showed increased expression 
and 165 decreased expression during in vivo vs. in vitro growth (S4 Table; and 
Fig. 4A). Functional enrichment analysis was performed to define how the 
gonococcus alters gene expression during infection (Fig. 4B and C). We 
observed that genes involved in membrane composition/function, iron 
scavenging, transposases and tRNAs were strongly enriched among genes with 
increased expression in vivo compared to growth in CDM.  In contrast, several 
housekeeping genes were enriched among genes showing decreased 
expression, suggesting changes in growth and replication rates of N. 
gonorrhoeae during infection compared to growth in CDM (Fig. 4B and C).  Other 
categories such as pilin and lipoprotein genes also were enriched among genes 
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showing decreased expression despite the fact that when examining subjects 
individually these genes were found to be enriched among genes showing 
increased expression. Interestingly, 20 genes encoding phage-associated 
proteins showed statistically significant regulation, with six of these genes 
showing increased expression during infection as compared to growth in CDM 
(S4 Table). Phage-associated genes were also slightly enriched among genes 
showing decreased expression in vivo.  The expression levels of all genes from 
cervico-vaginal lavage samples compared to strains grown in CDM are shown in 
S3 Table. 
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Fig. 4. Composite comparisons between transcriptomes of N. gonorrhoeae 
in natural infection vs. growth in CDM. (A) Log values of expression (RPKM) 
levels are indicated.  Expression levels in all 4 cervico-lavage samples were 
averaged and compared to the average expression levels of the three isolated N. 
gonorrhoeae strains grown in vitro in CDM supplemented with ferric nitrate (100 
µM final concentration).  Genes in blue had q-values < 0.05. (B) Functional 
enrichment of genes showing changes in expression when examining 
gonococcal transcriptomes during natural infection compared to growth in CDM 
supplemented with ferric nitrate (100 µM final concentration).  Availability of 
several subject samples permitted statistical analysis and genes were considered 
to be differentially expressed between two samples if the q value was < 0.05 and 
the fold change > 2.  Blue bars indicate functional enrichment of genes showing 
increased expression during natural infection in vivo compared to growth in CDM.  
Red bars indicate functional enrichment of genes showing decreased expression 
during natural infection in vivo compared to growth in CDM.  
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 A small number of genes that encoded DNA binding regulatory proteins 
also exhibited statistically significant regulation when infection in vivo vs. growth 
in vitro in CDM was compared.  Some were the same regulatory proteins that 
showed changes in expression when individual subjects were examined; for 
example an ArsC transcriptional regulator (NGK_2588) was expressed 
approximately 4-fold higher during in vivo infection vs. growth in vitro and was 
also regulated in Subjects 1 and 2 individually (Table 3).  
 We also identified 75 non-coding RNAs between 30-250 nucleotides in 
length in the composite analysis that possibly represented sRNAs (S3 Table).  
Expression of putative sRNAs was observed both as antisense transcripts 
opposite known ORFs and from intergenic regions. Ten of these sRNAs showed 
increased expression during natural infection compared to growth in CDM; 16 
sRNAs showed decreased expression (S4 Table).  Several of the sRNAs 
expressed during infection have previously been identified in N. gonorrhoeae 
under a variety of in vitro conditions (8, 29).  For example, the sRNA NrrF 
exhibited statistically significant increased expression in vivo as compared to in 
vitro.  We also detected transcription of the sRNAs 4.5S and M1 (30).  Others 
sRNAs, including a total of ~70% of sRNAs that had been experimentally verified 
in a previous study (8) were also detected, including one at genomic coordinates 
1201200-1201287 and one at 1253992-1254075, both of which showed 
decreased expression in vivo compared to in vitro (S4 Table) (8). We did not 
detect expression of the pilin antigenic variation small RNA (5).  A large number 
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of transfer RNAs (tRNAs) also exhibited statistically significant changes in 
expression (S4 Table).  Most tRNAs were detected at higher levels during natural 
infection compared to growth in CDM.  Of 33 tRNAs that showed significant 
regulation, only one was expressed at higher levels during growth in CDM 
compared to natural infection. 
 
Expression and regulation of gonococcal genes that encode for iron 
scavenging proteins during natural mucosal infection relative to growth in 
CDM 
 Previously, we reported that the gonococcal iron and Fur-regulated genes 
were expressed in urethral and cervico-vaginal lavage samples obtained from 
men and women with gonococcal infections (16, 17).  While these studies 
confirmed expression of tbp and fbp genes during infection, they did not address 
differential expression relative to corresponding infecting strains grown in vitro. In 
the current study we examined expression of tbp and fbp genes in the three 
culture-positive subject samples and compared this expression to the 
corresponding strains grown in vitro. Predominantly, increased expression of iron 
regulated tbpA and tbpB genes was seen in samples from each subject as 
compared to expression in vitro, although expression in individual samples 
varied. We also observed increased expression of fbpABC genes in vivo (except 
fbpC expression in Subject 2) as compared to expression in vitro (Fig. 5). 
Analysis of average expression of tbpAB and fbpABC genes from all cervico-
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vaginal lavage samples also revealed statistically significant increased levels 
compared to organisms growth in CDM with ferric nitrate (q  < 0.0001; Fig. 5).  
Consistent with these results, the repressor of these genes, Fur, was expressed 
at lower levels during natural infection compared to growth in CDM with ferric 
nitrate (Table 3 and S3 Table). Other iron-regulated genes also showed 
regulation; both hpuA and hpuB were highly expressed in vivo as compared to in 
vitro, and two out of four heme utilization proteins also showed a similar pattern 
(although not statistically significant).  In contrast, lactoferrin binding proteins 
showed higher expression in vitro compared to in vivo (Fig. 5). Because in vitro 
growth was performed under iron-replete conditions (when iron scavenging 
genes exhibit low expression), the high in vivo expression of tbp, fbp, and hpu 
genes, as well as NrrF, combined with the low expression of Fur suggests that 
gonococci encounter an iron-deplete environment in the female genital tract. 
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Fig. 5.  Expression of Gonococcal fbp and tbp genes. (A) Expression levels 
of fbpC, (blue) fbpB (red), lbpB (green), lbpA (purple), hbpA (cyan), hbpB 
(orange), hbpC (light blue), tbpA (pink), tbpB (light green), hpuB (light purple), 
and hpuA (teal) genes in RNA isolated from individual cervico-lavage samples 
compared to RNA isolated from the corresponding infecting N. gonorrhoeae 
strains grown in vitro in CDM supplemented with ferric nitrate (100 µM final 
concentration). (B) Expression levels of fbpA (blue) and hpbD (red) genes in 
RNA isolated from individual cervico-lavage samples compared to RNA isolated 
from the corresponding infecting N. gonorrhoeae strains grown in vitro in CDM 
supplemented with ferric nitrate (100 µM final concentration).  These genes were 
expressed at significantly higher levels and were placed in a separate graph for 
ease of viewing. (C) Average expression levels of fbpC, fbpB, lbpB, lbpA, hbpA, 
hbpB, hbpC, tbpA, tbpB, hpuB, and hpuA gene expression in RNA isolated from 
4 cervico-lavage samples (red bars) and average expression levels from the 3 
isolated N. gonorrhoeae strains grown in vitro in CDM supplemented with ferric 
nitrate (100 µM final concentration) (blue bars).  Expression levels (RPKM) are 
shown on the x-axis and represent averages of all cervico-vaginal lavage 
samples or all isolated strains grown in CDM.  * Indicates a q-value of < 0.0001.  
(D) Average expression levels of fbpA and hpbD gene expression combined in 
RNA isolated from 4 cervico-lavage samples (red bars) and average expression 
levels from the 3 isolated N. gonorrhoeae strains grown in vitro in CDM 
supplemented with ferric nitrate (100 µM final concentration) (blue bars).  
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Expression levels (RPKM) are shown on the x-axis and represent averages of all 
cervico-vaginal lavage samples or all isolated strains grown in CDM.  * Indicates 
a q-value of < 0.0001.   
 
Discussion 
In this study we report the complete gonococcal transcriptome expressed during 
infection in women. Our results show that more than 65% of the genome was 
transcribed and detected. Genes that were highly expressed across all subjects 
during infection included genes associated with stress response, outer 
membrane and hypothetical proteins, and a high number of phage genes which 
previously have not been well characterized in N. gonorrhoeae.  Phage 
associated genes have been shown previously to be intimately involved in 
infection including in the closely related human pathogen N. meningitidis (31-33).   
While prior studies have reported the presence of at least 9 complete phage 
genomes within the genome of N. gonorrhoeae, the function of these phage 
genomes has not been investigated (34, 35).  A recent study reported on the 
possible function of these phage proteins in the context of infection (36).  Prior 
studies from our group identified a phage-associated DNA binding regulatory 
protein that controls genes required for gonococcal infection of human epithelial 
cells and colonization in a mouse model (37).  Our analysis showed that 20 
phage-associated genes were regulated during infection as compared to growth 
in vitro and further analysis of these genes may provide new information on the 
	  	  213	  
function of these genes during human gonococcal infection. 
Of particular relevance in light of an alarming increase in antibiotic-resistant 
strains of N. gonorrhoeae were the high levels of expression of the multiple 
transferable resistance (mtr) CDE locus genes and a corresponding low 
expression of the mtrR repressor that controls expression of the operon in the 
gonococcal strains and samples obtained directly from subjects.  Strains isolated 
in this study were not resistant to ceftriaxone (the recommended treatment in the 
United States), but other gonococcal strains with decreased susceptibility to 
ceftriaxone have been isolated recently in China and in the United States (4).  
The mtrCDE locus confers resistance to several host-derived antimicrobials, 
including cationic antimicrobial peptides (eg. LL-37), long chained fatty acids and 
other hydrophobic and artificial compounds (i.e. protegrin-1, progesterone and 
Triton X-100). Exposure of N. gonorrhoeae to macrolides (azithromycin), β-
lactam antimicrobials (penicillin) ciprofloxacin, tetracycline, rifampicin and 
extended spectrum cephalosporins, results in increased MICs to these 
antimicrobials (23-26, 38).  The mtrCDE locus is under the control of two 
classical DNA binding proteins: the Mtr repressor (MtrR) protein, which down 
regulates expression of the mtrC transcript and presumably other proteins in the 
operon (27), and the Mtr activator (MtrA) (28), which enhances expression of 
mtrCDE.  Several studies have shown that mutations of MtrR lead to enhanced 
fitness of N. gonorrhoeae in a mouse model of infection, suggesting that this 
system may also be crucial for survival of the organism in the human host (38, 
	  	  214	  
39).   
 A parallel comparative analysis of the transcriptome of N. gonorrhoeae in 
individual subjects and corresponding infecting isolates grown in vitro in a CDM 
identified 140 genes with increased expression and 165 genes with decreased 
expression. Predictably, there were subject-specific changes in the 
transcriptomes of N. gonorrhoeae isolates, due to the unique genital tract 
environment of individual subjects, which lead to tailored and specific N. 
gonorrhoeae responses during infection.  These specific responses are likely 
mediated, in part, by DNA-binding transcription factors, several of which were 
found to be expressed and regulated during infection, including Fur and MtrR, 
and an ArsR-like regulator.  We have shown that the latter is crucial to N. 
gonorrhoeae survival during infection of female endocervical cells, and that this 
regulator is also regulated by Fur (C. A. Genco, unpublished data).  We found 
that numerous other regulators showed variable expression during infection, 
particularly those involved in nutrient acquisition and metabolism (NGK_1662, 
GntR, RegF, BasS).  This likely reflects the large differences in metabolite 
composition in the female genital tract as compared to growth in CDM.  In 
addition to well-known transcription factors, others such as NGK_1277, 
NGK_1662, and NGK_1878 are relatively uncharacterized and may be involved 
in regulation of gene products that are crucial to gonococcal infection.   
 Increased expression of the iron regulated tbpAB and fbpABC genes 
during infection was also observed as compared to in vitro growth.  It is important 
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to note that our studies only examined gonococcal strains grown under iron-
replete conditions in vitro, and that a comparison of the gonococcal transcriptome 
expressed during infection with other in vitro conditions will likely identify 
additional genes that are differentially expressed during infection. We have 
previously reported that tbpAB and fbpA are expressed in vivo (17).  High 
expression and regulation of these proteins in uncomplicated cervical infection 
strongly suggests that the genital tract in women is an iron-deplete environment.  
 In addition, a large number of non-coding RNAs, including putative sRNAs 
and tRNAs, exhibited differential expression during infection. Relatively little is 
known regarding gonococcal sRNAs and studies on these regulators in N. 
gonorrhoeae are scarce.  Work from our group and others have described the 
repertoire of N. gonorrhoeae sRNAs expressed during in vitro growth (5-8). It is 
possible that post-transcriptional regulation by sRNAs plays an important role in 
N. gonorrhoeae gene expression during infection because of the relatively small 
number of DNA binding proteins expressed by gonococci compared to other 
Gram-negative bacteria.  
               In Streptococcus pneumoniae, Staphylococcus aureus, Enterococcus 
faecalis and Pseudomonas aeruginosa, expression of tRNAs have been reported 
to play a role in the development of antibiotic resistance through changes in 
membrane permeability (40-42).  Thus the increased expression of tRNAs 
observed during natural gonococcal infection relative to growth in vitro may 
represent an infection specific response to resist host-derived antimicrobial 
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components. The current study lacks an analysis of gonococcal gene expression 
during the course of natural during infection; it seems Iikely that the gonococcal 
transcriptome changes as disease progresses from initial attachment and 
invasion of host cells and the recruitment of immune cells.  Future studies will 
focus on such an analysis. 
 A number of bacterial factors expressed during mucosal infection likely 
contribute to development of gonococcal disease, to the persistent nature of the 
infection and to disparate symptomatic responses observed in men and women. 
However, the majority of these microbial factors have been identified through 
experimental conditions that may not faithfully replicate those encountered by 
bacteria in their specific host environment. It is likely that many pathogenicity-
associated factors expressed during natural infection are still unknown or 
undetected. Our studies using RNA-seq analysis are the first to define the 
gonococcal global transcriptome during natural mucosal infection. Collectively, 
we demonstrate that a large portion of the gonococcal genome is expressed 
during mucosal infection and that the gonococcus responds specifically to the 
anti-microbial and iron-deplete nature of the lower genital tract in women.  Future 
studies should focus on examining highly expressed genes for both therapeutic 
and vaccine studies, as well as genes specifically regulated as a function of 
infection to increase our knowledge of the molecular mechanisms of infection of 
this pathogen 
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Materials and Methods  
Ethics statement 
All subjects provided informed written consent.  The BUMC Institutional Review 
Boards (IRB) at the University of Massachusetts Medical School, Boston 
University Medical Campus (protocol number H-28858), and at the Institute of 
Dermatology, Chinese Academy of Medical Sciences Nanjing approved the study 
including the protocol described in this manuscript and have determined that the 
study meets the requirements set forth by the IRB.  
Subject samples 
Cervico-vaginal lavage samples (for RNA isolation) and swabs (for isolation of 
infecting strains) were obtained from four subjects attending the National Center 
for Sexually Transmitted Diseases (NCSTD) in Nanjing, China. Women were the 
exclusive sex-contacts of male subjects who had presented to the clinic with 
symptomatic urethritis; men were diagnosed with gonorrhea by Gram’s stain and 
culture (see below). Women were screened for N. gonorrhoeae infection by 
culture and PCR (see below), and tested positive by one or both methods. 
Cervico-vaginal lavage specimens were obtained according to standard 
collection methods (43), also demonstrated in the Microbicide Trials Network 
(MTN) training video used for NIAID/NIH sponsored clinical trials. Lavage fluid 
was stored in RLT Buffer (Qiagen) at -80°C and shipped to the United States on 
dry ice. Additional specimens were used for culturing and isolation/ identification 
of N. gonorrhoeae as described below. 
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Isolation, culture and polymerase chain reaction (PCR) to identify N. 
gonorrhoeae in cervical swab specimens  
Cervical swab specimens were taken and inoculated onto Thayer-Martin 
agar plates and cultured in candle jars at 36°C for 24 - 48 hr. Following growth on 
plates, bacteria were examined by colony morphology, Gram’s stain and oxidase 
testing. Colonies identified as N. gonorrhoeae by these criteria were isolated and 
sub-cultured onto chocolate agar plates overnight. The next day, colonies were 
resuspended in Trypticase Soy Broth/Glycerol and frozen at -70°C.  PCR testing 
to identify N. gonorrhoeae was performed utilizing primers directed against the 
gonococcal porA pseudogene (44) and touchdown PCR for amplification (45).  
Mean inhibitory concentrations (MICs) of individual strains against: penicillin, 
tetracycline, spectinomycin, ceftriaxone and ciprofloxacin were determined by the 
agar dilution method (46).  
Cervical swab specimens were also tested for Chlamydia trachomatis and 
Mycoplasma genitalium by PCR, and Ureaplasma urealyticum and Mycoplasma 
hominis by culture. Vaginal swabs were collected and tested for BV, candidiasis 
and trichomoniasis by wet mount microscopy. Wet mount slides were examined 
by trained medical technicians.  
For analysis of the transcriptome of N. gonorrhoeae in vitro, individual 
strains were grown on gonococcal base (GCB) agar plates for 16-18 hr at 37°C 
in 5% CO2 before they were resuspended in Chemically Defined Media (CDM) 
(47) containing ferric nitrate (100 µM final concentration).  Cultures were started 
	  	  219	  
at an O.D.600 of 0.1 and grown for 3 hrs before 2 ml cultures were centrifuged at 
2000 rpm for 5 min and the resulting pellet used for RNA extraction. 
 
RNA isolation 
RNA was isolated from cervico-vaginal lavage samples or from in vitro-
grown organisms using identical protocols to avoid method-based biases.  TRIzol 
(Invitrogen) was used to isolate RNA directly from cervico-vaginal samples or 
from in vitro-grown N. gonorrhoeae pellets. RNA was washed twice with 70% 
ethanol and treated with TURBO DNase (Ambion) per the manufacturer’s 
instructions. Eukaryotic rRNA was depleted from samples using the RiboMinus 
Kit (Invitrogen).  To avoid biases, in vitro-grown N. gonorrhoeae was also treated 
with the eukaryotic rRNA depletion kit.  Prokaryotic rRNA was depleted using the 
Microbe EXPRESS Kit (Ambion). Extractions were repeated twice to ensure 
sufficient depletion of rRNA.  At no time was EDTA used. All aqueous solutions 
used for RNA isolation were in Diethylpyrocarbonate (DEPC)-treated water. 
 
RNA sequencing and analysis 
Representative samples of RNA were prepared for sequencing using BioChain’s 
High Yield Directional mRNA Sample Prep Kit per the manufacturer’s 
instructions. cDNA libraries were electrophoresed on 8% Tris/Borate/EDTA 
(TBE) gels for 60 min at 140 V.  cDNA fragments between 200-500 base pairs 
were extracted from the gel in TE buffer with agitation and libraries were 
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analyzed on an Agilent Technologies 2100 Bioanalyzer to confirm cDNA library 
size and quantity.  Libraries were sequenced using 72 and 100 single-end base 
pair reads on an Illumina GAIIx or High-Seq machine respectively. All analysis of 
RNA-seq results was carried out using the Rockhopper program (21) with 
expression of genes defined in reads per kilobase per million reads (RPKM).  All 
reads from each subject’s sample were aligned to the three fully sequenced 
strains of N. gonorrhoeae in NCBI (NCCP11945, TCDCNGO8107 and FA1090) 
and the strain with the closest alignment (NCCP11945) used for downstream 
analysis.   
To define gonococcal genes that were regulated by infection, comparisons were 
made between individual subject samples that yielded an isolate (total of 3; the 
4th was positive by PCR only) and their corresponding infecting strains (total of 
3). This analysis considered genes to be regulated if they showed a fold change 
of > 3 between natural infection and growth in vitro.  Not having an isolate 
available, Subject 4 was not used for this analysis. An additional analysis was 
made between a composite average of all 4 cervico-lavage samples compared to 
a composite average of 3 gonococcal strains grown in vitro.  In this second 
analysis, availability of more than one sample permitted statistical analysis; 
genes were considered to be differentially expressed between two samples if the 
q value was < 0.05 and the fold-change was > 2. Categorization of genes was 
carried out using the NCBI RefSeq public database.  Gene information for the 
NCCP11945 strain was used, the same strain used for sequence alignment.  
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Functional enrichment was carried out after assigning all genes in the N. 
gonorrhoeae genome to one of 21 different categories.  Functional enrichment 
ratios were derived through determining the percentage of genes in a given set 
(for example, increased expression in vivo compared to growth in CDM) that 
were assigned to a particular function and dividing this number by the percentage 
of genes assigned to this function in the genome as a whole.  This ratio was used 
to interpret how enriched a given gene set was for a particular function. 
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